
<html lang="en"     class="pb-page"  data-request-id="94f4a1a6-1bf2-4f16-a72b-9e2bf4f18f9c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2013.56.issue-15;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm400634n;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Potent, Isoform-Selective Inhibitors of Histone Deacetylase Containing Chiral Heterocyclic Capping Groups and a N-(2-Aminophenyl)benzamide Binding Unit" /></meta><meta name="dc.Creator" content="Charles M.  Marson" /></meta><meta name="dc.Creator" content="Christopher J.  Matthews" /></meta><meta name="dc.Creator" content="Elena  Yiannaki" /></meta><meta name="dc.Creator" content="Stephen J.  Atkinson" /></meta><meta name="dc.Creator" content="Peter E.  Soden" /></meta><meta name="dc.Creator" content="Lena  Shukla" /></meta><meta name="dc.Creator" content="Nermina  Lamadema" /></meta><meta name="dc.Creator" content="N. Shaun B.  Thomas" /></meta><meta name="dc.Description" content="The synthesis of a novel series of potent chiral inhibitors of histone deacetylase (HDAC) is described that contain a heterocyclic capping group and a N-(2-aminophenyl)benzamide unit that binds in ..." /></meta><meta name="Description" content="The synthesis of a novel series of potent chiral inhibitors of histone deacetylase (HDAC) is described that contain a heterocyclic capping group and a N-(2-aminophenyl)benzamide unit that binds in ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 23, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400634n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400634n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400634n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400634n" /></link>
        
    
    

<title>Discovery of Potent, Isoform-Selective Inhibitors of Histone Deacetylase Containing Chiral Heterocyclic Capping Groups and a N-(2-Aminophenyl)benzamide Binding Unit | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400634n" /></meta><meta property="og:title" content="Discovery of Potent, Isoform-Selective Inhibitors of Histone Deacetylase Containing Chiral Heterocyclic Capping Groups and a N-(2-Aminophenyl)benzamide Binding Unit" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0015.jpeg" /></meta><meta property="og:description" content="The synthesis of a novel series of potent chiral inhibitors of histone deacetylase (HDAC) is described that contain a heterocyclic capping group and a N-(2-aminophenyl)benzamide unit that binds in the active site. In vitro assays for the inhibition of HDAC1, HDAC2, HDAC3-NCoR1, and HDAC8 by the N-(2-aminophenyl)benzamide 24a gave respective IC50 values of 930, 85, 12, and 4100 nM, exhibiting class I selectivity and potent inhibition of HDAC3-NCoR1. Both imidazolinone and thiazoline rings are shown to be effective replacements for the pyrimidine ring present in many other 2-(aminophenyl)benzamides previously reported, an example of each ring system at 1 μM causing an increase in histone H3K9 acetylation in the human cell lines Jurkat and HeLa and an increase in cell death consistent with induction of apoptosis. Inhibition of the growth of MCF-7, A549, DU145, and HCT116 cell lines by 24a was observed, with respective IC50 values of 5.4, 5.8, 6.4, and 2.2 mM." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400634n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400634n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400634n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400634n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400634n&amp;href=/doi/10.1021/jm400634n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6156-6174</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4006302" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400644z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Potent, Isoform-Selective Inhibitors of Histone Deacetylase Containing Chiral Heterocyclic Capping Groups and a <i>N</i>-(2-Aminophenyl)benzamide Binding Unit</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+M.++Marson">Charles M. Marson</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Matthews">Christopher J. Matthews</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elena++Yiannaki">Elena Yiannaki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+J.++Atkinson">Stephen J. Atkinson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+E.++Soden">Peter E. Soden</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lena++Shukla">Lena Shukla</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nermina++Lamadema">Nermina Lamadema</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=N.+Shaun+B.++Thomas">N. Shaun B. Thomas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Chemistry, University College London, Christopher Ingold Laboratories, 20 Gordon Street, London WC1H OAJ, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Epinova DPU, Immuno-Inflammation Therapy Area Unit, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts SG1 2NY, U.K.</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Allergic Inflammation DPU, Respiratory Therapy Area Unit, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts SG1 2NY, U.K.</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Haematological Medicine, Leukemia Sciences Laboratories, Rayne Institute, King’s College London, 123 Coldharbour Lane, London SE5 9NU, U.K.</span></div><div class="corresp-info"><strong>*</strong>Fax: +44(0)20 7679 7463. E-mail: <a href="/cdn-cgi/l/email-protection#fe9dd093d0939f8c8d9190be8b9d92d09f9dd08b95"><span class="__cf_email__" data-cfemail="85e6abe8abe8e4f7f6eaebc5f0e6e9abe4e6abf0ee">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400634n&amp;href=/doi/10.1021%2Fjm400634n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6156–6174</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 6, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 April 2013</li><li><span class="item_label"><b>Published</b> online</span>23 July 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 August 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400634n" title="DOI URL">https://doi.org/10.1021/jm400634n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6156%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DCharles%2BM.%2BMarson%252C%2BChristopher%2BJ.%2BMatthews%252C%2BElena%2BYiannaki%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D15%26contentID%3Djm400634n%26title%3DDiscovery%2Bof%2BPotent%252C%2BIsoform-Selective%2BInhibitors%2Bof%2BHistone%2BDeacetylase%2BContaining%2BChiral%2BHeterocyclic%2BCapping%2BGroups%2Band%2Ba%2BN-%25282-Aminophenyl%2529benzamide%2BBinding%2BUnit%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6174%26publicationDate%3DAugust%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400634n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3133</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">40</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400634n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Potent, Isoform-Selective Inhibitors of Histone Deacetylase Containing Chiral Heterocyclic Capping Groups and a N-(2-Aminophenyl)benzamide Binding Unit&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;M. Marson&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Matthews&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Yiannaki&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;J. Atkinson&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;E. Soden&quot;},{&quot;first_name&quot;:&quot;Lena&quot;,&quot;last_name&quot;:&quot;Shukla&quot;},{&quot;first_name&quot;:&quot;Nermina&quot;,&quot;last_name&quot;:&quot;Lamadema&quot;},{&quot;first_name&quot;:&quot;N.&quot;,&quot;last_name&quot;:&quot;Shaun B. Thomas&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;6156-6174&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400634n&quot;},&quot;abstract&quot;:&quot;The synthesis of a novel series of potent chiral inhibitors of histone deacetylase (HDAC) is described that contain a heterocyclic capping group and a N-(2-aminophenyl)benzamide unit that binds in the active site. In vitro assays for the inhibition of HDAC1, HDAC2, HDAC3-NCoR1, and HDAC8 by the N-(2-aminophenyl)benzamide 24a gave respective IC50 values of 930, 85, 12, and 4100 nM, exhibiting class I selectivity and potent inhibition of HDAC3-NCoR1. Both imidazolinone and thiazoline rings are shown to be effective replacements for the pyrimidine ring present in many other 2-(aminophenyl)benzamides previously reported, an example of each ring system at 1 μM causing an increase in histone H3K9 acetylation in the human cell lines Jurkat and HeLa and an increase in cell death consistent with induction of apoptosis. Inhibition of the growth of MCF-7, A549, DU145, and HCT116 cell lines by 24a was observed, with respective IC50 values of 5.4, 5.8, 6.4, and 2.2 mM.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400634n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400634n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400634n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400634n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400634n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400634n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400634n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400634n&amp;href=/doi/10.1021/jm400634n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400634n" /></input><a href="/doi/pdf/10.1021/jm400634n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400634n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400634n%26sid%3Dliteratum%253Aachs%26pmid%3D23829483%26genre%3Darticle%26aulast%3DMarson%26date%3D2013%26atitle%3DDiscovery%2Bof%2BPotent%252C%2BIsoform-Selective%2BInhibitors%2Bof%2BHistone%2BDeacetylase%2BContaining%2BChiral%2BHeterocyclic%2BCapping%2BGroups%2Band%2Ba%2BN-%25282-Aminophenyl%2529benzamide%2BBinding%2BUnit%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D15%26spage%3D6156%26epage%3D6174%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jmcmar.2013.56.issue-15/production/jmcmar.2013.56.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The synthesis of a novel series of potent chiral inhibitors of histone deacetylase (HDAC) is described that contain a heterocyclic capping group and a <i>N</i>-(2-aminophenyl)benzamide unit that binds in the active site. In vitro assays for the inhibition of HDAC1, HDAC2, HDAC3-NCoR1, and HDAC8 by the <i>N</i>-(2-aminophenyl)benzamide <b>24a</b> gave respective IC<sub>50</sub> values of 930, 85, 12, and 4100 nM, exhibiting class I selectivity and potent inhibition of HDAC3-NCoR1. Both imidazolinone and thiazoline rings are shown to be effective replacements for the pyrimidine ring present in many other 2-(aminophenyl)benzamides previously reported, an example of each ring system at 1 μM causing an increase in histone H3K9 acetylation in the human cell lines Jurkat and HeLa and an increase in cell death consistent with induction of apoptosis. Inhibition of the growth of MCF-7, A549, DU145, and HCT116 cell lines by <b>24a</b> was observed, with respective IC<sub>50</sub> values of 5.4, 5.8, 6.4, and 2.2 mM.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58484" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58484" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Epigenetic therapy represents a paradigm shift in terms of the selection of the biology to drug targets.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Of the post-translational modifications relevant to disease, histone protein acetylation status has received much attention in regard to potential for epigenetic cancer therapy. Deacetylation of histone protein at the e-amino group of lysine residues in the N-terminal tails of core histones in the nucleosome through the action of histone deacetylases (HDACs) increases the number of protonated lysine termini; those bind closely to the negatively charged DNA phosphate groups, leading to chromatin compaction that reduces accessibility of transcription factors to DNA<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and hence to transcriptional repression.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> Such hypoacetylation has been associated with precancerous or malignant states, and relief of transcriptional repression present in various leukemias<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> has been achieved using HDAC inhibitors.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> In addition, the inappropriate recruitment of HDAC enzymes by oncogenic proteins may alter gene expression in favor of arrested differentiation and/or unregulated proliferation.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> HDAC inhibitors reduce cancer cell proliferation by induction of cell cycle arrest, differentiation, and/or apoptosis.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10-13)</a> HDAC inhibitors have been shown to affect several pathways involving proliferation and differentiation, including the TGF-β and JAK-STAT pathways and myc and Bcl-6 expression in lymphoid cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of clinical HDAC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">HDAC inhibitors are a promising class of anticancer agents<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> of which those currently approved for clinical use (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) comprise three structural classes: hydroxamic acids, including vorinostat (suberoylanilide hydroxamic acid, Merck & Co., for the treatment of cutaneous T-cell lymphoma),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> the aminoanilides mocetinosat (MethylGene Inc., for the treatment of myelodysplastic syndromes and leukemia, especially acute myelogenous leukemia),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and MS-275 (Syndax Pharmaceuticals/Schering AG, for the treatment of metastatic melanoma),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and the cyclic disulfide romidepsin (cyclodepsipeptide or FK-228, Gloucester Pharmaceuticals, for the treatment of cutaneous T-cell lymphoma).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> With the wide range of known hydroxamic acids available, mainly with limitations of efficacy and toxicity, and the limited number of potential disulfide inhibitors, we sought alternative structures to mocetinosat that were also aminoanilides and could be expected to show similar slow, tight-binding<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> to HDACs, the slow decomplexation also leading to prolonged inhibitory effects and longer intervals between dosing.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> In addition, mocetinostat did not show acquired resistance, at least to HCT116 colon tumor cells, unlike hydroxamic acid HDAC inhibitors.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> We describe here the synthesis and preliminary evaluation of new classes of aminoanilides containing chirality as part of a heterocyclic ring.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02625" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02625" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A series of analogues having in common the linker and cap region of mocetinostat was prepared by coupling carboxylic acid <b>7</b> with a set of arylamines (Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). In order to ensure regiocontrolled acylation, routes via the corresponding <i>o</i>-nitroanilines were developed (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SOCl<sub>2</sub>, MeOH, reflux, 16 h; (b) PhCH<sub>2</sub>Br, Na<sub>2</sub>CO<sub>3</sub>, DMF, 20 °C, 18 h; (c) <b>2a</b>, DIBAL, THF–CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 1 h, then 20 °C, 1 h, then 20 °C, 3 h; (d) TBSCl, imidazole, DMF, 20 °C, 16 h; (e) PhB(OH)<sub>2</sub>, (Ph<sub>3</sub>P)<sub>4</sub>Pd, Na<sub>2</sub>CO<sub>3</sub>, aqueous 1,2-dimethoxyetjame, 80 °C, 48 h.</p></p></figure><div class="NLM_p">Methyl 4-(guanidinomethyl)benzoate<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and (<i>E</i>)-3-(dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> were heated in propan-2-ol for 20 h at reflux to give methyl 4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzoate as previously described<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (67%); hydrolysis of this ester to the carboxylic acid <b>7</b> was achieved using aqueous lithium hydroxide (24 h, 20 °C, 97%).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Condensation of acid <b>7</b> with a range of arylamines (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) afforded the corresponding aminoanilides. The nitroaniline derivatives (e.g., Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) could not be directly acylated; however, deprotonation of the aromatic amino group using NaH permitted coupling with carboxylic acids activated by (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) or, for the preparation of <b>8h</b> and <b>8i</b>, with the acid chloride of <b>7</b>. The aminoanilides were further modified by standard functional group manipulations to afford <b>8a</b>–<b>i</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SOCl<sub>2</sub>, reflux, 3 h; (ii) naphthalene-2,3-diamine, Et<sub>2</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, DMF, 0 °C, 30 min, then 20 °C, 1 h; (b) BOP, <b>6</b>, pyridine, then NaH, 20 °C, 7 h; (c) H<sub>2</sub>, 10% Pd/C, MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C, 6 h; (d) <b>5</b>, NaH, BOP, pyridine, Et<sub>3</sub>N,20 °C 2.5 h; (e) FeSO<sub>4</sub>·7H<sub>2</sub>O, aqueous NH<sub>3</sub>, EtOH, 60 °C, 4 h; (f) 3-methoxyphenylene-1,2-diamine, BOP, Et<sub>3</sub>N, DMF, 20 °C, 27 h; (g) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C h; (h) BOP, <b>4</b>, pyridine, then NaH, 20 °C, 2.5 h; (i) H<sub>2</sub>, 10% Pd/C, MeOH, CHCl<sub>3</sub>, 20 °C, 7 h; (j) SnCl<sub>2</sub>·2H<sub>2</sub>O, OAc, 1:1:1 THF/MeOH/H<sub>2</sub>O, 20 °C, 21 h, then 50 °C, 1 h; (k) NaH and <b>2b</b>, anhydrous pyridine, −10 °C, 5 min; then addition of acid chloride (<b>7</b>, SOCl<sub>2</sub>, toluene, reflux, 3 h), 20 °C, 2 h; (l) H<sub>2</sub>, 10% Pd/C, MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C, 5.5 h; (m) H<sub>2</sub>, 10% Pd/C, MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C, 45 h; (n) phenylene-1,2-diamine, BOP, DMF, 20 °C, 24 h.</p></p></figure><div class="NLM_p">Substituted imidazolin-4-ones (Schemes <a class="ref internalNav" href="#sch3" aria-label="3">3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) were prepared from the corresponding thiohydantoins <b>10</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and <b>15</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> During S-methylation to give the corresponding methylthio derivatives <b>11</b> and <b>16</b>, racemization occurred presumably because of enolate formation in the presence of K<sub>2</sub>CO<sub>3</sub>. Those 2-(methylthio)imidazolin-4-ones were reacted with 4-(methylamino)benzoic acid in ethanol at reflux to give the corresponding carboxylic acids <b>12</b> and <b>17</b> which could then be converted into the aminoanilides <b>13</b> and <b>18</b> by BOP-mediated amide formation and subsequent deprotection of <b>18</b> to give <b>19</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NH<sub>4</sub>SCN, Ac<sub>2</sub>O, 100 °C (1 h, <b>9a</b>; 10 min, <b>9b</b>); (b) Mel, K<sub>2</sub>CO<sub>3</sub>, MeCN, 20 °C, 2.5 h; (c) 4-(methylamino)benzoic acid, ethanol, reflux, 16 h; (d) BOP, Et<sub>3</sub>N, phenylene-1,2-diamine, DMF, 20 °C, 3.5 h.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethoxycarbonyl isothiocyanate, pyridine, MeCN, 20 °C, 18 h; (b) Mel, K<sub>2</sub>CO<sub>3</sub>, MeCN, 20 °C, 2.5 h; (c) 4-(methylamino)benzoic acid, ethanol, reflux, 4 h (18 h for <b>17a</b>); (d) BOP, Et<sub>3</sub>N, phenylene-1,2-diamine, DMF, 20 °C, 3 h; (e)TFA, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C, 3 h.</p></p></figure><div class="NLM_p">In view of the lack of stereointegrity in the imidazolin-4-one series, an unsaturated five-membered ring system that lacked a carbonyl group was sought; a set of 2-aminothiazoline derivatives <b>24</b> was prepared (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Several approaches were attempted, the first by analogy with Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Addition of 4-(methylamino)benzoic acid to 2-(methylthio)-4-substituted thiazolines failed, although addition of the corresponding methyl ester was successful. However, this could not be progressed because phenylene-1,2-diamine could not be satisfactorily reacted with the carboxylic acids derived from latter adducts. In the second approach, reaction of <i>N</i>-(2-aminophenyl)-4′-(aminomethyl)benzamide, or its Boc derivative <b>21b</b>, with 2-(methylthio)-4-substituted thiazolines was also unsuccessful.</div><div class="NLM_p">Since displacement of the 2-thiomethyl group by substituted benzylamines could not be achieved, advantage was taken of the S-nucleophilic nature of thioureas (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). By analogy with previous work,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> the isothiocyanate <b>22</b> was reacted with enantiopure 1,2-amino alcohols to give the corresponding thioureas <b>23</b> which underwent acid-catalyzed ring closure to the desired 2-aminothiazolines <b>24</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). However, ring closure to the thiazoline was unsuccessful for <b>24</b>, where R = (3-indolyl)methyl, and for <b>24c</b>. Consequently, Mitsunobu conditions<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> were applied to <b>23c</b> and afforded the desired thiazoline which was then deprotected to <b>24c</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>3</sub>N, (COCl)<sub>2</sub>, DMF, CH<sub>2</sub>Cl<sub>2</sub>; then <i>N</i>-Boc-phenylene-1,2-diamine, 20 °C, 20 h; (b) K<sub>2</sub>CO<sub>3</sub>, aqueous MeOH, 70 °C, 4 h; (c) CS<sub>2</sub>, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C, 10 min, then 0 °C and TsCl, 10 min; (d) 1,2-amino alcohol, MeCN, 20 °C, 16 h; (e) concentrated HCl, 90 °C (for all <b>23</b> except <b>23c</b>); (f) diethyl azodicarboxylate, Ph<sub>3</sub>P, THF, 20 °C, 75 min, then HCl in Et<sub>2</sub>O, 20 °C, 5 h (for <b>23c</b>).</p></p></figure><div class="NLM_p">The sulfur-linked thiazolines <b>30</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>) were prepared by S-alkylation of the corresponding thiazoline-2-thiones.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The method was established by reaction of the chloromethyl compound <b>28a</b> with <b>26a</b>, affording after Boc deprotection (conditions d, Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>) the thiazoline <b>30a</b>. The unprotected alkylating agent <b>28b</b> was then tested and proved to be effective, affording the thiazolines <b>30b</b> and <b>30c</b>. To our knowledge, the use of preassembled aminoanilide linkers of types <b>22</b> and <b>28</b> that contain electrophilic centers appropriate for subsequent reaction is a novel approach to aminoanilide HDAC inhibitors; this route has greater convergence and also avoids a late-stage amination with the feebly nucleophilic 1,2-phenylenediamine derivative.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CS<sub>2</sub>, aqueous KOH, reflux, 20 h; (b) <i>N</i>-Boc-phenylene-1,2-diamine, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, −10 to 20 °C, 2 h; (c) <b>28a</b>, Nal, acetone, reflux, 2 h; then <b>26a</b>, 20 °C, 28 h; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C, 2.5 h; (e) <b>26b/26c</b>, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 17 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62387" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62387" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To our knowledge, few SAR data or details of mocetinosat analogues have been reported and no chiral heterocyclic analogues have been reported; indeed some planar analogues showed less potency to the extent they were evaluated, namely, against HDAC1 and a few cell lines.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> A 5-(2-thienyl) substituent on the <i>o</i>-phenylenediamine ring enhanced potency in some cases;<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> regarding the zinc-binding group, replacement of the 2-amino group by hydroxy retained activity in some aminoanilides,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> but that specific analogue of mocetinostat has not been described. Since effects of 4-substitution on the terminal aryl ring of mocetinostat were largely unknown,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> a range of 4-substituted derivatives of mocetinostat were prepared and evaluated (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Of that series, 4-methoxy and 4-hydroxy substituents (entries 4 and 5) were most potent against HDAC2 and HDAC3-NCoR1. For both isoforms, the 4-methoxy substituent conferred some 6-fold greater potency than the 4-hydroxy compound. An aminonaphthyl terminus (entry 1) conferred good selectivity for HDAC3-NCoR1 over all other isoforms tested, including HDAC1 (>20 mM). In contrast, a 4-phenyl derivative (entry 2) showed no inhibition, suggesting that there is a strict limit on the length of the 4-substituent to retain HDAC3 inhibition. The greater inhibition of HDAC2 and HDAC3-NCoR1 for entries 4 and 5 in this series may reflect a stronger binding to zinc arising from increased electron density provided by the mesomeric effect of the methoxy and hydroxy groups, respectively. Since investigation of the series of compounds <b>8a</b>–<b>i</b> did not disclose a substituted <i>N</i>-(2-aminophenyl)benzamide unit of improved potency, the binding moiety present in mocetinostat was used in further studies.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Inhibition of Histone Deacetylase Isoforms by Substituted Benzamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0012.gif" alt="" id="fx1" /></img><div></div></div><div class="NLM_p">There have been few reports of alternative ring systems to replace the pyrimidine ring in mocetinostat; only planar, fused rings have been substituted, leading to high molecular weight compounds with nonoptimal aqueous solubility, albeit with medicinal potential.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Our view was that five-membered semisaturated ring systems could prove to be effective, also offering the possibility of introducing a chiral center, as well as variable substituents that would be alternatives to the terminal 3-pyridyl ring present in mocetinostat. The imidazolin-4-one ring indeed proved to be effective (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, entries 1–6), these compounds showing appreciable isoform selectivity for HDAC3-NCoR1. Of particular note is entry 6; this suggests that the imidazolin-4-one ring is a good mimic of pyrimidine and that the 5-phenyl substituent occupies a location in HDAC closely similar to that of the 3-pyridyl group in mocetinostat. Entry 6 showed at least as great potency as did mocetinostat against HDAC3-NCoR1.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Inhibition of Histone Deacetylase Isoforms as a Function of Cap Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0013.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">A thiazoline ring was next examined in order to establish whether a single nitrogen atom in the ring was compatible with HDAC inhibitory activity; that is the case, as shown by entries 7–9 (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Once again, a phenyl substituent was the most potent in inhibiting HDAC3-NCoR1, with the 2-arylmethylthio linkage in entry 9 being notable as the first <i>N</i>-(2-aminophenyl)benzamide HDAC inhibitor lacking an aminomethyl linker that exhibits an appreciably low nanomolar IC<sub>50</sub> value. Its aminomethyl analogue (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, entry 1) was an even more potent inhibitor and likely more potent than mocetinostat against HDAC3-NCoR1. For inhibition of HDAC1 and HDAC2, a (4<i>R</i>)-configuration (entries 2, 5, and 7) shows somewhat greater inhibition than the corresponding (4<i>S</i>)-enantiomer (entries 1, 4, and 6). However for <b>24a</b>/<b>24b</b>, the (4<i>S</i>)-enantiomer (entry 1) is the more potent inhibitor of HDAC3-NCoR1. Although phenyl, 4-hydroxyphenyl, and benzyl monosubstitution was consistent with good potency, bulkier 4,5-diphenyl substitution (entries 8 and 9) was found to be deleterious to all HDAC inhibition investigated.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Inhibition of Histone Deacetylase Isoforms by 2-Aminothiazolines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0014.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_p">As expected, most thiazolines prepared (Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) inhibited HDAC8 only weakly, binding to the cap region being ineffective owing to the short tunnel that leads to the catalytic site in HDAC8. As for compounds studied previously,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> inhibition of HDAC6 by any of the novel benzamides was not detected. Molecular modeling of thiazoline <b>24a</b> bound to HDAC3 (modification of PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A69">4A69</a>) showed the coordination to zinc to both the carbonyl group (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) of the benzamide linkage and to the aniline nitrogen atom. The largely hydrophobic tunnel (including Leu266, Phe144, Phe200) accommodates the benzamide ring, whereas contacts to the protein periphery (including Phe199) are made by the terminal phenyl and thiazoline rings.</div><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Molecular modeling of thiazoline <b>24a</b> (turquoise) bound to HDAC3 (derived by modification of PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A69">4A69</a> using AutoDockTools 1.5.4) and docked using AutoDock Vina.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> A side-on view of <b>24a</b> is depicted in PyMOL with residues bound to zinc and other residues near <b>24a</b> shown in pink.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Two benzamide inhibitors, including MS-275, were previously shown to exhibit slow, tight-binding kinetics for HDAC1, HDAC2, and HDAC3, although the mechanism and rate of binding for HDAC3 differed from HDAC1 and HDAC2.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> This assay, in our hands, identified a two-step binding mechanism for the binding of mocetinostat to HDAC3-NCoR1 and additionally revealed compound <b>24a</b> as a slow tight-binding inhibitor of HDAC3-NCoR1 (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for graphs). These results contrasted with the hydroxamic acid <b>31</b> which showed the expected fast, competitive inhibition of HDAC3-NCoR1. The above slow tight-binding behavior is therefore attributable to the <i>N</i>-(2-aminophenyl)benzamide moiety.</div><div class="NLM_p">Thiazoline <b>24a</b> possesses good physicochemical properties as exemplified by its calculated lipophilicity value (Daylight clogP = 2.91), measured lipophilicity values (Chrom log <i>D</i><sub>pH7.4</sub> <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> = 4.24; Chrom log <i>P</i> <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> = 4.65), and its calculated polar surface area (tpsa <a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> = 79.5 Å<sup>2</sup>). Inhibitor <b>24a</b> has good measured solubility, with chemiluminescent nitrogen detection solubility<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> of 239 μM, and is also predicted to have good cell permeability (artificial membrane permeability<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> of 510 nm/s). The cytochrome P450 inhibition profile of <b>24a</b> showed only weak inhibition of all tested isoforms except CYP2D6 (isoform IC<sub>50</sub> values: 2C19 = 32 μM; 2C9 = 16 μM; 2D6 = 80 nM; 3A4 (Vivid Red substrate) = 25 μM; 3A4 (Vivid Green substrate) = 16 μM). Owing to the inhibition of CYP2D6, the risk of drug–drug interactions would need to be evaluated further during any development of <b>24a</b>.</div><div class="NLM_p">Cell growth inhibition data for four cell lines are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Despite good in vitro inhibitory potency against HDAC2 and HDAC3, the imidazolin-4-ones <b>19a</b> and <b>19c</b> showed poor inhibition of the cancer cell lines. However, thiazolines <b>24a</b>, <b>24d</b>, and <b>30b</b> were more potent, having low micromolar IC<sub>50</sub> values for the four cell lines tested, their pIC<sub>50</sub> values approaching those of mocetinostat and vorinostat.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Cell Growth Inhibition Data (IC<sub>50</sub>)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">A549</th><th class="colsep0 rowsep0" align="center">DU145</th><th class="colsep0 rowsep0" align="center">HCT116</th><th class="colsep0 rowsep0" align="center">MCF-7</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">16.6 ± 0.22</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19c</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">18.2 ± 0.15</td><td class="colsep0 rowsep0" align="left">30.1 ± 0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24a</b></td><td class="colsep0 rowsep0" align="left">5.78 ± 0.03</td><td class="colsep0 rowsep0" align="left">6.40 ± 0.02</td><td class="colsep0 rowsep0" align="left">2.17 ± 0.03</td><td class="colsep0 rowsep0" align="left">5.43 ± 0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24d</b></td><td class="colsep0 rowsep0" align="left">6.37 ± 0.03</td><td class="colsep0 rowsep0" align="left">5.45 ± 0.06</td><td class="colsep0 rowsep0" align="left">1.95 ± 0.05</td><td class="colsep0 rowsep0" align="left">3.09 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30b</b></td><td class="colsep0 rowsep0" align="left">9.53 ± 0.38</td><td class="colsep0 rowsep0" align="left">2.80 ± 0.10</td><td class="colsep0 rowsep0" align="left">3.64 ± 0.21</td><td class="colsep0 rowsep0" align="left">9.91 ± 0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mocetinostat</td><td class="colsep0 rowsep0" align="left">1.73 ± 0.03</td><td class="colsep0 rowsep0" align="left">2.06 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.70 ± 0.04</td><td class="colsep0 rowsep0" align="left">1.26 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vorinostat</td><td class="colsep0 rowsep0" align="left">2.27 ± 0.04</td><td class="colsep0 rowsep0" align="left">2.58 ± 0.02</td><td class="colsep0 rowsep0" align="left">1.39 ± 0.03</td><td class="colsep0 rowsep0" align="left">2.29 ± 0.06</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Average of triplicate runs, μM.</p></div></div></div><div class="NLM_p">Changes in histone acetylation status were assayed by analyzing histone H3 acetylated on lysine 9 (H3K9Ac) following addition of <i>N</i>-(2-aminophenyl)benzamides. To determine whether mocetinostat, <b>19c</b>, or <b>24a</b> increase histone H3 acetylation levels, the human cell lines HeLa and Jurkat were cultured in the presence of each compound (10 or 1 μM) or an equivalent volume of the diluent (DMSO) was added as the control. The cells were cultured for 24 h, and H3K9Ac was analyzed by Western blotting. The data show that 10 or 1 μM mocetinostat and <b>24a</b> both cause an increase in histone H3K9Ac with respect to histone H3 expression in Jurkat and in HeLa cells. Imidazolin-4-one <b>19c</b> (10 or 1 μM) also caused an increase in H3K9Ac in Jurkat cells but not in HeLa cells (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). These data are consistent with an inhibition of endogenous cellular HDAC activity which would cause net acetylation of histone H3K9.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Analysis of histone H3 acetylation by Western blotting: Jurkat and HeLa cells cultured for 24 h with DMSO control and mocetinostat and <b>19c</b> and <b>24a</b> (each at 10 and 1 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Previous studies showed that mocetinostat causes an increase in H3K9Ac in HeLa cells and leads to cell death by apoptosis.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Consequently, in the present study flow cytometry analyses of DNA and protein content of cells cultured with the compounds were carried out to determine whether <b>19c</b> and <b>24a</b> also cause apoptosis. These data (Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) show that mocetinostat (10 or 1 μM) and <b>24a</b> increase the percentage of Jurkat cells with sub-G<sub>1</sub> DNA content, consistent with an induction of apoptosis. However, HeLa cells cultured with either <b>19c</b> or <b>24a</b> at 10 μM appeared to accumulate in G<sub>2</sub>/M, whereas there was an increase in the percentage of Jurkat cells in S-phase, indicating a difference in underlying mechanisms in these two cell types. In contrast, culturing Jurkat cells with <b>19c</b> did not result in the appearance of cells with sub-G<sub>1</sub> DNA content and did not significantly alter the percentage of cells in each cell cycle phase. The poly-ADP ribose polymerase (PARP) protein is degraded during apoptosis by activation of caspase 3 as was here observed in Jurkat cells (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). However, no apparent cleavage of PARP occurred in HeLa cells, consistent with data previously reported<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> on apoptosis induced by mocetinostat.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Analysis of DNA and protein content using compounds at 10 μM. Samples cultured as described in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> were stained with dyes to identify protein and DNA, followed by flow cytometry. Shown is the percentage of cells in G<sub>0</sub>/G<sub>1</sub>, S, and G<sub>2</sub>/M cell cycle phases and with sub-G<sub>1</sub> DNA content and low protein content characteristic of apoptotic cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Analysis of DNA and protein content using compounds at 1 μM. Samples cultured as described in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> were stained with dyes to identify protein and DNA, followed by flow cytometry. Shown is the percentage of cells in G<sub>0</sub>/G<sub>1</sub>, S, and G<sub>2</sub>/M cell cycle phases and with sub-G<sub>1</sub> DNA content and low protein content characteristic of apoptotic cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Summary</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54040" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54040" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For the first time, chiral cyclic capping groups have been shown to be effective for <i>N</i>-(2-aminophenyl)benzamide HDAC inhibitors. Inhibition of HDAC1, HDAC2, and HDAC3 (class I) was generally potent, and in a few of the examples studied, this novel class of inhibitors exceeded (low nanomolar IC<sub>50</sub>) potency against HDAC3-NCoR1, compared with mocetinostat, one of the most potent benzamide HDAC inhibitors previously reported. The present study shows the importance of future work to address the central question of whether improved isoform selectivity and potency over existing <i>N</i>-(2-aminophenyl)benzamide inhibitors can be achieved by new, enantiopure compounds of the appropriate absolute configuration and of the classes here disclosed. This study has shown the efficacy of chiral heterocyclic capping groups, in particular substituted imidazolin-4-ones and thiazolines, especially the latter, which conferred low-nanomolar potency for the inhibition of HDAC3-NCoR1 and may be of use as an alternative to the 2-[3-(3′-pyridyl)]pyrimidinyl group present in the clinical benzamide inhibitor MGCD0103. Both mocetinostat and thiazoline <b>24a</b> (each at 1 μM) increased histone H3K9 acetylation in Jurkat and HeLa cell lines and caused cell death of Jurkat cells consistent with induction of apoptosis. Additionally, convergent routes were established to HDAC inhibitors containing a variety of chiral heterocyclic capping groups by use of a preassembled <i>N</i>-(2-aminophenyl)benzamide unit, new methodology that should apply to heterocyclic systems other than those described here.</div><div class="NLM_p last">Further work is needed to establish the detailed advantages of this novel class of HDAC inhibitors over existing <i>N</i>-(2-aminophenyl)benzamides, but these may include benefits from the absence of the commonly required 3-pyridyl terminal capping group and its metabolism to the <i>N</i>-oxide and, of particular interest, a new means by which HDAC isoform selectivity could be increased. This study demonstrates that, in terms of HDAC inhibition, other ring systems can replace either of or both the pyridine and pyrimidine rings present in mocetinostat and hence supports design of new, chiral, class I selective HDAC inhibitors.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25836" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25836" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Chemistry</h3><div class="NLM_p">All chemicals were used as supplied except 1,2-phenylenediamine, which was recrystallized from ethanol. Solvents used were reagent grade, and anhydrous solvents were obtained from Anhydrous Engineering (U.S.) solvent systems after passing through an alumina column. Compound homogeneity was monitored by ascending thin-layer chromatography, performed on Merck 0.2 mm aluminum-backed silica gel 60 F<sub>254</sub> plates, and visualized using an alkaline potassium permanganate dip or by ultraviolet light. Flash column chromatography was performed using Merck 0.040–0.063 mm, 230–400 mesh silica gel. Evaporation refers to the removal of solvent under reduced pressure. Melting points were determined using an Electrothermal digital melting point apparatus. Infrared (IR) spectra were recorded on a Perkin-Elmer spectrum 100 FT-IR spectrometer as neat powders or as thin films. <sup>1</sup>H NMR spectra were recorded at 300 MHz on a Bruker AMX300 spectrometer, at 400 MHz on a Bruker AMX400, at 500 MHz on a Bruker Avance 500 spectrometer, or at 600 MHz on a Bruker Avance 600 spectrometer in the stated solvent. Chemical shifts are reported in δ (ppm) relative to the internal reference tetramethylsilane. Mass spectra were obtained on a Fisons VG70-SE mass spectrometer or Thermo Finnigan MAT900xp instrument. Purity of tested compounds was assessed to be at least 95% by HPLC analysis unless indicated otherwise. Parameters were Dionex on an Supelco Discovery BIO widepore C18 column (250 mm × 4.6 mm, 10 μm particle size) using gradient elution of acetonitrile in water, 2–98% for 20 min at a flow rate of 1 mL/min with detection at 254 nm wavelength. For all samples 0.1% TFA was added to both eluents.</div><div class="NLM_p last">The following compounds were prepared according to the literature: methyl 4-amino-3-nitrobenzoate (<b>2a</b>);<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> 2-nitro-4-phenylaniline (<b>6</b>);<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> methyl 4-(guanidinomethyl)benzoate;<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (<i>E</i>)-3-(dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one;<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> methyl 4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzoate;<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> 4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzoic acid (<b>7</b>);<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a><i>N</i>-(2-aminophenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide (mocetinostat);<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (5<i>S</i>)-1-acetyl-5-benzyl-2-thiohydantoin (<b>10a</b>);<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (5<i>S</i>)-1-acetyl-5-(1<i>H</i>-indol-3-ylmethyl)-2-thiohydantoin (<b>10b</b>);<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><i>N</i>-(<i>tert-</i>butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-phenylalanine (<b>14a</b>),<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a><i>N</i>-(<i>tert-</i>butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-tryptophan (<b>14b</b>);<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a><i>N-(tert</i>-butoxycarbonyl)-<span class="smallcaps smallerCapital">d</span>-phenylglycine (<b>14c</b>);<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> (5<i>S</i>)-1-(<i>tert-</i>butoxycarbonyl)-5-benzyl-2-thiohydantoin (<b>15a</b>);<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> 4-[(trifluoroacetamido)methyl]benzoic acid (<b>20</b>);<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a><i>tert</i>-butyl (2-aminophenyl)carbamate);<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a><i>tert</i>-butyl <i>N</i>-(2-{4-[(trifluoroacetamido)methyl]benzamido}phenyl)carbamate (<b>21a</b>);<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a><i>tert</i>-butyl <i>N</i>-{2-[4-(aminomethyl)benzamido]phenyl}carbamate (<b>21b</b>);<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a><span class="smallcaps smallerCapital">d</span>-phenylalaninol;<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a><span class="smallcaps smallerCapital">l</span>-phenylalaninol (<b>25a</b>);<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> (2<i>R</i>)-2-amino-2-phenylethan-1-ol;<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> (2<i>S</i>)-2-amino-2-phenylethan-1-ol (<b>25c</b>);<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (4<i>S</i>)-4-benzyl-1,3-thiazolidine-2-thione (<b>26a</b>);<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> (4<i>S</i>)-4-phenyl-1,3-thiazolidine-2-thione (<b>26c</b>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> <i>N</i>-(2-Amino-4-bromophenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide (<b>8c</b>)</h3><div class="NLM_p last">To a solution of iron(II) sulfate heptahydrate (1.87 g, 6.74 mmol) in water (4 mL) and 30% aqueous ammonia (4 mL) heated to 60 °C was added a suspension of <i>N</i>-(4-bromo-2-nitrophenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide (0.28 g, 0.56 mmol) in ethanol (4 mL). The mixture was stirred at 60 °C for 4 h and then cooled to 20 °C, filtered through Celite and the Celite washed with 1:9 methanol/dichloromethane (100 mL) and dichloromethane 100 mL). The combined filtrates were washed with water (100 mL) and then with brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and evaporated to give a pale yellow solid (0.24 g) that was purified by column chromatography on silica gel (5% methanol in chloroform) to give <b>8c</b> as a white solid (0.164 g, 61%), mp 206–208 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3247, 3055, 1633, 1608; <sup>1</sup>H NMR (500 MHz, DMSO<i>-d</i><sub>6</sub>) δ 4.64 (2H, d, <i>J</i> = 6.2 Hz), 5.19 (2H, s), 6.69 (1H, dd, <i>J</i> = 8.4, 2.0 Hz), 6.93 (1H, d, <i>J</i> = 2.0 Hz), 7.09 (1H, d, <i>J</i> = 8.4 Hz), 7.24 (1H, d, <i>J</i> = 5.2 Hz), 7.44–7.55 (3H, m), 7.90 (2H, d, <i>J</i> = 8.2 Hz), 7.97 (1H, t, <i>J</i> = 6.2 Hz), 8.40 (2H, d, <i>J</i> = 5.2 Hz), 8.67 (1H, d, <i>J</i> = 3.6 Hz), 9.23 (1H, br s), 9.53 (1H, s); <sup>13</sup>C NMR (150 MHz, DMSO<i>-d</i><sub>6</sub>) δ 44.0, 106.0, 117.7, 118.3, 118.8, 122.5, 123.9, 126.9, 127.9, 128.6, 132.4, 132.8, 134.2, 144.3, 145.1, 148.1, 151.3, 159.1, 159.6, 162.4, 165.4; <i>m</i>/<i>z</i> (ES<sup>+</sup>, %) 475 (53), 307 (100); HRMS C<sub>23</sub>H<sub>20</sub>BrN<sub>6</sub>O calcd for [M + H]<sup>+</sup> 475.0882, found 475.0866.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <i>N</i>-(2-Amino-4-methoxyphenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide (<b>8d</b>)</h3><div class="NLM_p last">To a solution of acid <b>5</b> (0.306 g, 1.0 mmol), 4-methoxy-1,2-phenylenediamine (0.531 g, 1.1 mmol), and (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) (0.531 g, 1.2 mmol) in DMF (10 mL) was added triethylamine (0.28 mL, 2.0 mmol). The mixture was stirred under a blanket of nitrogen at 20 °C for 27 h, then diluted with ethyl acetate (50 mL), washed with brine (3 × 50 mL) and then with saturated aqueous sodium hydrogen carbonate (25 mL). The combined aqueous layers were extracted with ethyl acetate (25 mL), and the combined organic layers were washed with brine (2 × 25 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. Column chromatography on silica gel (ethyl acetate) gave <b>8d</b> as a cream solid (0.21 g, 49%), mp 176–178 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3435, 3249, 1628; <sup>1</sup>H NMR (400 MHz, DMSO<i>-d</i><sub>6</sub>) δ 3.67 (3H, s), 4.65 (2H, d, <i>J</i> = 5.9 Hz), 4.91 (2H, br s), 6.18 (1H, dd, <i>J</i> = 8.5, 2.5 Hz), 6.35 (1H, d, <i>J</i> = 2.5 Hz), 6.99 (1H, d, <i>J</i> = 8.5 Hz), 7.27 (1H, d, <i>J</i> = 5.0 Hz), 7.41–7.60 (3H, m), 7.92 (2H, d, <i>J</i> = 8.0 Hz), 8.02 (1H, t, <i>J</i> = 5.9 Hz), 8.42 (2H, d, <i>J</i> = 5.3 Hz), 8.69 (1H, d, <i>J</i> = 3.3 Hz), 9.25 (1H, br s), 9.49 (1H, br s); <sup>13</sup>C NMR <b>(</b>150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 44.0, 54.9, 100.7, 101.9, 106.1, 116.6, 123.9, 126.9, 127.7, 127.9, 132.4, 133.0, 134.2, 144.1, 144.6, 148.1, 151.3, 158.2, 159.2, 159.6, 162.4, 165.3; <i>m</i>/<i>z</i> (ES<sup>–</sup>, %) 425 (100); HRMS calcd for C<sub>24</sub>H<sub>21</sub>N<sub>6</sub>O<sub>2</sub> [M – H]<sup>−</sup> 425.1731, found 425.1732.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> (±)-1-Acetyl-5-benzyl-2-(methylsulfanyl)-4,5-dihydro-1<i>H</i>-imidazol-4-one (<b>11a</b>)</h3><div class="NLM_p last">To a stirred mixture of the thiohydantoin <b>10a</b> (0.70 g, 2.82 mmol) and anhydrous potassium carbonate (0.468 g, 3.38 mmol) in acetonitrile (35 mL) under nitrogen at 20 °C was added iodomethane (0.263 mL, 4.23 mmol) dropwise. The mixture was stirred vigorously at 20 °C under nitrogen for 3.5 h, then filtered and the filtrate evaporated. The resulting cream solid was purified by column chromatography (1:9 to 2:1 ethyl acetate/hexane) to give <b>11a</b> as a white solid (0.203 g, 27%), mp 142–143 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 1725, 1698; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.24 (3H, s), 2.39 (3H, s), 3.17 (1H, dd, <i>J</i> = 14.3, 2.7 Hz), 3.35 (1H, dd, <i>J</i> = 14.3, 6.0 Hz), 4.96 (1H, dd, <i>J</i> = 6.0, 2.8 Hz), 6.97–7.06 (2H, m), 7.22 (3H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 15.7, 23.6, 36.1, 64.1, 127.1, 128.2, 129.4, 134.0, 168.5, 184.5, 185.4; <i>m</i>/<i>z</i> (EI<sup>+</sup>, %) 262 (12); HRMS calcd for C<sub>13</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>S M<sup>+</sup> 262.0771, found 262.0765.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (±)-1-Acetyl-5-(1<i>H</i>-indol-3-ylmethyl)-2-(methylsulfanyl)-4,5-dihydro-1<i>H</i>-imidazol-4-one (<b>11b</b>)</h3><div class="NLM_p last">To thiohydantoin <b>10b</b> (0.907 g, 3.38 mmol) and anhydrous potassium carbonate (0.56 g, 4.05 mmol) in acetonitrile (40 mL) under nitrogen at 20 °C was added iodomethane (0.32 mL, 5.06 mmol) dropwise. The mixture was stirred vigorously at 20 °C under nitrogen for 2.5 h, then filtered and the filtrate evaporated. Purification of the residue by column chromatography (1:1 and then 2:1 ethyl acetate/hexane) gave <b>11b</b> as a cream solid (0.61 g, 60%), mp 187–190 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3234, 1725, 1698; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.22 (3H, s), 2.39 (3H, s), 3.35 (1H, dd, <i>J</i> = 15.4, 2.9 Hz), 3.47 (1H, dd, <i>J</i> = 15.4, 5.8 Hz), 4.94 (1H, dd, <i>J</i> = 5.8, 3.0 Hz), 6.93 (1H, t, <i>J</i> = 7.5 Hz), 6.96 (1H, d, <i>J</i> = 2.4 Hz), 7.03 (1H, t, <i>J</i> = 7.5 Hz), 7.29 (1H, d, <i>J</i> = 8.0 Hz), 7.40 (1H, d, <i>J</i> = 8.0 Hz), 10.90 (1H, br s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 15.6, 23.6, 26.4, 64.1, 106.4, 111.3, 118.3, 118.5, 121.0, 124.1, 127.2, 135.7, 168.5, 185.1, 185.3; <i>m</i>/<i>z</i> (EI<sup>+</sup>, %) 301 (10), 130 (100); HRMS calcd for C<sub>15</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub>S M<sup>+</sup> 301.0879, found 301.0878.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 4-({[(±)-1-Acetyl-5-benzyl-4-oxo-4,5-dihydro-1<i>H</i>-imidazol-2-yl]amino}methyl)benzoic Acid (<b>12a</b>)</h3><div class="NLM_p last">To a solution of the imidazolin-4-one <b>11a</b> (179 mg, 0.682 mmol) in ethanol (8 mL) was added 4-(methylamino)benzoic acid (103 mg, 0.682 mmol). The mixture was stirred at reflux under nitrogen for 18 h. The solution was cooled to 20 °C, then cooled in a refrigerator, filtered and the solid dried under vacuum to give <b>12a</b> as a cream solid (122 mg, 49%), mp 232–234 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3263, 2938, 1688; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.42 (3H, s), 3.14 (1H, dd, <i>J</i> = 14.2, 1.9 Hz), 3.30 (1H, dd, <i>J</i> = 14.2, 5.7 Hz), 4.37 (1H, dd, <i>J</i> = 15.8, 6.0 Hz), 4.52 (1H, dd, <i>J</i> = 15.8, 6.6 Hz), 4.77 (1H, dd, <i>J</i> = 5.7, 1.9 Hz), 6.91 (2H, d, <i>J</i> = 8.2 Hz), 6.99–7.08 (2H, m), 7.18–7.32 (3H, m), 7.77 (2H, d, <i>J</i> = 8.2 Hz), 9.28 (1H, t, <i>J</i> = 6.3 Hz); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 24.2, 35.7, 45.4, 63.1, 126.6, 126.8, 128.1, 129.2, 129.6, 134.4, 142.9, 167.2, 167.6, 171.2, 183.4; <i>m</i>/<i>z</i> (ES, %) 366 ([M + H]<sup>+</sup>100); HRMS calcd for C<sub>20</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 366.1448, found 366.1448.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 4-({[(±)-1-Acetyl-5-(1<i>H</i>-indol-3-ylmethyl)-4-oxo-4,5-dihydro-1<i>H</i>-imidazol-2-yl]amino}methyl)benzoic Acid (<b>12b</b>)</h3><div class="NLM_p last">The imidazolin-4-one <b>11b</b> (0.60 g, 1.99 mmol) was reacted with 4-(methylamino)benzoic acid according to the above procedure for <b>12a</b>. Filtration gave <b>12b</b> as a tan solid (0.295 g, 37%). The mother liquor was evaporated and the residue recrystallized from ethanol to give further <b>12b</b> as a tan solid (0.13 g, 16%), overall yield 53%, mp 163–166 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3315, 1728, 1674, 1663; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.46 (3H, s), 3.31 (1H, dd, <i>J</i> = 15.1, 2.2 Hz), 3.45 (1H, dd, <i>J</i> = 15.1, 5.4 Hz), 4.32 (1H, dd, <i>J</i> = 15.8, 5.7 Hz), 4.49 (1H, dd, <i>J</i> = 15.8, 6.9 Hz), 4.75 (1H, dd, <i>J</i> = 5.4, 2.2 Hz), 6.74 (2H, d, <i>J</i> = 8.0 Hz), 6.92 (1H, t, <i>J</i> = 7.3 Hz), 6.99 (1H, d, <i>J</i> = 2.0 Hz), 7.04 (1H, t, <i>J</i> = 7.4 Hz), 7.36 (1H, d, <i>J</i> = 8.2 Hz), 7.41 (1H, d, <i>J</i> = 7.9 Hz), 7.74 (2H, d, <i>J</i> = 8.2 Hz), 9.20 (1H, t, <i>J</i> = 6.3 Hz), 11.00 (1H, br s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 24.2, 26.2, 45.3, 63.3, 106.6, 111.3, 118.3, 118.5, 120.8, 124.3, 126.2, 127.5, 129.3, 129.3, 135.9, 142.9, 167.2, 167.8, 171.2, 184.1; <i>m</i>/<i>z</i> (ES<sup>–</sup>, %) 403 ([M – H]<sup>−</sup>, 95); HRMS calcd for C<sub>22</sub>H<sub>19</sub>N<sub>4</sub>O<sub>4</sub> [M – H]<sup>−</sup> 403.1412, found 403.1412.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 4-({[(±)-1-Acetyl-5-benzyl-4-oxo-4,5-dihydro-1<i>H</i>-imidazol-2-yl]amino}methyl)-<i>N</i>-(2-aminophenyl)benzamide (<b>13a</b>)</h3><div class="NLM_p last">To a solution of acid <b>12a</b> (114 mg, 0.312 mmol) and (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) (165 mg, 0.374 mmol) in anhydrous DMF (1.4 mL) was added triethylamine (174 μL, 1.25 mmol), and the mixture was stirred at 20 °C under nitrogen for 15 min. Phenylene-1,2-diamine (40 mg, 0.374 mmol) was then added and the solution stirred at 20 °C under nitrogen for 3.5 h. The mixture was diluted with ethyl acetate (50 mL), then washed with water (25 mL), saturated aqueous sodium hydrogen carbonate (25 mL), and last with brine (25 mL). The organic layer was dried over MgSO<sub>4</sub>, filtered, and evaporated to give an orange solid. Purification by column chromatography (4% methanol in dichloromethane) gave <b>13a</b> as a white solid (21 mg, 15%), mp 235–236 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3283, 1720, 1671; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.44 (3H, s), 3.16 (1H, dd, <i>J</i> = 14.0, 2.3 Hz), 3.31 (1H, dd, <i>J</i> = 14.0, 5.6 Hz), 4.40 (1H, dd, <i>J</i> = 15.6, 5.6 Hz), 4.54 (1H, dd, <i>J</i> = 15.6, 6.6 Hz), 4.80 (1H, dd, <i>J</i> = 5.6, 2.3 Hz), 4.91 (2H, br s), 6.61 (1H, t, <i>J</i> = 7.3 Hz), 6.79 (1H, d, <i>J</i> = 7.2 Hz), 6.94–7.00 (3H, m), 7.07 (2H, d, <i>J</i> = 7.2 Hz), 7.17 (1H, d, <i>J</i> = 7.5 Hz), 7.28 (2H, t, <i>J</i> = 7.5 Hz), 7.32 (1H, t, <i>J</i> = 7.2 Hz), 7.84 (2H, d, <i>J</i> = 7.5 Hz), 9.30 (1H, t, <i>J</i> = 6.4 Hz), 9.64 (1H, s); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 24.3, 35.8, 45.4, 63.1, 116.1, 116.3, 123.3, 126.5, 126.6, 126.8, 127.0, 127.7, 128.3, 129.6, 133.2, 134.4, 141.4, 143.2, 165.1, 167.6, 171.3, 183.5; <i>m</i>/<i>z</i> (ES, %) 456 (M<sup>+</sup>, 80); HRMS calcd for C<sub>26</sub>H<sub>26</sub>N<sub>5</sub>O<sub>3</sub> M<sup>+</sup> 456.2030, found 456.2017.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 4-({[(±)-1-Acetyl-5-(1<i>H</i>-indol-3-ylmethyl)-4-oxo-4,5-dihydro-1<i>H</i>-imidazol-2-yl]amino}methyl)-<i>N</i>-(2-aminophenyl)benzamide (<b>13b</b>)</h3><div class="NLM_p last">Acid <b>12b</b> (240 mg, 0.593 mmol) was reacted with phenylene-1,2-diamine according to the above procedure for <b>13a</b>. Column chromatography of the residue (6% methanol in dichloromethane) afforded a solid that was recrystallized from methanol–dichloromethane to give <b>13b</b> as a cream crystalline solid (182 mg, 62%), mp 168–170 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3267, 1720, 1676; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.45 (3H, s), 3.31 (1H, dd, <i>J</i> = 15.1, 2.4 Hz), 3.46 (1H, dd, <i>J</i> = 15.1, 5.4 Hz), 4.36 (1H, dd, <i>J</i> = 15.6, 6.0 Hz), 4.49 (1H, dd, <i>J</i> = 15.6, 6.8 Hz), 4.76 (1H, dd, <i>J</i> = 5.4, 2.4 Hz), 4.90 (2H, br s), 6.61 (1H, t, <i>J</i> = 8.0 Hz), 6.79 (1H, dd, <i>J</i> = 8.0, 1.1 Hz), 6.84 (2H, d, <i>J</i> = 8.0 Hz), 6.92–7.00 (3H, m), 7.05 (1H, t, <i>J</i> = 8.0 Hz), 7.19 (1H, d, <i>J</i> = 7.7 Hz), 7.38 (1H, d, <i>J</i> = 8.0 Hz), 7.43 (1H, d, <i>J</i> = 8.0 Hz), 7.79 (2H, d, <i>J</i> = 8.0 Hz), 9.22 (1H, t, <i>J</i> = 6.4 Hz), 9.55 (1H, s), 10.96 (1H, br d, <i>J</i> = 1.6 Hz); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 24.2, 26.2, 45.3, 63.3, 106.6, 111.4, 116.1, 116.3, 118.3, 118.5, 120.9, 123.4, 124.2, 126.2, 126.5, 126.6, 127.5, 127.7, 133.2, 135.8, 141.3, 143.1, 165.2, 167.7, 171.2, 184.1; <i>m</i>/<i>z</i> (ES<sup>+</sup>, %) 495 ([M + H]<sup>+</sup>, 100); HRMS calcd for C<sub>28</sub>H<sub>27</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 495.2139, found 495.2129.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (5<i>S</i>)-1-(<i>tert-</i>Butoxycarbonyl)-5-(1<i>H</i>-indol-3-ylmethyl)-2-thiohydantoin (<b>15b</b>)</h3><div class="NLM_p last">To a stirred solution of <i>N</i>-(<i>tert</i>-butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-tryptophan (<b>14b</b>) (2.11 g, 6.93 mmol) in acetonitrile (155 mL) were added ethoxycarbonyl isothiocyanate (0.98 mL, 8.3 mmol) and pyridine (0.67 mL, 8.3 mmol). The mixture was stirred at 20 °C for 17 h, evaporated and the residue purified by column chromatography (1:2 ethyl acetate/hexane) to give <b>15b</b> as a white solid (1.98 g, 82%), mp 85–87 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3354, 1736; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.64 (9H, s), 3.53 (1H, dd, <i>J</i> = 15.0, 2.8 Hz), 3.63 (1H, dd, <i>J</i> = 15.1, 5.3 Hz), 4.81 (1H, dd, <i>J</i> = 5.3, 2.9 Hz), 6.93 (1H, d, <i>J</i> = 2.0 Hz), 7.10 (1H, t, <i>J</i> = 7.2 Hz), 7.17 (1H, t, <i>J</i> = 7.2 Hz), 7.31 (1H, d, <i>J</i> = 8.0 Hz), 7.56 (1H, d, <i>J</i> = 8.0 Hz), 8.12 (1H, br s), 8.35 (1H, br s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 26.1, 28.2, 64.4, 85.5, 107.1, 111.3, 118.7, 120.0, 122.4, 123.7, 127.4, 135.9, 148.8, 171.5, 178.6; <i>m</i>/<i>z</i> (EI<sup>+</sup>, %) 345 (M<sup>+</sup>, 12), 130 (97); HRMS calcd for C<sub>17</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 345.1142, found 345.1144.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (5<i>S</i>)-1-(<i>tert-</i>Butoxycarbonyl)-5-phenyl-2-thiohydantoin (<b>15c</b>)</h3><div class="NLM_p last">To a stirred solution of <i>N</i>-Boc-<span class="smallcaps smallerCapital">d</span>-phenylglycine (<b>14c</b>) (2.50 g, 9.95 mmol) in acetonitrile (200 mL) were added ethoxycarbonyl isothiocyanate (1.4 mL, 12.0 mmol) and pyridine (0.96 mL, 12.0 mmol). The mixture was stirred at 20 °C for 17 h, evaporated and the residue purified by column chromatography (1:3 ethyl acetate/hexane) to give a sticky mass that was recrystallized from chloroform to give <b>15c</b> as a white solid (1.71 g, 59%), mp 172–173 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3111, 1740; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.17 (9H, s), 5.62 (1H, s), 7.23 (2H, d, <i>J</i> = 6.9 Hz), 7.34–7.47 (3H, m), 12.63 (1H, br s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 27.2, 66.6, 83.3, 126.4, 128.7, 129.0, 134.9, 147.5, 171.3, 180.9 (HNC═O); <i>m</i>/<i>z</i> (EI<sup>+</sup>, %) 292 (M<sup>+</sup>, 3%), 192 (100); HRMS calcd for C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub>S M<sup>+</sup> 292.0876, found 292.0870.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (±)-1-(<i>tert-</i>Butoxycarbonyl)-5-benzyl-2-(methylsulfanyl)-4,5-dihydro-1<i>H</i>-imidazol-4-one (<b>16a</b>)</h3><div class="NLM_p last">To a vigorously stirred mixture of the thiohydantoin <b>15a</b> (0.90 g, 2.9 mmol) and anhydrous potassium carbonate (0.481 g, 3.48 mmol) in acetonitrile (35 mL) under nitrogen at 20 °C was added iodomethane (0.27 mL, 4.35 mmol) dropwise. The mixture was stirred at 20 °C under nitrogen for 2.5 h, then filtered and the filtrate evaporated. Purification by column chromatography (1:2 ethyl acetate/hexane) gave <b>16a</b> as a white solid (0.586 g, 63%), mp 105–107 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 2979, 2933, 1722; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.61 (9H, s), 2.37 (3H, s), 3.32 (1H, dd, <i>J</i> = 13.9, 2.5 Hz), 3.42 (1H, dd, <i>J</i> = 13.9, 6.0 Hz), 4.52 (1H, dd, <i>J</i> = 6.0, 2.5 Hz), 7.02–7.10 (2H, m), 7.18–7.25 (3H, m); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 16.2, 28.2, 36.1, 64.5, 85.7, 127.4, 128.6, 129.5, 133.8, 148.4, 184.7, 186.0; <i>m</i>/<i>z</i> (ES, %) 321 ([M + H]<sup>+</sup>, 100); HRMS calcd for C<sub>16</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 321.1267, found 321.1273.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (±)-1-(<i>tert-</i>Butoxycarbonyl)-5-(1<i>H</i>-indol-3-ylmethyl)-2-(methylsulfanyl)-4,5-dihydro-1<i>H</i>-imidazol-4-one (<b>16b</b>)</h3><div class="NLM_p last">To a vigorously stirred mixture of the thiohydantoin <b>15b</b> (1.85 g, 5.36 mmol) and anhydrous potassium carbonate (0.89 g, 6.4 mmol) in acetonitrile (65 mL) under nitrogen at 20 °C was added iodomethane (0.50 mL, 8.04 mmol) dropwise. The mixture was stirred vigorously at 20 °C under nitrogen for 2.5 h, then filtered and the filtrate evaporated. Purification of the residue by column chromatography (2:3 and then 1:1 ethyl acetate/hexane) gave <b>16b</b> as a cream solid (1.35 g, 70%), mp 96–98 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3312, 1720; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.60 (9H, s), 2.33 (3H, s), 3.49 (1H, dd, <i>J</i> = 15.1, 3.0 Hz), 3.64 (1H, dd, <i>J</i> = 15.0, 5.5 Hz), 4.60 (1H, dd, <i>J</i> = 5.5, 3.0 Hz), 6.95 (1H, d, <i>J</i> = 2.4 Hz), 7.07 (1H, t, <i>J</i> = 7.5 Hz), 7.14 (1H, t, <i>J</i> = 7.6 Hz), 7.30 (1H, d, <i>J</i> = 8.0 Hz), 7.53 (1H, d, <i>J</i> = 8.0 Hz), 8.26 (1H, br s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 16.2, 26.0, 28.2, 64.8, 85.8, 107.9, 111.2, 118.5, 119.6, 122.0, 123.5, 127.8, 135.9, 148.5, 185.4, 186.1; <i>m</i>/<i>z</i> (ES, %) 382 ([M + Na]<sup>+</sup>, 90); HRMS calcd for C<sub>18</sub>H<sub>21</sub>N<sub>3</sub>NaO<sub>3</sub>S [M + Na]<sup>+</sup> 382.1196, found 382.1188.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (±)-1-(<i>tert-</i>Butoxycarbonyl)-5-phenyl-2-(methylsulfanyl)-4,5-dihydro-1<i>H</i>-imidazol-4-one (<b>16c</b>)</h3><div class="NLM_p last">To a vigorously stirred mixture of the imidazol-4-one <b>15c</b> (0.25 g, 0.855 mmol) and anhydrous potassium carbonate (0.141 g, 1.03 mmol) in acetonitrile (10 mL) at 20 °C was added iodomethane (80 μL, 1.28 mmol) dropwise. The mixture was stirred vigorously at 20 °C under nitrogen for 2.5 h, then evaporated. Ethyl acetate (20 mL) was added to the residue, and the mixture was stirred and filtered. The filtrate was evaporated to give <b>16c</b> as a white solid (0.26 g, 99%), mp 145–147 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 1737, 1713; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.26 (9H, s), 2.67 (3H, s), 5.18 (1H, s), 7.15–7.23 (2H, m), 7.30–7.39 (3H, m); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 16.4, 27.7, 67.6, 85.4, 126.4, 128.7, 129.0, 134.5, 148.4, 183.0, 186.6; <i>m</i>/<i>z</i> (EI<sup>+</sup>, %) 306 (M<sup>+</sup>, 3), 205 (100); HRMS calcd for C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 306.1033, found 306.1036.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 4-({[(±)-1-(<i>tert-</i>Butoxycarbonyl)-5-benzyl-4-oxo-4,5-dihydro-1<i>H</i>-imidazol-2-yl]amino}methyl)benzoic Acid (<b>17a</b>)</h3><div class="NLM_p last">To a stirred solution of the imidazol-4-one <b>16a</b> (0.550 g, 1.72 mmol) in ethanol (15 mL) was added 4-(methylamino)benzoic acid (0.260 g, 1.72 mmol). The mixture was stirred at reflux under nitrogen for 18 h. The solvent was evaporated and the residue shaken with ethyl acetate (50 mL). The organic layer was washed with water (50 mL) and then with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, and evaporated. Purification of the residue by column chromatography (ethyl acetate) gave <b>17a</b> as a cream solid (0.238 g, 33%), mp 137–140 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3386, 2975, 1702; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.62 (9H, br s), 3.22–3.40 (2H, m), 4.36 (1H, m), 4.49 (1H, br s), 4.77 (1H, dd, <i>J</i> = 14.8, 6.6 Hz), 6.96 (2H, d, <i>J</i> = 7.3 Hz), 7.10 (2H, d, <i>J</i> = 6.3 Hz), 7.15–7.34 (3H, m), 7.94 (2H, d, <i>J</i> = 7.3 Hz), 8.43 (1H, br s), 8.95 (1H, br s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 28.3, 35.8, 46.4, 63.5, 85.7, 127.2, 127.4, 128.6, 128.9, 129.7, 130.6, 134.1, 142.2, 167.8, 170.5, 174.1, 184.3; <i>m</i>/<i>z</i> (ES, %) 422 ([M – H]<sup>−</sup>, 100); HRMS calcd for C<sub>23</sub>H<sub>24</sub>N<sub>3</sub>O<sub>5</sub> [M – H]<sup>−</sup> 422.1721, found 422.1707.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 4-({[(±)-1-(<i>tert-</i>Butoxycarbonyl)-5-(1<i>H</i>-indol-3-ylmethyl)-4-oxo-4,5-dihydro-1<i>H-</i>imidazol-2-yl]amino}methyl)benzoic Acid (<b>17b</b>)</h3><div class="NLM_p last">To a solution of the imidazol-4-one <b>16b</b> (1.30 g, 3.62 mmol) in ethanol (30 mL) was added 4-(methylamino)benzoic acid (0.547 g, 3.62 mmol). The mixture was stirred at reflux under nitrogen for 4 h. The solvent was evaporated and the resulting yellow solid purified by column chromatography (6% methanol in dichloromethane) to give <b>17b</b> as a cream solid (1.0 g, 60%), mp 187–190 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3271, 1746, 1697, 1693; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.58 (9H, s), 3.23 (1H, dd, <i>J</i> = 14.7, 2.3 Hz), 3.44 (1H, dd, <i>J</i> = 14.7, 5.3 Hz), 4.31 (1H, dd, <i>J</i> = 15.8, 5.8 Hz), 4.45–4.52 (2H, m), 6.76 (2H, d, <i>J</i> = 8.2 Hz), 6.88 (1H, d, <i>J</i> = 2.2 Hz), 6.92 (1H, t, <i>J</i> = 7.5 Hz), 7.04 (1H, t, <i>J</i> = 7.5 Hz), 7.36 (1H, d, <i>J</i> = 8.0 Hz), 7.44 (1H, d, <i>J</i> = 8.0 Hz), 7.74 (2H, d, <i>J</i> = 8.2 Hz), 8.72 (1H, br t, <i>J</i> = 5.7, 5.7 Hz), 10.97 (1H, br d, <i>J</i> = 2.2 Hz); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 25.2, 27.7, 45.3, 63.2, 84.0, 107.0, 111.3, 118.2, 118.4, 120.8, 123.8, 126.2, 127.6, 129.2, 135.8, 150.2, 167.2, 184.0; <i>m</i>/<i>z</i> (ES, %) 463 ([M + H]<sup>+</sup>, 10); HRMS calcd for C<sub>25</sub>H<sub>27</sub>N<sub>4</sub>O<sub>5</sub> [M + H]<sup>+</sup> 463.1976, found 463.1993.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 4-(([(±)-1-(<i>tert-</i>Butoxycarbonyl)-5-phenyl-4-oxo-4,5-dihydro-1<i>H</i>-imidazol-2-yl]amino)methyl)benzoic Acid (<b>17c</b>)</h3><div class="NLM_p last">To a solution of the imidazol-4-one <b>16c</b> (0.25 g, 0.817 mmol) in ethanol (5 mL) was added 4-(aminomethyl)benzoic acid (0.124 g, 0.817 mmol). The mixture was heated under reflux for 4 h with stirring. After cooling to 20 °C, the mixture was placed in the refrigerator (1 h) and then filtered. The filtrate was evaporated and the residue was purified by column chromatography (4:1 ethyl acetate/hexane) to give <b>17c</b> as a white solid (0.131 g, 39%), mp 166–168 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3315, 1702; <sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>) δ 1.24 (9H, s), 4.76–4.84 (2H, m), 5.28 (1H, s), 7.24 (2H, d, <i>J</i> = 7.3 Hz), 7.32–7.43 (3H, m), 7.52 (2H, d, <i>J</i> = 8.2 Hz), 8.03 (2H, d, <i>J</i> = 8.5 Hz); <sup>13</sup>C NMR (125 MHz, methanol-<i>d</i><sub>4</sub>) δ 27.9, 47.5, 68.1, 86.1, 127.8, 128.5, 129.5, 129.9, 131.2, 131.4, 137.2, 143.9, 151.7, 169.4, 169.5, 185.7; <i>m</i>/<i>z</i> (ES, %) 410 ([M + H]<sup>+</sup>, 8); HRMS calcd for C<sub>22</sub>H<sub>24</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 410.1710, found 410.1704.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1-<i>tert</i>-Butyloxycarbonyl-(±)-2-[({4-[(2-ainophenyl)carbamoyl]phenyl}methyl)amino]-5-benzyl-4-oxo-4,5-dihydro-1<i>H</i>-imidazole (<b>18a</b>)</h3><div class="NLM_p last">To a solution of acid <b>17a</b> (230 mg, 0.543 mmol) and (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) (0.287 g, 0.65 mmol) in anhydrous DMF (2.5 mL) was added triethylamine (0.30 mL, 2.16 mmol), and the mixture stirred at 20 °C under nitrogen for 30 min. Phenylene-1,2-diamine (70 mg, 0.65 mmol) was then added and the solution stirred at 20 °C under nitrogen for 5.5 h. The mixture was diluted with water (50 mL) and then extracted with ethyl acetate (100 mL, then 50 mL). The combined organic layers were washed with saturated aqueous sodium hydrogen carbonate (50 mL) and then with brine (50 mL). The organic layer was dried over MgSO<sub>4</sub>, filtered, and evaporated to give an orange solid. Purification by column chromatography (2% methanol in dichloromethane) gave <b>18a</b> as a cream solid (154 mg, 55%), mp 121–124 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3304, 1699; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.65 (9H, s), 3.29–3.39 (2H, m), 3.92 (2H, br s), 4.40 (1H, dd, <i>J</i> = 15.4, 5.4 Hz), 4.44–4.50 (1H, m), 4.73 (1H, dd, <i>J</i> = 15.4, 7.2 Hz), 6.81–6.89 (2H, m), 7.02 (2H, d, <i>J</i> = 8.0 Hz), 7.07–7.14 (3H, m), 7.17–7.40 (4H, m), 7.81 (2H, d, <i>J</i> = 8.0 Hz), 8.15 (1H, br s), 8.41 (1H, br s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 28.3, 35.8, 46.2, 63.4, 85.6, 118.4, 119.8, 124.7, 125.4, 127.3, 127.3, 127.6, 127.9, 128.6, 129.7, 133.6, 134.2, 140.6, 140.8, 151.1, 165.5, 167.8, 184.1; <i>m</i>/<i>z</i> (ES, %) 514 ([M + H]<sup>+</sup>, 10), 536 ([M + Na]<sup>+</sup>, 19); HRMS calcd for C<sub>29</sub>H<sub>31</sub>N<sub>5</sub>NaO<sub>4</sub> [M + Na]<sup>+</sup> 536.2268, found 536.2277.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-<i>tert</i>-Butyloxycarbonyl-(±)-2-[({4-[(2-ainophenyl)carbamoyl]phenyl}methyl)amino]-5-(1<i>H-</i>indol-3-ylmethyl)-4-oxo-4,5-dihydro-1<i>H</i>-imidazole (<b>18b</b>)</h3><div class="NLM_p last">To a solution of acid <b>17b</b> (0.97 g, 2.10 mmol) and (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) (1.12 g, 2.52 mmol) in anhydrous DMF (10 mL) was added triethylamine (1.17 mL, 8.4 mmol), and the mixture was stirred at 20 °C under nitrogen for 15 min. Phenylene-1,2-diamine (0.272 g, 2.52 mmol) was then added and the solution stirred at 20 °C under nitrogen for 5 h. The mixture was diluted with ethyl acetate (240 mL), washed with water (90 mL), then with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, and evaporated to give an orange solid. Purification by column chromatography (6% methanol in chloroform) gave <b>18b</b> as a cream solid (0.398 g, 34%), mp 185–186 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3288, 1732, 1699; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.66 (9H, s), 3.30 (1H, dd, <i>J</i> = 14.8, 2.4 Hz), 3.49 (1H, dd, <i>J</i> = 14.8, 3.7 Hz), 3.98 (2H, br s), 4.12 (1H, dd, <i>J</i> = 15.8, 5.2 Hz), 4.43 (1H, m), 4.58 (1H, dd, <i>J</i> = 15.8, 7.7 Hz), 6.52 (2H, d, <i>J</i> = 8.0 Hz), 6.67 (1H, d, <i>J</i> = 1.7 Hz), 6.75–6.82 (2H, m), 6.99 (1H, t, <i>J</i> = 7.5 Hz), 7.03–7.12 (2H, m), 7.34 (1H, d, <i>J</i> = 7.7 Hz), 7.41 (1H, d, <i>J</i> = 8.4 Hz), 7.44 (1H, d, <i>J</i> = 8.2 Hz), 7.66 (2H, d, <i>J</i> = 7.7 Hz), 8.31 (1H, br s), 8.71 (1H, br s), 9.11 (1H, br s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 25.7, 28.3, 45.9, 64.2, 85.7, 107.1, 111.8, 117.8, 118.1, 119.3, 119.4, 121.7, 124.2, 124.6, 125.8, 126.5, 127.2, 127.9, 128.0, 133.2, 136.0, 140.3, 141.2, 151.0, 166.0, 168.0, 185.4; <i>m</i>/<i>z</i> (ES, %) 553 ([M + H]<sup>+</sup>, 15), 575 ([M + Na]<sup>+</sup>, 8); HRMS calcd for C<sub>31</sub>H<sub>32</sub>N<sub>6</sub>NaO<sub>4</sub>, [M + Na]<sup>+</sup> 575.2377, found 575.2389.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-<i>tert</i>-Butyloxycarbonyl-(±)-2-[({4-[(2-aminophenyl)carbamoyl]phenyl}methyl)amino]-5-phenyl-4-oxo-4,5-dihydro-1<i>H</i>-imidazole (<b>18c</b>)</h3><div class="NLM_p last">To a solution of acid <b>17c</b> (0.115 g, 0.281 mmol), (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) (0.143 g, 0.323 mmol), and phenylene-1,2-diamine (0.061 g, 0.562 mmol) in DMF (3 mL) was added triethylamine (0.075 mL, 0.562 mmol). The mixture was stirred at 20 °C for 4 h. Some DMF was removed in vacuo, and the residual oil was diluted with ethyl acetate (50 mL). The organic layer washed with saturated aqueous lithium chloride (20 mL), then with brine (2 × 20 mL). Evaporation gave a residue that was purified by column chromatography on silica gel (ethyl acetate) to give <b>18c</b> as a cream solid (0.14 g, 98%), mp 178–180 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3318, 1736, 1700, 1596; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.22 (9H, s), 4.02 (2H, br s), 4.71 (1H, d, <i>J</i> = 15.1 Hz), 4.76 (1H, d, <i>J</i> = 15.1 Hz), 5.10 (1H, s), 6.78 (2H, d, <i>J</i> = 7.3 Hz), 7.03 (1H, t, <i>J</i> = 7.6 Hz), 7.17 (2H, d, <i>J</i> = 7.3 Hz), 7.24 (1H, d, <i>J</i> = 7.6 Hz), 7.27–7.39 (5H, m), 7.82 (2H, d, <i>J</i> = 7.3 Hz), 8.44 (1H, br s), 8.79 (1H, br s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 27.7, 46.8, 66.7, 85.5, 118.5, 119.9, 124.6, 125.7, 126.5, 127.3, 128.0, 128.2, 128.6, 128.9, 133.8, 135.2, 140.4, 140.5, 150.8, 165.8, 168.0, 183.1; <i>m</i>/<i>z</i> (ES, %) 522 ([M + Na]<sup>+</sup>, 45); HRMS calcd for C<sub>28</sub>H<sub>29</sub>N<sub>5</sub>NaO<sub>4</sub> [M + Na]<sup>+</sup> 522.2112, found 522.2103.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (±)<i>-N</i>-(2-Aminophenyl)-4-({5-benzyl-4-oxo-4,5-dihydro-1<i>H</i>-imidazol-2-yl]amino}methyl)benzamide (<b>19a</b>)</h3><div class="NLM_p last">To a solution of the imidazole <b>18a</b> (100 mg, 0.195 mmol) in dichloromethane (1 mL) was added trifluoroacetic acid (1 mL). The solution was stirred at 20 °C for 3 h, then evaporated and toluene (3 mL) added to the residue. Evaporation of the solvent afforded a pink solid that was partitioned between saturated aqueous sodium hydrogen carbonate (50 mL) and ethyl acetate (50 mL). The organic layer was washed with brine, dried over MgSO<sub>4</sub>, filtered, and evaporated to give a solid that was purified by column chromatography (10% methanol in dichloromethane) to give <b>19a</b> as a pale yellow solid (58 mg, 72%), mp 157–160 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3197, 1699; <sup>1</sup>H NMR (2:1 mixture of tautomers) (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.76 (1H, dd, <i>J</i> = 13.6, 6.4 Hz), 2.97 (1H, m, minor tautomer), 3.03 (1H, dd, <i>J</i> = 13.4, 3.2 Hz, major tautomer), 4.06 (1H, app. t, <i>J</i> = 5.1 Hz), 4.28–4.52 (2H, m), 4.91 (2H, br s), 6.60 (1H, t, <i>J</i> = 7.3 Hz), 6.79 (1H, d, <i>J</i> = 7.9 Hz), 6.97 (1H, t, <i>J</i> = 7.5 Hz), 7.10–7.31 (8H, m), 7.68 (2H, br s, major tautomer), 7.89 (2H, d, <i>J</i> = 7.2 Hz, major tautomer), 7.95 (2H, br d, <i>J</i> = 7.2 Hz, minor tautomer), 8.28 (2H, br s, minor tautomer), 9.67 (1H, br s); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 37.2, 43.7, 44.7, 61.2, 116.1, 116.3, 123.3, 126.3, 126.5, 126.7, 126.7, 126.9, 127.8, 128.0, 128.1, 129.5, 129.6, 133.2, 133.3, 136.9, 137.3, 141.8, 142.8, 143.2, 165.1, 170.8, 171.5, 187.6, 188.1 (tautomers); <i>m</i>/<i>z</i> (CI, %) 414 ([M + H]<sup>+</sup>, 15); HRMS calcd for C<sub>24</sub>H<sub>24</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 414.1925, found 414.1935.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (±)<i>-N</i>-(2-Aminophenyl)-4-({[5-(1<i>H</i>-indol-3-ylmethyl)-4-oxo-4,5-dihydro-1<i>H-</i>imidazol-2-yl]amino}methyl)benzamide (<b>19b</b>)</h3><div class="NLM_p last">To a solution of the imidazole <b>18b</b> (300 mg, 0.543 mmol) in dichloromethane (3 mL) was added trifluoroacetic acid (1.5 mL). The solution was stirred at 20 °C for 3 h, then evaporated and toluene (3 mL) added to the residue. Evaporation of the solvent afforded a solid that was partitioned between saturated aqueous sodium hydrogen carbonate (100 mL) and ethyl acetate (150 mL). The organic layer was washed with brine, dried over MgSO<sub>4</sub>, filtered, and evaporated to give <b>19b</b> as a pale yellow solid (0.24 g, 98%), mp 205–207 °C. Recrystallization of 50 mg from dichloromethane–methanol gave <b>19b</b> (30 mg) as a cream solid, mp 214–215 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3216, 1689, 1662; <sup>1</sup>H NMR (2:1 mixture of tautomers) (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.86 (1H, dd, <i>J</i> = 14.8, 7.0 Hz), 3.16 (1H, br dd, <i>J</i> = 14.8, 5.3 Hz), 4.06 (1H, m), 4.34–4.50 (2H, m), 4.91 (2H, br s), 6.61 (1H, t, <i>J</i> = 7.4 Hz), 6.79 (1H, d, <i>J</i> = 7.5 Hz), 6.90–7.39 (8H, m), 7.57 (6H, m), 9.62 (1H, br s), 10.87 (1H, br s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 27.4, 43.7, 44.7, 48.6, 54.9, 61.1, 76.6, 106.8, 109.9, 111.2, 116.1, 116.3, 118.2, 118.6, 120.8, 123.3, 126.5, 126.6, 127.5, 127.8, 133.2, 136.0, 142.8, 143.1, 165.1, 171.7, 178.1, 184.9, 188.6 (tautomers); <i>m</i>/<i>z</i> (ES<sup>+</sup>, %) 453 ([M + H]<sup>+</sup>, 100); HRMS calcd for C<sub>26</sub>H<sub>25</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 453.2034, found 453.2023.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (±)-<i>N</i>-(2-Aminophenyl)-4-(4-oxo-5-phenyl-4,5-dihydro-1<i>H</i>-imidazol-2-yl]amino)methyl)benzamide (<b>19c</b>)</h3><div class="NLM_p last">To a solution of the imidazole <b>18c</b> (0.135 g, 0.27 mmol) in dichloromethane (1.5 mL) was added trifluoroacetic acid (0.75 mL). The solution was stirred at 20 °C for 3 h, then evaporated and toluene (3 mL) added to the residue. The solvent was evaporated and the process repeated three more times. The residue was then dissolved in methanol (10 mL) and stirred with saturated aqueous sodium hydrogen carbonate (10 mL) for 30 min. The methanol was then evaporated, and then water (10 mL) was added. The suspension was sonicated for 5 min. The precipitate was filtered, washed with water, then with diethyl ether, and dried under vacuum to give <b>19c</b> as a cream solid (75 mg, 70%), mp 221–223 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3263, 3062, 1706, 1654; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) (3:2 mixture of NH tautomers) δ 4.47–4.63 (2H, m), 4.85 (1H, s), 4.89 (2H, br s), 6.59 (1H, t, <i>J</i> = 7.1 Hz), 6.77 (1H, d, <i>J</i> = 7.9 Hz), 6.96 (1H, t, <i>J</i> = 7.1 Hz), 7.12–7.20 (2H, m), 7.20–7.30 (2H, m), 7.30–7.39 (2H, m), 7.41–7.49 (2H, m), 7.92–8.02 (2H, m), 8.12–8.24 (1H, m, major tautomer), 8.72 (1H, br s, minor tautomer), 9.63 (1H, br s); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 43.4, 43.8, 45.0, 45.1, 63.8, 116.2, 116.5, 123.2, 123.3, 125.6, 125.8, 126.5, 126.6, 126.7, 127.0, 127.1, 127.2, 127.4, 127.5, 127.5, 127.7, 128.0, 128.2, 128.3, 128.4, 128.6, 133.3, 133.4, 137.7, 141.6, 142.7, 143.0, 143.1, 165.2, 171.7, 186.7 (tautomers); <i>m</i>/<i>z</i> (ES, %) 400 ([M + H]<sup>+</sup>, 100); HRMS calcd for C<sub>23</sub>H<sub>22</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 400.1768, found 400.1755. Purity by HPLC was determined to be 92%.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>tert</i>-Butyl <i>N</i>-{2-[4-Isothiocyanatomethyl)benzamido]phenyl}carbamate (<b>22</b>)</h3><div class="NLM_p last">A previously described protocol for preparing isothiocyanates was used.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> To a stirred solution of amine <b>21b</b> (0.341 g, 1.0 mmol) in dichloromethane (10 mL) was added carbon disulfide (1 mL, 10.4 mmol. CAUTION: FLAMMABLE). The mixture was stirred at 20 °C for 1 min. Then triethylamine (0.14 mL, 1.0 mmol) was added and stirring at 20 °C continued for a further 10 min. The mixture was cooled in an ice bath, and <i>p</i>-toluenesulfonyl chloride (0.191 g, 1.0 mmol) was added. The mixture was stirred at 0 °C for 10 min, then hydrochloric acid (10 mL, 1M) added. The mixture was extracted with dichloromethane (2 × 10 mL), and the combined organic layers were washed with brine (20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. Purification of the residue by column chromatography on silica gel (1:3 ethyl acetate/hexane) gave <b>22</b> as a white solid (0.26 g, 68%), mp 152–153 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3277, 2086, 1693, 1656; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.54 (9H, s), 4.81 (2H, s), 6.87 (1H, s), 7.12–7.26 (3H, m), 7.43 (2H, d, <i>J</i> = 8.3 Hz), 7.81 (1H, d, <i>J</i> = 7.8 Hz), 8.01 (2H, d, <i>J</i> = 8.3 Hz), 9.35 (1H, br s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 28.4, 48.4, 81.6, 124.6, 125.9, 126.1, 126.1, 127.0, 128.2, 129.9, 130.9, 133.6, 134.5, 138.2, 154.8, 164.9; <i>m</i>/<i>z</i> (ES, %) 406 ([M + Na]<sup>+</sup>, 93), 284 (20); HRMS calcd for C<sub>20</sub>H<sub>21</sub>N<sub>3</sub>NaO<sub>3</sub>S [M + Na]<sup>+</sup> 406.1196, found 406.1198.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Synthesis of Thioureas: General Procedure A</h3><div class="NLM_p last">To a solution of the amino alcohol (1 equiv) in acetonitrile (4 mL/mmol) was added isothiocyanate <b>22</b> (1 equiv), and the resulting suspension was stirred at 20 °C for 16 h, then evaporated, and either purified or used directly, as described below.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>tert</i>-Butyl <i>N</i>-(2-{4-[({[(1<i>S</i>)-2-Hydroxy-1-phenylethyl]carbamothioyl}amino)methyl]benzamido}phenyl)carbamate (<b>23a</b>)</h3><div class="NLM_p last">To a solution of (<i>S</i>)-2-phenylglycinol (0.165 g, 1.2 mmol) in acetonitrile (4 mL) was added <b>22</b> (0.384 g, 1.0 mmol). The resulting suspension was stirred at 20 °C for 16.5 h, then evaporated. The residue was purified by column chromatography on silica gel (3:2 and then 2:1 ethyl acetate/hexane) to give <b>23a</b> as a white solid (0.464 g, 89%), mp 108–111 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3285, 1691, 1646; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 1.46 (9H, s), 1.84 (1H, s), 3.45 (1H, br s), 3.61–3.69 (1H, m), 3.77 (1H, m), 4.53–4.81 (2H, m), 5.19 (1H, br s), 7.08 (2H, br s), 7.11–7.18 (3H, m), 7.20 (2H, d, <i>J</i> = 7.2 Hz), 7.24–7.32 (5H, m), 7.59 (1H, d, <i>J</i> = 6.8 Hz), 7.67 (2H, d, <i>J</i> = 7.5 Hz), 9.33 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 28.4, 48.4, 60.2, 66.5, 81.7, 124.9, 125.9, 126.0, 126.5, 126.9, 127.4, 127.8, 128.3, 129.1, 130.4, 130.7, 132.7, 138.2, 142.3, 154.9, 166.2, 182.7; <i>m</i>/<i>z</i> (ES, %) 521 ([M + H]<sup>+</sup>, 20), 543 (50); HRMS calcd for C<sub>28</sub>H<sub>31</sub>N<sub>4</sub>O<sub>4</sub>S [M – H]<sup>−</sup> 519.2071, found 519.2094.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>tert</i>-Butyl <i>N</i>-(2-{4-[({[(1R)-2-Hydroxy-1-phenylethyl]carbamothioyl}amino)methyl]benzamido}phenyl)carbamate (<b>23b</b>)</h3><div class="NLM_p last">(<i>R</i>)<i>-</i>2-Phenylglycinol (0.112 g, 0.82 mmol) was reacted according to general procedure A and the product purified by column chromatography on silica gel (3:2 and then 2:1 ethyl acetate/hexane) to give <b>23b</b> as a white solid (0.37 g, 96%), mp 107–109 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3278, 1692, 1648; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.49 (9H, s), 1.88 (1H, br s), 3.49 (1H, br s), 3.66 (1H, m), 3.79 (1H, d, <i>J</i> = 8.8 Hz), 4.69 (2H, d, <i>J</i> = 2.8 Hz), 5.20 (1H, br s), 6.97–7.39 (11H, m), 7.59 (1H, d, <i>J</i> = 6.8 Hz), 7.69 (2H, d, <i>J</i> = 8.0 Hz), 9.35 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 28.4, 48.4, 60.2, 66.5, 81.7, 124.9, 125.9, 126.0, 126.5, 126.9, 127.4, 127.8, 128.3, 129.1, 130.4, 130.7, 132.7, 138.2, 142.3, 154.9, 166.2, 182.7; <i>m</i>/<i>z</i> (ES, %) 521 ([M + H]<sup>+</sup>, 80), 421 (100); HRMS calcd for C<sub>28</sub>H<sub>33</sub>N<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 521.2217, found 521.2195.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>S</i>)-<i>tert</i>-Butyl <i>N</i>-(2-(4-((3-(2-Hydroxy-1-(4-hydroxyphenyl)ethyl)thioureido)methyl)benzamido)phenyl)carbamate (<b>23c</b>)</h3><div class="NLM_p">An oven-dried three-necked flask was charged with a stirrer bar, sodium borohydride (0.756 g, 20.0 mmol), and anhydrous THF (20 mL) and then cooled in an ice bath. To this stirring suspension was added a solution of iodine (2.54 g, 10.0 mmol) in anhydrous THF (10 mL) dropwise over 15 min (CAUTION: hydrogen gas evolved). After evolution of gas had ceased, 4-hydroxy-<span class="smallcaps smallerCapital">l</span>-phenylglycine (1.67 g, 10.0 mmol) was added and the mixture was heated at reflux for 14 h. After the mixture was cooled to 20 °C, methanol (∼5 mL) was added cautiously until a clear solution formed. After being stirred for 30 min, the mixture was evaporated and the resulting white paste was dissolved in aqueous potassium hydroxide (20%, 20 mL). The mixture was stirred at 20 °C for 4 h and then neutralized to pH 8–9. The product could not be extracted into an organic solvent, and so the water was removed using a freeze drier. The resulting hygroscopic white solid was stirred with ethanol/chloroform (1:1, 200 mL) for 1 h and then filtered and the filtrate evaporated. The residue was suspended in ethanol/chloroform (1:9, 200 mL), stirred for 1 h, then filtered. The filtrate was dried over MgSO<sub>4</sub> and evaporated to give (<i>S</i>)-4-(1-amino-2-hydroxyethyl)phenol as a hygroscopic white solid (1.50 g, 98%), which was used without further purification.</div><div class="NLM_p last">To a suspension of the crude (<i>S</i>)-4-(1-amino-2-hydroxyethyl)phenol (0.536 g, 3.5 mmol) in acetonitrile (12 mL) was added <b>22</b> (0.384 g, 1.0 mmol). The resulting mixture was stirred vigorously at 25 °C for 17.5 h, then evaporated, and the residue partitioned between ethyl acetate (100 mL) and aqueous hydrochloric acid (1 M, 50 mL). The organic layer was washed with water (50 mL), brine (50 mL), dried over MgSO<sub>4</sub>, and evaporated. Purification of the yellow solid by column chromatography on silica gel (3:1 ethyl acetate/hexane) gave <b>23c</b> as a white solid (0.359 g, 67%); mp 128–132 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3250, 1685, 1646; <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 1.51 (9H, s), 3.79 (2H, d, <i>J</i> = 5.8 Hz), 4.62–4.82 (1H, m), 4.86–5.00 (1H, m), 5.27 (1H, br s), 6.79 (2H, d, <i>J</i> = 8.5 Hz), 7.12–7.29 (4H, m), 7.30–7.41 (2H, m), 7.42–7.50 (1H, m), 7.58–7.66 (1H, m), 7.90 (2H, d, <i>J</i> = 8.0 Hz); <sup>13</sup>C NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 28.7, 60.4, 66.4, 79.5, 81.8, 116.3, 125.6, 126.3, 127.2, 127.5, 128.5, 128.7, 129.3, 131.6, 133.0, 134.0, 144.9, 156.3, 158.0, 168.2, 183.9; <i>m</i>/<i>z</i> (ES, %) 535 ([M – H]<sup>−</sup>, 100); HRMS calcd for C<sub>28</sub>H<sub>31</sub>N<sub>4</sub>O<sub>5</sub>S [M – H]<sup>−</sup> 535.2021, found 535.2017.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>tert</i>-Butyl <i>N</i>-(2-{4-[({[(2S)-1-Hydroxy-3-phenylpropan-2-yl]carbamothioyl}amino)methyl]benzamido}phenyl)carbamate (<b>23d</b>)</h3><div class="NLM_p last">To a suspension of <b>22</b> (0.24 g, 0.625 mmol) in toluene (5 mL) was added <span class="smallcaps smallerCapital">l</span>-phenylalaninol (<b>25a</b>) (0.095 g, 0.625 mmol). The mixture was stirred at 20 °C under an atmosphere of nitrogen for 63 h. Evaporation afforded a residue to which dichloromethane (5 mL) was added, and the mixture then evaporated. The residue was purified by column chromatography on silica gel (2:1 ethyl acetate/hexane) to give <b>23d</b> as a white solid (0.29 g, 87%), mp 103–106 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3287, 1693, 1648; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.49 (9H, s), 1.81 (1H, br s), 2.73 (1H, dd, <i>J</i> = 13.7, 7.8 Hz), 2.85 (1H, dd, <i>J</i> = 13.7, 6.0 Hz), 3.20 (1H, br s), 3.40 (1H, m), 3.62 (1H, br d, <i>J</i> = 8.3 Hz), 4.36–4.84 (3H, m), 6.61 (1H, br s), 7.06–7.35 (11H, m), 7.63 (1H, m), 7.69 (2H, d, <i>J</i> = 8.0 Hz), 9.35 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 28.4, 37.3, 48.0, 57.2, 64.2, 81.8, 124.9, 125.9, 126.1, 126.6, 126.8, 127.5, 127.8, 128.8, 129.3, 130.4, 130.7, 132.6, 137.5, 142.5, 154.9, 166.3, 182.8; <i>m</i>/<i>z</i> (ES, %) 557 ([M + Na]<sup>+</sup>, 36), 435 (100); HRMS calcd for C<sub>29</sub>H<sub>34</sub>N<sub>4</sub>NaO<sub>4</sub>S [M + Na]<sup>+</sup> 557.2193, found 557.2192.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>tert</i>-Butyl <i>N</i>-(2-{4-[({[(2<i>R</i>)-1-Hydroxy-3-phenylpropan-2-yl]carbamothioyl}amino)methyl]benzamido}phenyl)carbamate (<b>23e</b>)</h3><div class="NLM_p last"><span class="smallcaps smallerCapital">d</span>-Phenylalaninol (0.126 g, 0.83 mmol) was reacted according to general procedure A and the product purified by column chromatography on silica gel (2:1 ethyl acetate/hexane) to give <b>23e</b> as a white solid (0.382 g, 94%), mp 101–103 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3279, 1692, 1648; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.49 (9H, s), 1.88 (1H, s), 2.72 (1H, dd, <i>J</i> = 13.6, 8.0 Hz), 2.84 (1H, dd, <i>J</i> = 13.6, 5.8 Hz), 3.37 (2H, br s), 3.60 (1H, d, <i>J</i> = 10.5 Hz), 4.28–5.00 (3H, m), 6.65 (1H, br s), 7.06–7.37 (10H, m), 7.60 (1H, d, <i>J</i> = 7.3 Hz), 7.67 (2H, d, <i>J</i> = 7.8 Hz), 9.38 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 28.4, 37.3, 48.0, 57.2, 64.1, 81.8, 124.9, 125.9, 126.1, 126.6, 126.8, 127.5, 127.8, 128.8, 129.3, 130.4, 130.7, 132.6, 137.5, 142.5, 154.9, 166.3, 182.8; <i>m</i>/<i>z</i> (ES, %) 557 ([M + Na]<sup>+</sup>, 100); HRMS (CI) calcd for C<sub>29</sub>H<sub>35</sub>N<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 535.2374, found 535.2378.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>S</i>)-<i>tert</i>-Butyl <i>N</i>-(2-(4-((3-(2-Hydroxy-2-phenylethyl)thioureido)methyl)benzamido)phenyl)carbamate (<b>23f</b>)</h3><div class="NLM_p last">(<i>S</i>)-(+)-2-Amino-1-phenylethanol (0.125 g, 0.91 mmol) was reacted according to general procedure A. The product was purified by column chromatography on silica gel (3:2 ethyl acetate/hexane) followed by column chromatography on silica gel (1:1 ethyl acetate/hexane) to give <b>23f</b> as a white solid (0.272 g, 57%), mp 150–154 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3284, 1682, 1661; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.48 (9H, s), 1.82 (1H, s), 3.48 (1H, br s), 3.58–4.35 (2H, m), 4.69 (3H, br s), 6.88 (1H, br s), 7.10–7.20 (2H, m), 7.20–7.40 (8H, m), 7.53–7.62 (1H, m), 7.68 (2H, d, <i>J</i> = 8.0 Hz), 9.41 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 28.4, 48.3, 52.0, 74.0, 81.8, 124.9, 125.9, 126.0, 126.1, 126.6, 127.7, 127.8, 128.0, 128.6, 130.4, 130.6, 132.7, 141.6, 142.4, 154.9, 166.2, 183.7; <i>m</i>/<i>z</i> (EI, %) 519 ([M – H]<sup>−</sup>, 35); HRMS (CI) calcd for C<sub>28</sub>H<sub>33</sub>N<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 521.2217, found 521.2208.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>R</i>)-<i>tert</i>-Butyl <i>N</i>-(2-(4-((3-(2-Hydroxy-2-phenylethyl)thioureido)methyl)benzamido)phenyl)carbamate (<b>23g</b>)</h3><div class="NLM_p last">(<i>R</i>)-(−)-2-Amino-1-phenylethanol (0.137 g, 1.0 mmol) was reacted according to general procedure A to give <b>23g</b> as a pale yellow solid (0.519 g, quantitative) which was used without purification, mp 153–156 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3287, 1682, 1660; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.48 (9H, s), 1.60 (1H, s), 3.29–4.08 (3H, m), 4.57–5.01 (3H, m), 6.64 (1H, br s), 7.06 (1H, br s), 7.15–7.23 (2H, m), 7.24–7.36 (7H, m), 7.66 (1H, d, <i>J</i> = 7.2 Hz), 7.73 (2H, d, <i>J</i> = 7.2 Hz), 9.36 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 28.4, 48.5, 52.0, 74.2, 81.9, 125.0, 125.9, 126.2, 126.5, 127.7, 127.9, 128.1, 128.7, 130.4, 130.7, 132.9, 141.6, 142.2, 154.9, 166.0, 183.8; <i>m</i>/<i>z</i> (EI, %) 519 ([M – H]<sup>−</sup>, 50); HRMS (CI) calcd for C<sub>28</sub>H<sub>33</sub>N<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 521.2217, found 521.2195.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>tert</i>-Butyl <i>N</i>-(2-(4-((3-((1<i>R</i>,2<i>S</i>)-2-Hydroxy-1,2-diphenylethyl)thioureido)methyl)benzamido)phenyl)carbamate (<b>23h</b>)</h3><div class="NLM_p last">(1<i>S</i>,2<i>R</i>)-(+)-2-Amino-1,2-diphenylethanol (0.213 g, 1.0 mmol) was reacted according to general procedure A to give <b>23h</b> as a pale yellow solid (0.59 g, 99%) which was used without purification, mp 130–133 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3275, 1693, 1650; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.49 (9H, s), 3.21 (1H, br s), 4.56 (1H, dd, <i>J</i> = 15.4, 4.9 Hz), 4.76 (1H, d, <i>J</i> = 15.0 Hz), 5.08 (1H, d, <i>J</i> = 3.8 Hz), 5.51 (1H, br s), 6.85–7.11 (10H, m), 7.12–7.30 (8H, m), 7.58–7.74 (3H, m), 9.35 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 28.4, 48.3, 63.8, 76.7, 81.7, 124.8, 125.9, 126.1, 126.4, 126.6, 127.5, 127.8, 128.0, 128.2, 128.2, 128.3, 130.3, 130.5, 133.0, 136.4, 139.6, 142.1, 154.8, 166.1, 182.4; <i>m</i>/<i>z</i> (EI, %) 595 ([M – H]<sup>−</sup>, 80); HRMS (CI) calcd for C<sub>34</sub>H<sub>37</sub>N<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 597.2530, found 597.2516.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>tert</i>-Butyl <i>N</i>-(2-(4-((3-((1<i>S</i>,2<i>R</i>)-2-Hydroxy-1,2-diphenylethyl)thioureido)methyl)benzamido)phenyl)carbamate (<b>23i</b>)</h3><div class="NLM_p last">(1<i>R</i>,2<i>S</i>)-(−)-2-Amino-1,2-diphenylethanol (0.213 g, 1.0 mmol) was reacted according to general procedure A to give <b>23i</b> as a pale yellow solid (0.59 g, quantitative) which was used without purification, mp 135–140 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3273, 1693, 1651; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.46 (9H, s), 3.21 (1H, br s), 4.54 (1H, dd, <i>J</i> = 15.1, 4.1 Hz), 4.72 (1H, br s), 5.06 (1H, d, <i>J</i> = 3.4 Hz), 5.51 (1H, br s), 6.87–7.10 (10H, m), 7.12–7.25 (8H, m), 7.58–7.70 (3H, m), 9.33 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 28.4, 48.3, 63.8, 76.6, 81.7, 124.8, 125.9, 126.0, 126.4, 126.6, 127.5, 127.8, 128.0, 128.2, 128.2, 128.3, 130.3, 130.5, 133.0, 136.4, 139.6, 142.1, 154.8, 166.1, 182.4; <i>m</i>/<i>z</i> (EI, %) 595 ([M – H]<sup>−</sup>, 60); HRMS (CI) calcd for C<sub>34</sub>H<sub>37</sub>N<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 597.2530, found 597.2524.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Synthesis of 2-Aminothiazolines: General Procedure B</h3><div class="NLM_p last">A solution of the thiourea (1 mmol) in concentrated hydrochloric acid (20 mL, 10 M) was heated at 90 °C under reflux with stirring for the given length of time. Aqueous sodium hydroxide (5 M) was then added to give pH ≈ 9, and the mixture was extracted with ethyl acetate (3 × 50 mL). The combined organic layers were washed with brine (2 × 100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified as described below.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-(2-Aminophenyl)-4-({[(4<i>S</i>)-4-phenyl-4,5-dihydro-1,3-thiazol-2-yl]amino}methyl)benzamide (<b>24a</b>)</h3><div class="NLM_p last">A solution of <b>23a</b> (0.460 g, 0.883 mmol) in concentrated hydrochloric acid (15 mL, 10M) was heated at 90 °C under reflux with stirring for 75 min. Aqueous sodium hydroxide (5M) was then added to give pH ≈ 9. The mixture was extracted with ethyl acetate (100 mL, then 2 × 50 mL). The combined organic layers were washed with brine, dried Na<sub>2</sub>SO<sub>4</sub>, and evaporated. Purification of the residue by column chromatography on silica gel (7:1 and then 8:1 ethyl acetate/hexane) gave a cream solid (257 mg) which was further purified by recrystallization from chloroform to give <b>24a</b> as a white solid (85 mg, 24%), mp 150–151 °C; [α]<sub class="stack">D</sub><sup class="stack">20</sup> +77.3 (<i>c</i> 1.0, methanol); ν<sub>max</sub> (cm<sup>–1</sup>) 3190, 1622; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.23 (1H, dd, <i>J</i> = 10.6, 8.3 Hz), 3.70 (1H, dd, <i>J</i> = 10.6, 7.7 Hz), 3.89 (2H, br s), 4.54 (2H, s), 5.28 (1H, app t, <i>J</i> = 8.0 Hz), 5.66 (1H, br s), 6.79–6.90 (2H, m), 7.11 (1H, td, <i>J</i> = 7.7, 1.5 Hz), 7.22–7.36 (6H, m), 7.40 (2H, d, <i>J</i> = 8.0 Hz), 7.84 (2H, d, <i>J</i> = 8.0 Hz), 8.04 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) d 42.5, 49.4, 74.4, 118.5, 119.9, 124.7, 125.4, 126.5, 127.3, 127.6, 127.7, 127.8, 128.6, 133.2, 140.9, 143.1, 143.3, 162.3, 165.8; <i>m</i>/<i>z</i> (CI, %) 403 ([M + H]<sup>+</sup>, 21), 385 (100); HRMS calcd for C<sub>23</sub>H<sub>23</sub>N<sub>4</sub>OS [M + H]<sup>+</sup> 403.1587, found 403.1585. Anal. Calcd for C<sub>23</sub>H<sub>22</sub>N<sub>4</sub>OS: C, 68.63; H, 5.51; N, 13.92. Found: C, 68.02; H, 5.38; N, 13.85.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-(2-Aminophenyl)-4-({[(4<i>R</i>)-4-phenyl-4,5-dihydro-1,3-thiazol-2-yl]amino}methyl)benzamide (<b>24b</b>)</h3><div class="NLM_p last">The thiourea <b>23b</b> (0.345 g, 0.663 mmol) was reacted according to general procedure B for 45 min. Purification of the residue by column chromatography on silica gel (8:1 ethyl acetate/hexane) afforded a cream solid (149 mg) which was recrystallized from chloroform to give <b>24b</b> as a white solid (62 mg, 23%), mp 155–156 °C; [α]<sub class="stack">D</sub><sup class="stack">20</sup> −62.0 (<i>c</i> 1.0, methanol); ν<sub>max</sub> (cm<sup>–1</sup>) 3281, 1612; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.23 (1H, dd, <i>J</i> = 10.5, 8.3 Hz), 3.70 (1H, dd, <i>J</i> = 10.5, 7.5 Hz), 3.90 (2H, br s), 4.47–4.60 (2H, m), 5.28 (1H, t, <i>J</i> = 7.9 Hz), 5.71 (1H, br s), 6.78–6.91 (2H, m), 7.11 (1H, td, <i>J</i> = 7.6, 1.0 Hz), 7.20–7.36 (6H, m), 7.40 (2H, d, <i>J</i> = 8.0 Hz), 7.85 (2H, d, <i>J</i> = 7.8 Hz), 8.05 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 42.5, 49.3, 74.5, 118.5, 119.9, 124.7, 125.4, 126.5, 127.3, 127.6, 127.7, 127.8, 128.6, 133.2, 140.8, 143.1, 143.3, 162.2, 165.7; <i>m</i>/<i>z</i> (ES, %) 403 ([M + H]<sup>+</sup>, 100); HRMS (CI) calcd for C<sub>23</sub>H<sub>23</sub>N<sub>4</sub>OS [M + H]<sup>+</sup> 403.1587, found 403.1570.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>S</i>)-<i>N</i>-(2-Aminophenyl)-4-(((4-(4-hydroxyphenyl)-4,5-dihydrothiazol-2-yl)amino)methyl)benzamide (<b>24c</b>)</h3><div class="NLM_p last">To a solution of the thiourea <b>23c</b> (0.35 g, 0.65 mmol) in anhydrous THF (10 mL) was added triphenylphosphine (0.26 g, 0.98 mmol), and then a solution of diethyl azodicarboxylate (0.155 mL, 0.98 mmol) in anhydrous THF (5.0 mL) was added dropwise by syringe over 5 min. The solution was stirred for 75 min at 20 °C. Then HCl in diethyl ether (2 M, 5.0 mL) was added and the mixture stirred for 5 h at 20 °C. The suspension was kept at 4 °C for 3 days, then filtered, and the hygroscopic white solid was partitioned between 5% methanol/dichloromethane (25 mL) and saturated aqueous sodium hydrogen carbonate (20 mL). The aqueous layer was extracted with 5% methanol/dichloromethane (2 × 25 mL). The combined organic layers were washed with brine (20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. Purification of the residue by column chromatography on silica gel (8% methanol/dichloromethane) gave <b>24c</b> as a white solid (0.128 g, 47%), mp 128–131 °C; [α]<sub class="stack">D</sub><sup class="stack">20</sup> −63.8 (<i>c</i> 1.0, methanol); ν<sub>max</sub> (cm<sup>–1</sup>) 3250, 1607; <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 3.15 (1H, dd, <i>J</i> = 10.5, 7.5 Hz), 3.66 (1H, dd, <i>J</i> = 10.7, 7.7 Hz), 4.53 (1H, m), 4.61 (1H, m), 5.21 (1H, t, <i>J</i> = 7.4 Hz), 6.74 (2H, d, <i>J</i> = 8.5 Hz), 6.80 (1H, t, <i>J</i> = 7.5 Hz), 6.93 (1H, d, <i>J</i> = 7.8 Hz), 7.03–7.16 (3H, m), 7.21 (1H, d, <i>J</i> = 7.8 Hz), 7.50 (2H, d, <i>J</i> = 8.2 Hz), 7.98 (2H, d, <i>J</i> = 8.2 Hz); <sup>13</sup>C NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 42.8, 49.9, 54.9, 75.4, 116.1, 118.8, 119.8, 125.4, 127.7, 128.6, 128.7, 129.1, 134.2, 135.4, 143.7, 144.8, 157.9, 165.0, 168.7; <i>m</i>/<i>z</i> (CI, %) 419 ([M + H]<sup>+</sup>, 85); HRMS calcd for C<sub>23</sub>H<sub>23</sub>N<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 419.1536, found 419.1525.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N-</i>(2-Aminophenyl)-4-(([(4<i>S</i>)-4-benzyl-4,5-dihydro-1,3-thiazol-2-yl]amino)methyl)benzamide (<b>24d</b>)</h3><div class="NLM_p last">A solution of <b>23d</b> (0.135 g, 0.252 mmol) in concentrated hydrochloric acid (10 M, 5 mL) was heated at 90 °C under reflux with stirring for 15 min. Aqueous sodium hydroxide (5 M) was then added to give pH ≈ 9, and the mixture was extracted with ethyl acetate (3 × 30 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. Purification of the residue by column chromatography on silica gel (1% methanol in ethyl acetate) gave a cream solid (68 mg) which was further purified by recrystallization from chloroform to give <b>24d</b> as a white solid (10 mg, 10%), mp 144–145 °C; [α]<sub class="stack">D</sub><sup class="stack">20</sup> −9.2 (<i>c</i> 1.0, methanol); ν<sub>max</sub> (cm<sup>–1</sup>) 3162, 1636, 1614; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.72 (1H, dd, <i>J</i> = 13.4, 8.8 Hz), 3.00–3.10 (2H, m), 3.24 (1H, dd, <i>J</i> = 10.6, 7.2 Hz), 3.94 (3H, br s), 4.34–4.42 (1H, m), 4.47 (2H, m), 6.74–6.86 (2H, m), 7.07 (1H, app t, <i>J</i> = 7.5 Hz), 7.19 (2H, d, <i>J</i> = 7.4 Hz), 7.22 (1H, d, <i>J</i> = 7.1 Hz), 7.25–7.31 (3H, m), 7.34 (2H, d, <i>J</i> = 7.7 Hz), 7.80 (2H, d, <i>J</i> = 7.7 Hz), 8.13 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 38.3, 41.3, 49.6, 71.9, 118.5, 119.8, 124.6, 125.5, 126.6, 127.3, 127.7, 127.8, 128.6, 129.4, 133.2, 138.8, 140.9, 143.2, 161.5, 165.8; <i>m</i>/<i>z</i> (ES, %) 417 ([M + H]<sup>+</sup>, 100); HRMS calcd for C<sub>24</sub>H<sub>25</sub>N<sub>4</sub>OS [M + H]<sup>+</sup> 417.1744, found 417.1738.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N-</i>(2-Aminophenyl)-4-(([(4<i>R</i>)-4-benzyl-4,5-dihydro-1,3-thiazol-2-yl]amino)methyl)benzamide (<b>24e</b>)</h3><div class="NLM_p last">The thiourea <b>23e</b> (0.355 g, 0.664 mmol) was reacted according to general procedure B for 15 min. Purification of the residue by column chromatography on silica gel (3:2 and then 2:1 ethyl acetate/hexane) gave a cream solid (117 mg) which was recrystallized from chloroform to give <b>24e</b> as a white solid (62 mg, 22%), mp 143–144 °C; [α]<sub class="stack">D</sub><sup class="stack">20</sup> +9.7 (<i>c</i> 1.0, methanol); ν<sub>max</sub> (cm<sup>–1</sup>) 3164, 1662, 1615; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.75 (1H, dd, <i>J</i> = 13.3, 8.8 Hz), 2.98–3.17 (2H, m), 3.28 (1H, dd, <i>J</i> = 10.7, 7.2 Hz), 3.90 (2H, br s), 4.38–4.47 (1H, m), 4.47–4.59 (2H, m), 5.16 (1H, br s), 6.76–6.93 (2H, m), 7.11 (1H, td, <i>J</i> = 7.7, 1.0 Hz), 7.17–7.35 (6H, m), 7.40 (2H, d, <i>J</i> = 8.0 Hz), 7.85 (2H, d, <i>J</i> = 8.0 Hz), 8.05 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 38.5, 41.3, 49.6, 72.1, 118.5, 119.9, 124.7, 125.3, 126.5, 127.3, 127.7, 127.8, 128.6, 129.4, 133.2, 138.8, 140.8, 143.3, 161.0, 165.7; <i>m</i>/<i>z</i> (ES, %) 417 ([M + H]<sup>+</sup>, 100); HRMS (CI) calcd for C<sub>24</sub>H<sub>25</sub>N<sub>4</sub>OS [M + H]<sup>+</sup> 417.1744, found 417.1723.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>R</i>)-<i>N</i>-(2-Aminophenyl)-4-(((5-phenyl-4,5-dihydrothiazol-2-yl)amino)methyl)benzamide (<b>24f</b>)</h3><div class="NLM_p last">The thiourea <b>23f</b> (0.25 g, 0.48 mmol) was reacted according to general procedure B for 45 min. The residue was purified by column chromatography on silica gel (5% methanol/dichloromethane) and then recrystallized from aqueous ethanol to give <b>24f</b> as a white solid (41 mg, 21%), mp 161–163 °C; [α]<sub class="stack">D</sub><sup class="stack">20</sup> +38.4 (<i>c</i> 1.0, methanol); ν<sub>max</sub> (cm<sup>–1</sup>) 3250, 1610; <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 4.00 (1H, dd, <i>J</i> = 13.2, 5.3 Hz), 4.27 (1H, dd, <i>J</i> = 13.2, 7.6 Hz), 4.57 (2H, s), 5.04 (1H, dd, <i>J</i> = 7.6, 5.3 Hz), 6.80 (1H, td, <i>J</i> = 7.7, 1.3 Hz), 6.93 (1H, dd, <i>J</i> = 8.0, 1.3 Hz), 7.10 (1H, m), 7.21 (1H, dd, <i>J</i> = 7.9, 1.1 Hz), 7.27 (1H, m), 7.30–7.36 (2H, m), 7.37–7.42 (2H, m), 7.51 (2H, d, <i>J</i> = 8.2 Hz), 7.99 (2H, d, <i>J</i> = 8.2 Hz); <sup>13</sup>C NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 48.5, 56.3, 68.3, 118.8, 119.7, 125.4, 127.7, 128.1, 128.4, 128.5, 128.7, 129.0, 129.7, 134.3, 143.1, 143.8, 144.7, 164.4, 168.7; <i>m</i>/<i>z</i> (CI, %) 403 ([M + H]<sup>+</sup>, 100); HRMS calcd for C<sub>23</sub>H<sub>23</sub>N<sub>4</sub>OS [M + H]<sup>+</sup>, 403.1587, found 403.1566.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>S</i>)-<i>N</i>-(2-Aminophenyl)-4-(((5-phenyl-4,5-dihydrothiazol-2-yl)amino)methyl)benzamide (<b>24g</b>)</h3><div class="NLM_p last">The thiourea <b>23g</b> (0.50 g, 0.96 mmol) was reacted according to general procedure B for 30 min. Purification by column chromatography on silica gel (7% methanol/dichloromethane) gave a residue that was twice recrystallized from ethanol and water to give <b>24g</b> as a white solid (0.19 g, 49%), mp 159–164 °C; [α]<sub class="stack">D</sub><sup class="stack">20</sup> −35.3 (<i>c</i> 1.0, methanol); ν<sub>max</sub> (cm<sup>–1</sup>) 3328, 1633, 1620; <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 3.98 (1H, dd, <i>J</i> = 13.2, 5.3 Hz), 4.25 (1H, dd, <i>J</i> = 13.2, 7.7 Hz), 4.55 (2H, br s), 5.03 (1H, m), 6.78 (1H, t, <i>J</i> = 7.5 Hz), 6.91 (1H, d, <i>J</i> = 7.9 Hz), 7.08 (1H, t, <i>J</i> = 7.5 Hz), 7.19 (1H, d, <i>J</i> = 7.5 Hz), 7.25 (1H, m), 7.28–7.40 (4H, m), 7.48 (2H, d, <i>J</i> = 7.9 Hz), 7.97 (2H, d, <i>J</i> = 7.9 Hz); <sup>13</sup>C NMR (150 MHz, methanol-<i>d</i><sub>4</sub>) δ 48.6, 56.3, 68.0, 118.9, 119.9, 125.5, 127.8, 128.3, 128.6, 128.7, 128.9, 129.2, 129.9, 134.5, 143.0, 143.9, 144.6, 164.9, 168.8; <i>m</i>/<i>z</i> (ES, %) 401 ([M – H]<sup>−</sup>, 100); HRMS calcd for C<sub>23</sub>H<sub>21</sub>N<sub>4</sub>OS [M – H]<sup>−</sup> 401.1442, found 401.1446.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>N</i>-(2-Aminophenyl)-4-((((4<i>R</i>,5<i>R</i>)-4,5-diphenyl-4,5-dihydrothiazol-2-yl)amino)methyl)benzamide (<b>24h</b>)</h3><div class="NLM_p last">The thiourea <b>23h</b> (0.570 g, 0.96 mmol) was reacted according to general procedure B for 10 min. The resulting off-white solid was recrystallized from ethyl acetate and hexane to give <b>24h</b> as a white solid (0.165 g, 36%), mp 166–168 °C; [α]<sub class="stack">D</sub><sup class="stack">20</sup> +80.3 (<i>c</i> 1.0, methanol); ν<sub>max</sub> (cm<sup>–1</sup>) 3272, 1610; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.87 (2H, br s), 4.49 (2H, s), 4.75 (1H, d, <i>J</i> = 6.7 Hz), 5.24 (1H, d, <i>J</i> = 6.7 Hz), 6.77–6.85 (2H, m), 7.08 (1H, t, <i>J</i> = 7.7 Hz), 7.10–7.17 (2H, m), 7.18–7.40 (11H, m), 7.80 (2H, d, <i>J</i> = 7.5 Hz), 8.20 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 49.2, 64.0, 82.7, 118.4, 119.8, 124.7, 125.5, 126.5, 127.3, 127.7, 127.7, 127.8, 127.9, 128.0, 128.5, 128.9, 133.2, 140.2, 140.9, 142.1, 143.3, 161.3, 165.9; <i>m</i>/<i>z</i> (ES, %) 477 ([M – H]<sup>−</sup>, 100); HRMS calcd for C<sub>29</sub>H<sub>25</sub>N<sub>4</sub>OS [M – H]<sup>−</sup> 477.1755, found 477.1770.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-(2-Aminophenyl)-4-((((4<i>S</i>,5<i>S</i>)-4,5-diphenyl-4,5-dihydrothiazol-2-yl)amino)methyl)benzamide (<b>24i</b>)</h3><div class="NLM_p last">The thiourea <b>23i</b> (0.572 g, 0.96 mmol) was reacted according to general procedure B for 10 min. The resulting off-white solid was recrystallized twice from ethyl acetate and hexane to give <b>24i</b> as a white solid (0.151 g, 33%), mp 162–164 °C; [α]<sub class="stack">D</sub><sup class="stack">20</sup> −79.3 (<i>c</i> 1.0, methanol); ν<sub>max</sub> (cm<sup>–1</sup>) 3239, 1610; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.31 (2H, br s), 4.50 (2H, s), 4.75 (1H, d, <i>J</i> = 6.8 Hz), 5.25 (1H, d, <i>J</i> = 6.8 Hz), 6.77–6.85 (2H, m), 7.08 (1H, t, <i>J</i> = 7.7 Hz), 7.10–7.16 (2H, m), 7.20–7.34 (9H, m), 7.36 (2H, d, <i>J</i> = 7.9 Hz), 7.82 (2H, d, <i>J</i> = 7.9 Hz), 8.17 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 49.3, 64.0, 82.6, 118.5, 119.8, 124.6, 125.5, 126.5, 127.4, 127.8, 127.8, 127.9, 128.1, 128.6, 128.9, 133.2, 140.1, 140.9, 142.0, 143.2, 161.5, 165.8; <i>m</i>/<i>z</i> (ES, %) 477 ([M – H]<sup>−</sup>, 100); HRMS calcd for C<sub>29</sub>H<sub>25</sub>N<sub>4</sub>OS [M – H]<sup>−</sup> 477.1755, found 477.1761.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (2<i>S</i>)-2-Amino-3-(1<i>H</i>-indol-3-yl)propan-1-ol (<b>25b</b>)</h3><div class="NLM_p last">To an oven-dried three-neck flask equipped with a magnetic stirrer and a reflux condenser was added sodium borohydride (0.756 g, 20.0 mmol) and <span class="smallcaps smallerCapital">l</span>-tryptophan (2.04 g, 10.0 mmol), followed by dry THF (20 mL). A dropping funnel was attached to the flask, and the mixture was then cooled to 0 °C in an ice bath. A solution of iodine (2.54 g, 10.0 mmol) in THF (10 mL) was added dropwise over 20 min. When the vigorous evolution of gas had ceased, the mixture was heated at reflux for 17 h. After the mixture was cooled to 20 °C, methanol was added slowly until the solution became clear, and the mixture was then stirred for 30 min. Evaporation gave a white paste which was dissolved in aqueous potassium hydroxide (20%, 20 mL), stirred for 20 h, then adjusted to pH 11 with hydrochloric acid (2 M). The solution was extracted with dichloromethane (3 × 20 mL) and then with a mixture of 1:4 ethanol/chloroform (4 × 25 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give <b>25b</b> as a yellow oil (1.38 g, 73%); ν<sub>max</sub> (cm<sup>–1</sup>) 3401, 3251, 3049; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.73 (3H, br s), 2.74 (1H, dd, <i>J</i> = 14.4, 8.4 Hz), 2.97 (1H, dd, <i>J</i> = 14.4, 5.1 Hz), 3.29 (1H, m), 3.46 (1H, dd, <i>J</i> = 10.5, 7.2 Hz), 3.72 (1H, dd, <i>J</i> = 10.5, 4.0 Hz), 7.08 (1H, d, <i>J</i> = 2.0 Hz), 7.15 (1H, t, <i>J</i> = 7.3 Hz), 7.24 (1H, t, <i>J</i> = 7.2 Hz), 7.40 (1H, d, <i>J</i> = 8.0 Hz), 7.64 (1H, d, <i>J</i> = 8.0 Hz), 8.09 (1H, br s); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 30.5, 53.0, 66.9, 111.3, 112.8, 119.0, 119.6, 122.3, 122.7, 127.7, 136.5.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (4<i>S</i>)-4-(1<i>H</i>-Indol-3-ylmethyl)-1,3-thiazolidine-2-thione (<b>26b</b>)</h3><div class="NLM_p last">To a mixture of amino alcohol <b>25b</b> (0.34 g, 1.79 mmol) in aqueous potassium hydroxide (9 mL, 1 M) was added carbon disulfide (0.54 mL, 8.95 mmol. CAUTION: FLAMMABLE). The mixture was stirred at reflux for 18 h and then cooled to 20 °C and extracted with dichloromethane (3 × 10 mL). The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, and evaporated. The residue was purified by column chromatography on silica gel (1:1 ethyl acetate/hexane) to give <b>26b</b> as a white solid (0.161 g, 36%), mp 73–75 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3310, 3146; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.12 (1H, dd, <i>J</i> = 14.3, 6.1 Hz), 3.16 (1H, dd, <i>J</i> = 14.3, 7.7 Hz), 3.35 (1H, dd, <i>J</i> = 11.1, 6.6 Hz), 3.61 (1H, dd, <i>J</i> = 11.1, 7.8 Hz), 4.56 (1H, m), 7.08 (1H, d, <i>J</i> = 2.4 Hz), 7.16 (1H, td, <i>J</i> = 7.4, 0.9 Hz), 7.24 (1H, td, <i>J</i> = 7.7, 0.9 Hz), 7.41 (1H, d, <i>J</i> = 8.2 Hz), 7.52–7.61 (2H, m), 8.22 (1H, br s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 30.1, 38.5, 64.4, 110.3, 111.7, 118.4, 120.1, 122.7, 123.1, 126.9, 136.4, 200.9; <i>m</i>/<i>z</i> (EI, %) 248 (M<sup>+</sup>, 100); HRMS calcd for C<sub>12</sub>H<sub>12</sub>N<sub>2</sub>S<sub>2</sub> M<sup>+</sup> 248.0436, found 248.0438.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>tert</i>-Butyl <i>N</i>-(2-([4-(Chloromethyl)benzoyl]amino)phenyl)carbamate (<b>28a</b>)</h3><div class="NLM_p last">To a solution of <i>tert</i>-butyl (2-aminophenyl)carbamate)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> (2.55 g, 12.2 mmol) in dichloromethane (50 mL) cooled to −10 °C was added triethylamine (1.86 mL, 13.4 mmol) followed by a solution of 4-(chloromethyl)benzoyl chloride (<b>27</b>) (2.54 g, 13.4 mmol) in dichloromethane (20 mL), added dropwise. The stirred solution was allowed to warm to 20 °C and then stirred for 1 h. Evaporation gave a solid that was dissolved in dichloromethane (200 mL) and the solution washed successively with saturated aqueous ammonium chloride (200 mL), saturated aqueous sodium hydrogen carbonate (200 mL), and brine, then dried over MgSO<sub>4</sub>, filtered, and evaporated to give <b>28a</b> as a white solid (4.02 g, 91%), mp 172–173 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3277, 1682, 1655, 1599; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.51 (9H, s), 4.63 (2H, s), 6.83 (1H, br s), 7.14 (1H, t, <i>J</i> = 7.6 Hz), 7.21 (2H, t, <i>J</i> = 7.6 Hz), 7.48 (2H, d, <i>J</i> = 8.2 Hz), 7.77 (1H, d, <i>J</i> = 7.9 Hz), 7.96 (2H, d, <i>J</i> = 8.2 Hz), 9.27 (1H, br s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 28.4, 45.5, 81.6, 124.6, 125.9, 126.1, 126.1, 127.9, 128.8, 129.9, 130.9, 134.3, 141.3, 154.8, 165.1; <i>m</i>/<i>z</i> (ES, %) 383 ([M + Na]<sup>+</sup>, 90); HRMS calcd for C<sub>19</sub>H<sub>21</sub>ClN<sub>2</sub>NaO<sub>3</sub> [M + Na]<sup>+</sup> 383.1133, found 383.1136.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>N-</i>(2-Aminophenyl)-4-(chloromethyl)benzamide (<b>28b</b>)</h3><div class="NLM_p last">To a solution of the benzyl chloride <b>28a</b> (0.361 g, 1.0 mmol) in dichloromethane (2.5 mL) was added trifluoroacetic acid (0.5 mL). The solution was stirred at 20 °C for 2.5 h, then evaporated and toluene (3 mL) added to the residue. The solvent was evaporated and the process repeated. The resulting yellow solid was triturated with diethyl ether three times, and the remaining white solid was partitioned between ethyl acetate (30 mL) and saturated aqueous sodium hydrogen carbonate (20 mL). The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give <b>28b</b> as a white solid (0.19 g, 73%), mp 132–133 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3370, 3279, 1645; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.83 (2H, s), 4.90 (2H, br s), 6.59 (1H, t, <i>J</i> = 7.4 Hz), 6.77 (1H, d, <i>J</i> = 7.3 Hz), 6.97 (1H, t, <i>J</i> = 7.6 Hz), 7.16 (1H, d, <i>J</i> = 7.6 Hz), 7.56 (2H, d, <i>J</i> = 7.9 Hz), 7.97 (2H, d, <i>J</i> = 7.9 Hz), 9.67 (1H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 45.5, 116.1, 116.2, 123.2, 126.6, 126.7, 128.1, 128.7, 134.5, 140.8, 143.1, 164.9; <i>m</i>/<i>z</i> (EI, %) 260 (M<sup>+</sup>, 11), 153 (30); HRMS calcd for C<sub>14</sub>H<sub>13</sub>ClN<sub>2</sub>O M<sup>+</sup> 260.0711, found 260.0708.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>tert</i>-Butyl <i>N-</i>(2-{[4-({[(4<i>S</i>)-4-Benzyl-4,5-dihydro-1,3-thiazol-2-yl]sulfanyl}methyl)benzene]amido}phenyl)carbamate (<b>29</b>)</h3><div class="NLM_p last">To a solution of the benzyl chloride <b>28a</b> (0.92 g, 2.55 mmol) in acetone (15 mL) was added sodium iodide (0.765 g, 5.10 mmol). The round-bottomed flask, oil bath, and condenser were wrapped in aluminum foil to exclude light, and the mixture was stirred at reflux for 2 h. When the mixture had cooled to 20 °C, a solution of thiazolidine-2-thione <b>26a</b> (0.485 g, 2.32 mmol) in dichloromethane (10 mL) was added followed by potassium carbonate (0.481 g, 3.48 mmol). The resulting mixture was stirred at 20 °C for 28 h (still with exclusion of light). Evaporation afforded a solid that was shaken with ethyl acetate. Filtration and evaporation of the filtrate gave a residue that was purified by column chromatography (dichloromethane and then 5% ethyl acetate in dichloromethane) to give <b>29</b> as a white solid (0.75 g, 61%), mp 67–69 °C; ν<sub>max</sub> (cm<sup>–1</sup>) 3275, 1693, 1656, 1600; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.50 (9H, s), 2.77 (1H, dd, <i>J</i> = 13.6, 8.5 Hz), 3.12–3.19 (2H, m), 3.35 (1H, dd, <i>J</i> = 10.7, 7.9 Hz), 4.36 (1H, d, <i>J</i> = 13.6 Hz), 4.43 (1H, d, <i>J</i> = 13.6 Hz), 4.70 (1H, m), 6.88 (1H, br s), 7.10–7.28 (6H, m), 7.32 (2H, t, <i>J</i> = 7.3 Hz), 7.45 (2H, d, <i>J</i> = 8.2 Hz), 7.74 (1H, d, <i>J</i> = 7.9 Hz), 7.90 (2H, d, <i>J</i> = 8.2 Hz), 9.18 (1H, br s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 28.4, 36.6, 39.4, 40.2, 77.5, 81.5, 124.6, 125.9, 126.0, 126.1, 126.7, 127.7, 128.6, 129.4, 129.4, 130.1, 130.9, 133.4, 138.3, 141.2, 154.7, 165.3; <i>m</i>/<i>z</i> (EI, %) 533 (M<sup>+</sup>, 35); HRMS calcd for C<sub>29</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub>S<sub>2</sub> M<sup>+</sup> 533.1801, found 533.1804.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>N-</i>(2-Aminophenyl)-4-(([(4<i>S</i>)-4-benzyl-4,5-dihydro-1,3-thiazol-2-yl]sulfanyl)methyl)benzamide (<b>30a</b>)</h3><div class="NLM_p last">To a solution of <b>29</b> (0.30 g, 0.562 mmol) in dichloromethane (2.5 mL) was added trifluoroacetic acid (0.5 mL). The solution was stirred at 20 °C for 2.5 h, then evaporated and toluene (3 mL) added to the residue. The solvent was evaporated and the process repeated three more times. The resulting solid was dissolved in dichloromethane (15 mL), and the solution was washed with saturated aqueous sodium hydrogen carbonate (15 mL). Additionally, the aqueous layer was extracted with dichloromethane (10 mL), and the combined organic layers were dried over MgSO<sub>4</sub> and evaporated. The residue was purified by column chromatography on silica gel (2:3 ethyl acetate/hexane) and the purified solid was recrystallized from dichloromethane and hexane to give <b>30a</b> as a white solid (0.135 g, 55%), mp 135–137 °C; [α]<sub class="stack">D</sub><sup class="stack">20</sup> −20.6 (<i>c</i> 1.0, methanol); ν<sub>max</sub> (cm<sup>–1</sup>) 3274, 1635, 1603; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.79 (1H, dd, <i>J</i> = 13.6, 8.8 Hz), 3.11–3.23 (2H, m), 3.36 (1H, dd, <i>J</i> = 10.9, 7.9 Hz), 3.84 (2H, br s), 4.37 (1H, d, <i>J</i> = 13.6 Hz), 4.42 (1H, d, <i>J</i> = 13.6 Hz), 4.71 (1H, m, CH), 6.78 −6.91 (2H, m), 7.09 (1H, t, <i>J</i> = 7.4 Hz), 7.19 −7.39 (6H, m), 7.46 (2H, d, <i>J</i> = 7.8 Hz), 7.83 (2H, d, <i>J</i> = 7.5 Hz), 8.06 (1H, br s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 36.5, 39.5, 40.2, 77.8, 118.6, 120.0, 124.7, 125.4, 126.7, 127.4, 127.7, 128.6, 129.4, 129.5, 133.2, 138.5, 140.5, 141.5, 163.9, 165.6; <i>m</i>/<i>z</i> (ES, %) 434 ([M + H]<sup>+</sup>, 100); HRMS calcd for C<sub>24</sub>H<sub>24</sub>N<sub>3</sub>OS<sub>2</sub> [M + H]<sup>+</sup> 434.1355, found 434.1360.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>-(2-Aminophenyl)-4-({[(4<i>S</i>)-4-(1<i>H</i>-indol-3-ylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]sulfanyl}methyl)benzamide (<b>30b</b>)</h3><div class="NLM_p last">To a solution of <b>26b</b> (0.229 g, 0.920 mmol) and <b>28b</b> (0.2 g, 0.767 mmol) in acetone (4 mL) was added potassium carbonate (0.159 g, 1.15 mmol). The mixture was stirred at reflux for 16.5 h. After the mixture was allowed to cool, the solvent was evaporated and the residue partitioned between water (25 mL) and ethyl acetate (25 mL). The aqueous layer was extracted with ethyl acetate (10 mL), and the combined organic layers were washed with brine (10 mL), dried over MgSO<sub>4</sub>, and evaporated to give a tan solid. Purification by column chromatography on silica gel (1:1 ethyl acetate/hexane) gave <b>30b</b> as a white solid (0.31 g, 86%), mp 138–140 °C; [α]<sub class="stack">D</sub><sup class="stack">20</sup> 16.5 (<i>c</i> 1.0, methanol); ν<sub>max</sub> (cm<sup>–1</sup>) 3379, 3324, 3209, 1638; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.96 (1H, dd, <i>J</i> = 14.6, 8.3 Hz), 3.13–3.27 (2H, m), 3.34 (1H, dd, <i>J</i> = 10.8, 8.0 Hz), 3.81 (2H, br s), 4.30 (1H, d, <i>J</i> = 13.6 Hz), 4.40 (1H, d, <i>J</i> = 13.6 Hz), 4.82 (1H, app. quintet, <i>J</i> = 7.1 Hz), 6.76–6.87 (2H, m), 6.91 (1H, s), 7.03–7.15 (2H, m), 7.18 (1H, t, <i>J</i> = 7.5 Hz), 7.26 (1H, d, <i>J</i> = 7.9 Hz), 7.33 (1H, d, <i>J</i> = 8.0 Hz), 7.39 (2H, d, <i>J</i> = 7.9 Hz), 7.64 (1H, d, <i>J</i> = 7.9 Hz), 7.72 (2H, d, <i>J</i> = 8.0 Hz), 7.98 (1H, br s), 8.36 (1H, br s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 29.8, 36.4, 39.8, 77.1, 111.4, 112.4, 118.4, 118.9, 119.4, 119.8, 122.1, 122.9, 124.4, 125.6, 127.5, 127.6, 127.7, 129.5, 133.1, 136.3, 141.0, 141.6, 163.5, 165.9; <i>m</i>/<i>z</i> (EI, %) 472 (M<sup>+</sup>, 10), 208 (100), 130 (100); HRMS calcd for C<sub>26</sub>H<sub>24</sub>N<sub>4</sub>OS<sub>2</sub> M<sup>+</sup> 472.1386, found 472.1393.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i>-(2-Aminophenyl)-4-({[(4<i>S</i>)-4-phenyl-4,5-dihydro-1,3-thiazol-2-yl]sulfanyl}methyl)benzamide (<b>30c</b>)</h3><div class="NLM_p last">To a solution of <b>26c</b> (83 mg, 0.425 mmol) and <b>28b</b> (110 mg, 0.422 mmol) in acetone (4 mL) was added potassium carbonate (88 mg, 0.638 mmol) and the mixture then stirred at reflux for 17 h. After the mixture had cooled, it was evaporated and the residue partitioned between water (15 mL) and ethyl acetate (15 mL). The aqueous layer was extracted with ethyl acetate (10 mL) and the combined organic layers were washed with brine (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated to give a tan solid. Purification by column chromatography on silica gel (1:7 ethyl acetate/dichloromethane) afforded <b>30c</b> (34 mg) and an impure fraction that was again purified by column chromatography on silica gel (2:3 ethyl acetate/hexane) to give <b>30c</b> as a white solid (total 115 mg, 62%), mp 113–114 °C; [α]<sub class="stack">D</sub><sup class="stack">20</sup> +75.5 (<i>c</i> 1.0, methanol); ν<sub>max</sub> (cm<sup>–1</sup>) 3276, 1647, 1614; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.30 (1H, dd, <i>J</i> = 10.9, 9.0 Hz), 3.63 (2H, br s), 3.78 (1H, dd, <i>J</i> = 10.9, 8.3 Hz), 4.40 (1H, d, <i>J</i> = 13.7 Hz), 4.46 (1H, d, <i>J</i> = 13.7 Hz), 5.49 (1H, t, <i>J</i> = 8.6 Hz), 6.74–6.85 (2H, m), 7.08 (1H, t, <i>J</i> = 7.3 Hz), 7.24–7.32 (4H, m), 7.32–7.38 (2H, m), 7.46 (2H, d, <i>J</i> = 7.9 Hz), 7.79 (2H, d, <i>J</i> = 7.9 Hz), 8.01 (1H, br s); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 36.5, 43.1, 79.6, 118.5, 119.9, 124.6, 125.4, 126.6, 127.4, 127.7, 127.9, 128.7, 129.6, 133.3, 140.8, 141.5, 141.6, 165.2, 165.6; <i>m</i>/<i>z</i> (EI<sup>+</sup>, %) 419 (M<sup>+</sup>, 100); HRMS calcd for C<sub>23</sub>H<sub>21</sub>N<sub>3</sub>OS<sub>2</sub> M<sup>+</sup>, 419.1121, found 419.1125.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Docking</h3><div class="NLM_p last">The PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A69">4A69</a> file was first processed using AutoDockTools 1.5.4; chains B–D, acetate (ACT), glycerol (GOL), inositol phosphate (IOP), potassium ions, and water molecules were removed. Polar hydrogen atoms and Kollman charges were added, and the charge on the Zn was set to +2.0. Compound <b>24a</b> was drawn in ChemBio3D Ultra 2012, and the structure was energy minimized using a MM2 minimize energy calculation, to a minimum rms gradient of 0.01. Docking was performed with AutoDock Vina (1.1.2) using an exhaustiveness of 1000 and a grid box of 18 Å × 18 Å × 16 Å, centered at the active site (34.60 (<i>x</i>), 58.97 (<i>y</i>), 27.32 (<i>z</i>)). The receptor was treated as rigid, and the ligand was treated as flexible. The maximum energy difference between the best and the worst binding modes displayed was set to be 2.5 kcal/mol. A maximum of 50 docking modes were output for further analysis. The image representing the best pose was prepared using PyMOL.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> In Vitro HDAC Inhibition Assay</h3><div class="NLM_p last">Recombinant HDAC isoforms were used. HDAC2 (1–488, His-tag), HDAC3-NCoR1, HDAC6 (His-tag), Fluor-de-Lys SIRT1, Fluor-de-Lys developer II, and TSA were purchased from Enzo Life Sciences, and porcine pancreatic trypsin (type IX-S) was from Sigma. HDAC1 (C-Flag) was purchased from Tebu Bio. HDAC8 was expressed in <i>Escherichia coli</i> BL21 cells and purified with a His-tag, which was removed prior to final purification by size exclusion chromatography. Boc-Lys(Ac)-7-amino-4-methylcoumarin (MAL) was synthesized according to the literature.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The in vitro HDAC assay used was based on a homogeneous fluorogenic HDAC assay.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Inhibitor solutions were prepared by serial dilution of a 5 mM DMSO stock solution with assay buffer in a 96-well white NBS microplate purified recombinant HDAC enzyme (HDAC1, 120 ng; HDAC2, 85 ng; HDAC3-NCoR1, 25 ng; HDAC6, 280 ng; HDAC8, 400 ng) in 20 μL of assay buffer comprising 50 mM Tris/Cl, pH 8.0, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl<sub>2</sub>, 1 mg/mL BSA. To each well was added inhibitor solution (10 μL). After incubation at 20–23 °C for the appropriate time (HDAC1, 1 h; HDAC2, HDAC3, and HDAC6, 3 h; HDAC8, 15 min) the fluorescent substrate (for HDAC1, HDAC2, HDAC3-NCoR1, and HDAC8, MAL (20 μL), to give concentrations of 60, 80, 14, and 200 mM; and for HDAC6, Fluor-de-Lys SIRT1, to give a concentration of 13 mM) was added and the plate was incubated for 60 min at 37 °C. A developer solution (for HDAC1, HDAC2, HDAC3-NCoR1, and HDAC8, 50 μL of 10 mg/mL trypsin and 2 mM TSA in assay buffer; for HDAC6 Fluor-de-Lys developer II and 2 mM TSA in 50 mM Tris/Cl, pH 8.0, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl<sub>2</sub>) was then added and the plate incubated for 30 min at 20 °C before the fluorescence was measured on a BMG FLUOstar Optima plate reader with excitation at 380 nm and emission at 460 nm.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Determination of IC<sub>50</sub> Values</h3><div class="NLM_p last">OriginPro 8 was used to determine IC<sub>50</sub> values from the sigmoidal line fitted to a graph of log[concentration] against the average percentage inhibition from two independent experiments, with at least six different concentrations. The SEM is the calculated standard error in the IC<sub>50</sub> value of the fitted line.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Calculation and Measurement of Physicochemical Properties</h3><div class="NLM_p last">clogP values were calculated using Daylight software, version 4.9: <a href="http://www.daylight.com/dayhtml/doc/clogp/index.html" class="extLink">http://www.daylight.com/dayhtml/doc/clogp/index.html</a>. (accessed June 27, 2013). Polar surface area (tpsa) was calculated according to a literature method.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Chrom log <i>D</i> and Chrom log <i>P</i> values<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and cell permeability (artificial membrane permeability)<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> were measured using procedures previously described. Solubility was measured using chemiluminescent nitrogen detection.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Cytochrome P450 inhibition data were obtained using an assay kit (Invitrogen) according to the protocol described at <a href="http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/Drug-Discovery/Target-Based-ADME-Tox-Assays/p450-assays/P450-Metabolism-Assays.html" class="extLink">http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/Drug-Discovery/Target-Based-ADME-Tox-Assays/p450-assays/P450-Metabolism-Assays.html</a> (accessed June 27, 2013) and using substrates sourced in house. The inhibition of isoform 3A4 was determined separately, using two different substrates, Vivid Red and Vivid Green, sourced from Invitrogen.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Cell Growth Inhibition Assays</h3><div class="NLM_p">A549, HCT116, and MCF-7 cells were maintained in RPMI 1640 (Invitrogen) supplemented with 10% (v/v) FCS, 5 mM glutamine (Invitrogen), 1× nonessential amino acids (Invitrogen), and 1× sodium pyruvate (Invitrogen). DU145 cells were grown in similarly supplemented DMEM media (Sigma). Cells were detached using trypsin EDTA solution (Invitrogen). Then an amount of 90 μL of cells (10 000 cells per well) was plated into 96-well plates (Greiner Microclear) in growth medium containing penicillin–streptomycin solution (Invitrogen) and cultured overnight at 37 °C in an incubator.</div><div class="NLM_p">Immediately prior to addition of compounds, one plate of each cell type was removed from the incubator and equilibrated at 20 °C for 1 h before assaying for ATP content by the addition of an equal volume of Cell Titre Glo solution (Promega). The resulting luminescence was measured using a Perkin-Elmer Envision 2104 multilabel reader in order to determine the zero time-point value.</div><div class="NLM_p">Test compounds (10 μL, in quadruplicate) were added to the cell plates. Final concentrations of compounds in the range 1.5 nM to 50 μM were used in assay medium containing 0.5% DMSO. Plates were cultured for a further 72 h at 37 °C, after which cellular ATP levels were assayed, as described above.</div><div class="NLM_p last">For each cell line, 72 h Cell Titre Glo data were expressed as the percentage of the zero time-point value. IC<sub>50</sub> values were generated by nonlinear regression of the data from three independent experiments using GraphPad Prism (version 5).</div></div><div id="sec5_58_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Histone H3 Acetylation Assay and Analysis of Cell Cycle Phases and Apoptosis. Cell Culture and Application of Compounds</h3><div class="NLM_p last">Human HeLa (epithelial adenocarcinoma) and human Jurkat (T cell leukemia) cell lines were cultured in a humidified incubator at 37 °C and 5% CO<sub>2</sub>. HeLa cells were maintained in Dulbecco’s modified Eagle medium supplemented with 10% v/v fetal bovine serum (Life Technologies) and <span class="smallcaps smallerCapital">l</span>-glutamine–penicillin–streptomycin solution (Sigma). The Jurkat cell line was maintained in RPMI 1640 medium supplemented 10% v/v fetal bovine serum (Life Technologies) and <span class="smallcaps smallerCapital">l</span>-glutamine–penicillin–streptomycin solution (Sigma). For both cell lines, cell density was adjusted to 1 × 10<sup>6</sup> cells in culture medium (10 mL) in 10 cm dishes for HeLa cells, or 25 mL flasks for Jurkat cells, prior to compound addition. By use of a 10 mM stock solution in DMSO, all HDAC inhibitors were dissolved sequentially at either 1 or 10 μM final concentration in fresh culture medium (500 μL), added dropwise to the adherent HeLa plates and Jurkat cell suspensions, mixed gently, and left to incubate for 24 h. An equivalent volume of DMSO was added to control cell cultures.</div></div><div id="sec5_58_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Cell Cycle Analysis by Flow Cytometry</h3><div class="NLM_p last">The method of Lea et al.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> was used. Briefly, samples of 1 × 10<sup>5</sup> cells were taken following a 24 h incubation with the compound and fixed in ethanol (400 μL, 70% v/v) at −20 °C. Following centrifugation at 400<i>g</i> for 8 min, the pellet was resuspended in FITC/PI cell cycle stain (400 μL) consisting of PI (40 μg, to stain for DNA content), FITC (5 μg/mL, protein staining), and RNase1 (1 μg/mL). The mixture was incubated at 37 °C for 30 min, then analyzed on a FACSCanto (Beckton Dickenson) flow cytometer. The FlowJo, version 10.0.6, program (Tree Star Inc.) was used to plot PI (FL2-A) against FITC (FL-1A) (<i>x</i>- and <i>y</i>-axes, respectively) to determine the percentage of cells in each cell cycle phase. Plotting FL2-W against FL2-H created a doublet discriminator gate to exclude doublets from the analysis. The percentage of cells in each cycle phase was calculated by applying gates manually around cell populations for the cell cycle phases indicated, as well as cell with sub-G1 DNA content.</div></div><div id="sec5_58_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Immunoblotting</h3><div class="NLM_p last">HeLa and Jurkat cell pellets containing 1 × 10<sup>6</sup> cells were resuspended in 1× SDS loading buffer (50 μL), vortexed, and heated for 5 min at 100 °C to denature the proteins. Samples were diluted 1:50 in SDS loading buffer and resolved by electrophoresis through polyacrylamide (4–12% w/v), Bis-Tris gels (Novex, Life Technologies). Proteins in each gel were transferred to a Hybond-C extra nitrocellulose membrane by electrophoresis at 25 V, 160 mA for 75 min. The nitrocellulose membrane was blocked with dried skimmed milk (Marvel, 5% w/v) and diluted in PBS–Tween 20 (0.05% v/v) for 1 h. Following a PBS–Tween 20 rinse, the membrane was immunoblotted with primary antibodies against histone H3 (DIH2), acetylated H3 (Lys 9) (C5BII, Cell Signaling Technologies), and PARP (Sc-8007). These were detected with anti-mouse or anti-rabbit horseradish peroxidase conjugated secondary antibodies (Dako or Santa Cruz), as appropriate, and ECL-plus detection reagent (GE Healthcare). Images were acquired by exposure to X-ray film (GE Healthcare).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70"><a href="/doi/suppl/10.1021/jm400634n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthesis and characterization of <b>2b</b>, <b>3</b>, <b>4</b>, <b>8a</b>, <b>8b</b>, <b>8e</b>–<b>i</b>, and <b>31</b>; experimental procedure for determination of the Michaelis–Menten constant <i>K</i><sub>m</sub> for MAL; profiles of the preincubation of HDAC3-NCoR1 and HDAC8 with mocetinostat; HDAC inhibition assay using a progression method and results. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400634n/suppl_file/jm400634n_si_001.pdf">jm400634n_si_001.pdf (1.08 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400634n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles M. Marson</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, University College London, Christopher Ingold Laboratories, 20 Gordon Street, London WC1H
OAJ, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#096a27642764687b7a6667497c6a6527686a277c62"><span class="__cf_email__" data-cfemail="5c3f723172313d2e2f33321c293f30723d3f722937">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Matthews</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, University College London, Christopher Ingold Laboratories, 20 Gordon Street, London WC1H
OAJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Yiannaki</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, University College London, Christopher Ingold Laboratories, 20 Gordon Street, London WC1H
OAJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen J. Atkinson</span> - <span class="hlFld-Affiliation affiliation">Epinova DPU,
Immuno-Inflammation Therapy Area Unit, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter E. Soden</span> - <span class="hlFld-Affiliation affiliation">Epinova DPU,
Immuno-Inflammation Therapy Area Unit, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lena Shukla</span> - <span class="hlFld-Affiliation affiliation">Allergic Inflammation DPU, Respiratory Therapy
Area Unit, GlaxoSmithKline, Gunnels Wood
Road, Stevenage, Herts SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nermina Lamadema</span> - <span class="hlFld-Affiliation affiliation">Department of Haematological Medicine, Leukemia Sciences Laboratories,
Rayne Institute, King’s College London, 123 Coldharbour Lane, London SE5 9NU, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">N. Shaun B. Thomas</span> - <span class="hlFld-Affiliation affiliation">Department of Haematological Medicine, Leukemia Sciences Laboratories,
Rayne Institute, King’s College London, 123 Coldharbour Lane, London SE5 9NU, U.K.</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d39e6189-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05524" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05524" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support from the GlaxoSmithKline and the EPSRC for a studentship (to C.J.M.) as part of the Drug Discovery Program at University College London is gratefully acknowledged. N.S.B.T. acknowledges support from Leukaemia and Lymphoma Research (LLR), and N.L. is supported by a project grant from the BBSRC to N.S.B.T. We are grateful to Simon Greenwood for providing recombinant HDAC8.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i72" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i72"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i73" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i73"> Abbreviations Used</h2><tr><td class="NLM_term">A549</td><td class="NLM_def"><p class="first last">adenocarcinomic human alveolar cell line</p></td></tr><tr><td class="NLM_term">Bis-tris</td><td class="NLM_def"><p class="first last">2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)-1,3-propanediol)</p></td></tr><tr><td class="NLM_term">BOP</td><td class="NLM_def"><p class="first last">benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle medium</p></td></tr><tr><td class="NLM_term">DU145</td><td class="NLM_def"><p class="first last">human prostate cancer cell line</p></td></tr><tr><td class="NLM_term">ECL</td><td class="NLM_def"><p class="first last">electrochemiluminescence</p></td></tr><tr><td class="NLM_term">FACS</td><td class="NLM_def"><p class="first last">fluorescence-activated cell sorting</p></td></tr><tr><td class="NLM_term">FCS</td><td class="NLM_def"><p class="first last">fetal calf serum</p></td></tr><tr><td class="NLM_term">FITC</td><td class="NLM_def"><p class="first last">fluorescein isothiocyanate</p></td></tr><tr><td class="NLM_term">H3K9</td><td class="NLM_def"><p class="first last">histone H3 lysine 9</p></td></tr><tr><td class="NLM_term">HCT116</td><td class="NLM_def"><p class="first last">human colorectal carcinoma cell line</p></td></tr><tr><td class="NLM_term">MAL</td><td class="NLM_def"><p class="first last">Boc-Lys(Ac)-7-amino-4-methylcoumarin</p></td></tr><tr><td class="NLM_term">MCF-7</td><td class="NLM_def"><p class="first last">human breast cancer cell line</p></td></tr><tr><td class="NLM_term">mocetinostat or MGCD0103</td><td class="NLM_def"><p class="first last"><i>N</i>-(2-aminophenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last">nonbinding surface</p></td></tr><tr><td class="NLM_term">NCoR1</td><td class="NLM_def"><p class="first last">nuclear receptor co-repressor 1</p></td></tr><tr><td class="NLM_term">Pd/C</td><td class="NLM_def"><p class="first last">palladium on activated carbon</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly-ADP ribose polymerase</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">propidium iodide</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">TSA</td><td class="NLM_def"><p class="first last">trichostatin A</p></td></tr><tr><td class="NLM_term">vorinostat</td><td class="NLM_def"><p class="first last">suberoylanilide hydroxamic acid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83783" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83783" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 54 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Marson, C. M.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors: design, structure–activity relationships and therapeutic implications for cancer</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=661-692&author=C.+M.+Marson&title=Histone+deacetylase+inhibitors%3A+design%2C+structure%E2%80%93activity+relationships+and+therapeutic+implications+for+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarson%26aufirst%3DC.%2BM.%26atitle%3DHistone%2520deacetylase%2520inhibitors%253A%2520design%252C%2520structure%25E2%2580%2593activity%2520relationships%2520and%2520therapeutic%2520implications%2520for%2520cancer%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D661%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelicci, G.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors and the promise of epigenetic (and more) treatment for cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1038%2Fnrc1779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=16397526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=38-51&author=S.+Minucciauthor=G.+Pelicci&title=Histone+deacetylase+inhibitors+and+the+promise+of+epigenetic+%28and+more%29+treatment+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer</span></div><div class="casAuthors">Minucci, Saverio; Pelicci, Pier Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-51</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are considered to be among the most promising targets in drug development for cancer therapy, and first-generation histone deacetylase inhibitors (HDACi) are currently being tested in phase I/II clin. trials.  A wide-ranging knowledge of the role of HDACs in tumorigenesis, and of the action of HDACi, has been achieved.  However, several basic aspects are not yet fully understood.  Investigating these aspects in the context of what we now understand about HDACi action both in vitro and in vivo will further improve the design of optimized clin. protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxXiACZV1sK7Vg90H21EOLACvtfcHk0liMf5B5VEXNlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GgsA%253D%253D&md5=384e1f8d676d61531e46843c060a9380</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc1779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1779%26sid%3Dliteratum%253Aachs%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DPelicci%26aufirst%3DG.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520and%2520the%2520promise%2520of%2520epigenetic%2520%2528and%2520more%2529%2520treatment%2520for%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D38%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Strahl, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">The language of covalent histone modifications</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">403</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1038%2F47412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=10638745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=2000&pages=41-45&author=B.+D.+Strahlauthor=C.+D.+Allis&title=The+language+of+covalent+histone+modifications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The language of covalent histone modifications</span></div><div class="casAuthors">Strahl B D; Allis C D</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">403</span>
        (<span class="NLM_cas:issue">6765</span>),
    <span class="NLM_cas:pages">41-5</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Histone proteins and the nucleosomes they form with DNA are the fundamental building blocks of eukaryotic chromatin.  A diverse array of post-translational modifications that often occur on tail domains of these proteins has been well documented.  Although the function of these highly conserved modifications has remained elusive, converging biochemical and genetic evidence suggests functions in several chromatin-based processes.  We propose that distinct histone modifications, on one or more tails, act sequentially or in combination to form a 'histone code' that is, read by other proteins to bring about distinct downstream events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyzhdlYh9sX7t7lRqEFUJVfW6udTcc2eas9L9ByXOc17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D&md5=2eb7d093151c6122ccd70fa2adcfd94b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F47412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F47412%26sid%3Dliteratum%253Aachs%26aulast%3DStrahl%26aufirst%3DB.%2BD.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DThe%2520language%2520of%2520covalent%2520histone%2520modifications%26jtitle%3DNature%26date%3D2000%26volume%3D403%26spage%3D41%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Jenuwein, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">Translating the histone code</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">1074</span><span class="NLM_x">–</span> <span class="NLM_lpage">1080</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1126%2Fscience.1063127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=11498575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtVWltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2001&pages=1074-1080&author=T.+Jenuweinauthor=C.+D.+Allis&title=Translating+the+histone+code"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Translating the histone code</span></div><div class="casAuthors">Jenuwein, Thomas; Allis, C. David</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">5532</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The review.  Chromatin, the physiol. template of all eukaryotic genetic information, is subject to a diverse array of posttranslational modifications that largely impinge on histone amino termini, thereby regulating access to the underlying DNA.  Distinct histone amino-terminal modifications can generate synergistic or antagonistic interaction affinities for chromatin-assocd. proteins, which in turn dictate dynamic transitions between transcriptionally active or transcriptionally silent chromatin states.  The combinatorial nature of histone amino-terminal modifications thus reveals a "histone code" that considerably extends the information potential of the genetic code.  We propose that this epigenetic marking system represents a fundamental regulatory mechanism that has an impact on most, if not all; chromatin-templated processes, with far-reaching consequences for cell fate decisions and both normal and pathol. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUFyHNepKcUbVg90H21EOLACvtfcHk0liH8h3Gu9ZdKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtVWltro%253D&md5=021dcd98a5e5bf2ed7eedef1897b2269</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1063127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1063127%26sid%3Dliteratum%253Aachs%26aulast%3DJenuwein%26aufirst%3DT.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DTranslating%2520the%2520histone%2520code%26jtitle%3DScience%26date%3D2001%26volume%3D293%26spage%3D1074%26epage%3D1080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Taunton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassig, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span> </span><span class="NLM_article-title">A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1126%2Fscience.272.5260.408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=8602529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADyaK28XisVegsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1996&pages=408-411&author=J.+Tauntonauthor=C.+A.+Hassigauthor=S.+L.+Schreiber&title=A+mammalian+histone+deacetylase+related+to+the+yeast+transcriptional+regulator+Rpd3p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p</span></div><div class="casAuthors">Taunton, Jack; Hassig, Christian A.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">5260</span>),
    <span class="NLM_cas:pages">408-11</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Trapoxin is a microbially derived cyclotetrapeptide that inhibits histone deacetylation in vivo and causes mammalian cells to arrest in the cell cycle.  A trapoxin affinity matrix was used to isolate two nuclear proteins that copurified with histone deacetylase activity.  Both proteins were identified by peptide microsequencing, and a complementary DNA encoding the histone deacetylase catalytic subunit (HD1) was cloned from a human Jurkat T cell library.  As the predicted protein is very similar to the yeast transcriptional regulator Rpd3p, these results support a role for histone deacetylase as a key regulator of eukaryotic transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBh4pS_nPMRLVg90H21EOLACvtfcHk0liH8h3Gu9ZdKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisVegsr8%253D&md5=fda244b40a10d5bc75f94fcc6fae189f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.272.5260.408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.272.5260.408%26sid%3Dliteratum%253Aachs%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DHassig%26aufirst%3DC.%2BA.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DA%2520mammalian%2520histone%2520deacetylase%2520related%2520to%2520the%2520yeast%2520transcriptional%2520regulator%2520Rpd3p%26jtitle%3DScience%26date%3D1996%26volume%3D272%26spage%3D408%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hassig, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span> </span><span class="NLM_article-title">Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1016%2FS1367-5931%2897%2980066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=9667866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADyaK2sXnt12mtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1997&pages=300-308&author=C.+A.+Hassigauthor=S.+L.+Schreiber&title=Nuclear+histone+acetylases+and+deacetylases+and+transcriptional+regulation%3A+HATs+off+to+HDACs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs</span></div><div class="casAuthors">Hassig, Christian A.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">300-308</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review with 60 refs.  Reversible acetylation of lysines on the amino-terminal tails of nucleosomal histones is correlated with changes in chromatin structure and transcription.  The recent characterization of enzymes directly responsible for regulating histone acetylation and deacetylation and the cloning of their encoding cDNAs have provided insights into the possible functional and regulatory mechanisms of these classes of mols.  Nuclear histone acetylases have been shown to be transcriptional coactivators and coactivator-assocd. proteins, while histone deacetylases have been identified as components of nuclear co-repressor complexes.  These findings confirm previous studies linking histone acetylation and transcriptional regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD9X5m19_84rVg90H21EOLACvtfcHk0liH8h3Gu9ZdKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt12mtL4%253D&md5=d6fb2f8ee6a4ab770c1a722dc895bddb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1367-5931%2897%2980066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1367-5931%252897%252980066-X%26sid%3Dliteratum%253Aachs%26aulast%3DHassig%26aufirst%3DC.%2BA.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DNuclear%2520histone%2520acetylases%2520and%2520deacetylases%2520and%2520transcriptional%2520regulation%253A%2520HATs%2520off%2520to%2520HDACs%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D1997%26volume%3D1%26spage%3D300%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Mahlknecht, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelzner, D.</span><span> </span><span class="NLM_article-title">Histone acetylation modifiers in the pathogenesis of malignant disease</span> <span class="citation_source-journal">Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=11055583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1Klsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=623-644&author=U.+Mahlknechtauthor=D.+Hoelzner&title=Histone+acetylation+modifiers+in+the+pathogenesis+of+malignant+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Histone acetylation modifiers in the pathogenesis of malignant disease</span></div><div class="casAuthors">Mahlknecht, Ulrich; Hoelzer, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">623-644</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Johns Hopkins University Press</span>)
        </div><div class="casAbstract">A review with 248 refs.  Chromatin structure is gaining increasing attention as a potential target in the treatment of cancer.  Relaxation of the chromatin fiber facilitates transcription and is regulated by 2 competing enzymic activities, histone acetyltransferases (HATs) and histone deacetylases (HDACs), which modify the acetylation state of histone proteins and other promoter-bound transcription factors.  While HATs, which are frequently part of multisubunit coactivator complexes, lead to the relaxation of chromatin structure and transcriptional activation, HDACs tend to assoc. with multisubunit corepressor complexes, which result in chromating condensation and transcriptional repression of specific target genes.  HATs and HDACs are known to be involved both in the pathogenesis as well as in the suppression of cancer.  Some of the genes encoding these enzymes have been shown to be rearranged in the context of chromosomal translocations in human acute leukemias and solid tumors, where fusions of regulatory and coding regions of a variety of transcription factor genes result in completely new gene products that may interfere with regulatory cascades controlling cell growth and differentiation.  On the other hand, some histone acetylation-modifying enzymes were located within chromosomal regions that are particularly prone to chromosomal breaks.  In these cases gains and losses of chromosomal material may effect the availability of functionally active HATs and HDACs, which in turn disturbs the tightly controlled equil. of histone acetylation.  The authors review herein the recent achievements, which further help to elucidate the biol. role of histone acetylation modifying enzymes and their potential impact on the current understanding of the mol. changes involved in the development of solid tumors and leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokkAo1pVT1sbVg90H21EOLACvtfcHk0lhaNvOlWKE_DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1Klsr4%253D&md5=ae8ccd70bde1c4af065380f9d7aed0d8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahlknecht%26aufirst%3DU.%26aulast%3DHoelzner%26aufirst%3DD.%26atitle%3DHistone%2520acetylation%2520modifiers%2520in%2520the%2520pathogenesis%2520of%2520malignant%2520disease%26jtitle%3DMol.%2520Med.%26date%3D2000%26volume%3D6%26spage%3D623%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Gayther, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batley, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorpe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowter, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delhanty, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponder, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas, C.</span><span> </span><span class="NLM_article-title">Mutations truncating the EP300 acetylase in human cancers</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1038%2F73536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=10700188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2000&pages=300-303&author=S.+A.+Gaytherauthor=S.+J.+Batleyauthor=L.+Lingerauthor=A.+Bannisterauthor=K.+Thorpeauthor=S.+F.+Chinauthor=Y.+Daigoauthor=P.+Russellauthor=A.+Wilsonauthor=H.+M.+Sowterauthor=J.+D.+Delhantyauthor=B.+A.+Ponderauthor=T.+Kouzaridesauthor=C.+Caldas&title=Mutations+truncating+the+EP300+acetylase+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations truncating the EP300 acetylase in human cancers</span></div><div class="casAuthors">Gayther, Simon A.; Batley, Sarah J.; Linger, Lori; Bannister, Andy; Thorpe, Karen; Chin, Suet-Feung; Daigo, Yataro; Russell, Paul; Wilson, Annie; Sowter, Heidi M.; Delhanty, Joy D. A.; Ponder, Bruce A. J.; Kouzarides, Tony; Caldas, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">300-303</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">The EP300 protein is a histone acetyltransferase that regulates transcription via chromatin remodelling and is important in the processes of cell proliferation and differentiation.  EP300 acetylation of TP53 in response to DNA damage regulates its DNA-binding and transcription functions.  A role for EP300 in cancer has been implied by the fact that it is targeted by viral oncoproteins, it is fused to MLL in leukemia and two missense sequence alterations in EP300 were identified in epithelial malignancies.  Nevertheless, direct demonstration of the role of EP300 in tumorigenesis by inactivating mutations in human cancers has been lacking.  Here the authors describe EP300 mutations, which predict a truncated protein, in 6 (3%) of 193 epithelial cancers analyzed.  Of these six mutations, two were in primary tumors (a colorectal cancer and a breast cancer) and four were in cancer cell lines (colorectal, breast and pancreatic).  In addn., the authors identified a somatic in-frame insertion in a primary breast cancer and missense alterations in a primary colorectal cancer and two cell lines (breast and pancreatic).  Inactivation of the second allele was demonstrated in five of six cases with truncating mutations and in two other cases.  The authors' data show that EP300 is mutated in epithelial cancers and provide the first evidence that it behaves as a classical tumor-suppressor gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmG241Ii2EyrVg90H21EOLACvtfcHk0lhaNvOlWKE_DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtL4%253D&md5=3bd677467a94dfa7dc29825f1d92ad59</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F73536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F73536%26sid%3Dliteratum%253Aachs%26aulast%3DGayther%26aufirst%3DS.%2BA.%26aulast%3DBatley%26aufirst%3DS.%2BJ.%26aulast%3DLinger%26aufirst%3DL.%26aulast%3DBannister%26aufirst%3DA.%26aulast%3DThorpe%26aufirst%3DK.%26aulast%3DChin%26aufirst%3DS.%2BF.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DRussell%26aufirst%3DP.%26aulast%3DWilson%26aufirst%3DA.%26aulast%3DSowter%26aufirst%3DH.%2BM.%26aulast%3DDelhanty%26aufirst%3DJ.%2BD.%26aulast%3DPonder%26aufirst%3DB.%2BA.%26aulast%3DKouzarides%26aufirst%3DT.%26aulast%3DCaldas%26aufirst%3DC.%26atitle%3DMutations%2520truncating%2520the%2520EP300%2520acetylase%2520in%2520human%2520cancers%26jtitle%3DNat.%2520Genet.%26date%3D2000%26volume%3D24%26spage%3D300%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Sambucetti, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabludoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trogani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, D.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">34940</span><span class="NLM_x">–</span> <span class="NLM_lpage">34947</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=34940-34947&author=L.+C.+Sambucettiauthor=D.+D.+Fischerauthor=S.+Zabludoffauthor=P.+O.+Kwonauthor=H.+Chamberlinauthor=N.+Troganiauthor=H.+Xuauthor=D.+Cohen&title=Histone+deacetylase+inhibition+selectively+alters+the+activity+and+expression+of+cell+cycle+proteins+leading+to+specific+chromatin+acetylation+and+antiproliferative+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSambucetti%26aufirst%3DL.%2BC.%26aulast%3DFischer%26aufirst%3DD.%2BD.%26aulast%3DZabludoff%26aufirst%3DS.%26aulast%3DKwon%26aufirst%3DP.%2BO.%26aulast%3DChamberlin%26aufirst%3DH.%26aulast%3DTrogani%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DCohen%26aufirst%3DD.%26atitle%3DHistone%2520deacetylase%2520inhibition%2520selectively%2520alters%2520the%2520activity%2520and%2520expression%2520of%2520cell%2520cycle%2520proteins%2520leading%2520to%2520specific%2520chromatin%2520acetylation%2520and%2520antiproliferative%2520effects%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D34940%26epage%3D34947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslow, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, W. K.</span><span> </span><span class="NLM_article-title">Histone deacetylases and cancer: causes and therapies</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1038%2F35106079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=11902574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=194-202&author=P.+A.+Marksauthor=R.+A.+Rifkindauthor=V.+M.+Richonauthor=R.+Breslowauthor=T.+Millerauthor=W.+K.+Kelly&title=Histone+deacetylases+and+cancer%3A+causes+and+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases and cancer: causes and therapies</span></div><div class="casAuthors">Marks, Paul A.; Rifkind, Richard A.; Richon, Victoria M.; Breslow, Ronald; Miller, Thomas; Kelly, William K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-202</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Together, histone acetyltransferases and histone deacetylases (HDACs) det. the acetylation status of histones.  This acetylation affects the regulation of gene expression, and inhibitors of HDACs have been found to cause growth arrest, differentiation and/or apoptosis of many tumors cells by altering the transcription of a small no. of genes.  HDAC inhibitors are proving to be an exciting therapeutic approach to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNXyL8yvd0OrVg90H21EOLACvtfcHk0lhZhGD_aefQiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qtr0%253D&md5=ea50a1a72a6df9ea3a0e1a6a0d5cda5e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F35106079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35106079%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DBreslow%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DKelly%26aufirst%3DW.%2BK.%26atitle%3DHistone%2520deacetylases%2520and%2520cancer%253A%2520causes%2520and%2520therapies%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26spage%3D194%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ruefli, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ausserlechner, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tainton, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kofler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span> </span><span class="NLM_article-title">The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">10833</span><span class="NLM_x">–</span> <span class="NLM_lpage">10838</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=10833-10838&author=A.+A.+Ruefliauthor=M.+J.+Ausserlechnerauthor=D.+Bernhardauthor=V.+R.+Suttonauthor=K.+M.+Taintonauthor=R.+Koflerauthor=M.+J.+Smythauthor=R.+W.+Johnstone&title=The+histone+deacetylase+inhibitor+and+chemotherapeutic+agent+suberoylanilide+hydroxamic+acid+%28SAHA%29+induces+a+cell-death+pathway+characterized+by+cleavage+of+Bid+and+production+of+reactive+oxygen+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuefli%26aufirst%3DA.%2BA.%26aulast%3DAusserlechner%26aufirst%3DM.%2BJ.%26aulast%3DBernhard%26aufirst%3DD.%26aulast%3DSutton%26aufirst%3DV.%2BR.%26aulast%3DTainton%26aufirst%3DK.%2BM.%26aulast%3DKofler%26aufirst%3DR.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DThe%2520histone%2520deacetylase%2520inhibitor%2520and%2520chemotherapeutic%2520agent%2520suberoylanilide%2520hydroxamic%2520acid%2520%2528SAHA%2529%2520induces%2520a%2520cell-death%2520pathway%2520characterized%2520by%2520cleavage%2520of%2520Bid%2520and%2520production%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D10833%26epage%3D10838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Rosato, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almenara, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span> </span><span class="NLM_article-title">The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">3637</span><span class="NLM_x">–</span> <span class="NLM_lpage">3645</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=3637-3645&author=R.+R.+Rosatoauthor=J.+A.+Almenaraauthor=S.+Grant&title=The+histone+deacetylase+inhibitor+MS-275+promotes+differentiation+or+apoptosis+in+human+leukemia+cells+through+a+process+regulated+by+generation+of+reactive+oxygen+species+and+induction+of+p21"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosato%26aufirst%3DR.%2BR.%26aulast%3DAlmenara%26aufirst%3DJ.%2BA.%26aulast%3DGrant%26aufirst%3DS.%26atitle%3DThe%2520histone%2520deacetylase%2520inhibitor%2520MS-275%2520promotes%2520differentiation%2520or%2520apoptosis%2520in%2520human%2520leukemia%2520cells%2520through%2520a%2520process%2520regulated%2520by%2520generation%2520of%2520reactive%2520oxygen%2520species%2520and%2520induction%2520of%2520p21%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D3637%26epage%3D3645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Xu, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dokmanovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span> </span><span class="NLM_article-title">Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">15540</span><span class="NLM_x">–</span> <span class="NLM_lpage">15545</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=15540-15545&author=W.+S.+Xuauthor=L.+Ngoauthor=G.+Perezauthor=M.+Dokmanovicauthor=P.+A.+Marks&title=Intrinsic+apoptotic+and+thioredoxin+pathways+in+human+prostate+cancer+cell+response+to+histone+deacetylase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%2BS.%26aulast%3DNgo%26aufirst%3DL.%26aulast%3DPerez%26aufirst%3DG.%26aulast%3DDokmanovic%26aufirst%3DM.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DIntrinsic%2520apoptotic%2520and%2520thioredoxin%2520pathways%2520in%2520human%2520prostate%2520cancer%2520cell%2520response%2520to%2520histone%2520deacetylase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D15540%26epage%3D15545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Zain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, O. A.</span><span> </span><span class="NLM_article-title">Targeting histone deacetyalses in the treatment of B- and T-cell malignancies</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">S58</span><span class="NLM_x">–</span> <span class="NLM_lpage">S78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=S58-S78&author=J.+Zainauthor=O.+A.+O%E2%80%99Connor&title=Targeting+histone+deacetyalses+in+the+treatment+of+B-+and+T-cell+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZain%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DO.%2BA.%26atitle%3DTargeting%2520histone%2520deacetyalses%2520in%2520the%2520treatment%2520of%2520B-%2520and%2520T-cell%2520malignancies%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2010%26volume%3D28%26spage%3DS58%26epage%3DS78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Vargas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardwick, J. S.</span><span> </span><span class="NLM_article-title">Development of vorinostat: current applications and future perspectives for cancer therapy</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1016%2Fj.canlet.2009.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=19181442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsF2jt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2009&pages=201-210&author=V.+M.+Richonauthor=J.+Garcia-Vargasauthor=J.+S.+Hardwick&title=Development+of+vorinostat%3A+current+applications+and+future+perspectives+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Development of vorinostat: Current applications and future perspectives for cancer therapy</span></div><div class="casAuthors">Richon, Victoria M.; Garcia-Vargas, Jose; Hardwick, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-210</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Vorinostat is a potent histone deacetylase inhibitor that blocks the catalytic site of these enzymes.  A large no. of cellular proteins are modified post-translationally by acetylation, leading to altered structure and/or function.  Many of these proteins, such as core nucleosomal histones and transcription factors, function in key cellular processes and signal transduction pathways that regulate cell growth, migration, and differentiation.  At concns. that are non-toxic to normal cells, vorinostat dramatically alters cellular acetylation patterns and causes growth arrest and death and in a wide range of transformed cells, both in vitro and in animal tumor models.  Vorinostat has shown promising clin. activity against hematol. and solid tumors at doses that have been well tolerated by patients.  Recent non-clin. expts. that explored the effects of vorinostat in combination with other chemotherapeutic agents have begun to illuminate potential mechanisms of action for this histone deacetylase inhibitor and are providing guidance for new avenues of clin. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLaRS24LfvvbVg90H21EOLACvtfcHk0lgTKBepG7jtuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsF2jt7k%253D&md5=c14a4b9ad3c37c5eb1e89c9f549040de</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2009.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2009.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DGarcia-Vargas%26aufirst%3DJ.%26aulast%3DHardwick%26aufirst%3DJ.%2BS.%26atitle%3DDevelopment%2520of%2520vorinostat%253A%2520current%2520applications%2520and%2520future%2520perspectives%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D280%26spage%3D201%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kelly, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krug, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiao, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGregore-Cortelli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secrist, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olgac, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span> </span><span class="NLM_article-title">Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patient with advanced cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3923</span><span class="NLM_x">–</span> <span class="NLM_lpage">3931</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1200%2FJCO.2005.14.167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=15897550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtVahtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=3923-3931&author=W.+K.+Kellyauthor=O.+A.+O%E2%80%99Connorauthor=L.+M.+Krugauthor=J.+H.+Chiaoauthor=M.+Heaneyauthor=T.+Curleyauthor=B.+MacGregore-Cortelliauthor=W.+Tongauthor=J.+P.+Secristauthor=L.+Schwartzauthor=S.+Richardsonauthor=E.+Chuauthor=S.+Olgacauthor=P.+A.+Marksauthor=H.+Scherauthor=V.+M.+Richon&title=Phase+I+study+of+an+oral+histone+deacetylase+inhibitor%2C+suberoylanilide+hydroxamic+acid%2C+in+patient+with+advanced+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer</span></div><div class="casAuthors">Kelly, William Kevin; O'Connor, Owen A.; Krug, Lee M.; Chiao, Judy H.; Heaney, Mark; Curley, Tracy; MacGregore-Cortelli, Barbara; Tong, William; Secrist, J. Paul; Schwartz, Lawrence; Richardson, Stacy; Chu, Elaina; Olgac, Semra; Marks, Paul A.; Scher, Howard; Richon, Victoria M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3923-3931</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To det. the safety, dosing schedules, pharmacokinetic profile, and biol. effect of orally administered histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) in patients with advanced cancer.  Patients and Methods: Patients with solid and hematol. malignancies were treated with oral SAHA administered once or twice a day on a continuous basis or twice daily for 3 consecutive days per wk.  Pharmacokinetic profile and bioavailability of oral SAHA were detd.  Western blots and enzyme-linked immunosorbent assays of histones isolated from peripheral-blood mononuclear cells (PBMNCs) pre and post-therapy were performed to evaluate target inhibition.  Results: Seventy-three patients were treated with oral SAHA and major dose-limiting toxicities were anorexia, dehydration, diarrhea, and fatigue.  The max. tolerated dose was 400 mg qd and 200 mg bid for continuous daily dosing and 300 mg bid for 3 consecutive days per wk dosing.  Oral SAHA had linear pharmacokinetics from 200 to 600 mg, with an apparent half-life ranging from 91 to 127 min and 43% oral bioavailability.  Histones isolated from PBMNCs showed consistent accumulation of acetylated histones post-therapy, and ELISA demonstrated a trend towards a dose-dependent accumulation of acetylated histones from 200 to 600 mg of oral SAHA.  There was one complete response, three partial responses, two unconfirmed partial responses, and 22 (30%) patients remained on study for 4 to 37+ months.  Conclusions: Oral SAHA has linear pharmacokinetics and good bioavailability, inhibits histone deacetylase activity in PBMNCs, can be safely administered chronically, and has a broad range of antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfHYxcbfdZ3LVg90H21EOLACvtfcHk0lgTKBepG7jtuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtVahtLw%253D&md5=b16db863c77bc6d45e355bd75b7a8f93</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.14.167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.14.167%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DW.%2BK.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DO.%2BA.%26aulast%3DKrug%26aufirst%3DL.%2BM.%26aulast%3DChiao%26aufirst%3DJ.%2BH.%26aulast%3DHeaney%26aufirst%3DM.%26aulast%3DCurley%26aufirst%3DT.%26aulast%3DMacGregore-Cortelli%26aufirst%3DB.%26aulast%3DTong%26aufirst%3DW.%26aulast%3DSecrist%26aufirst%3DJ.%2BP.%26aulast%3DSchwartz%26aufirst%3DL.%26aulast%3DRichardson%26aufirst%3DS.%26aulast%3DChu%26aufirst%3DE.%26aulast%3DOlgac%26aufirst%3DS.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DScher%26aufirst%3DH.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26atitle%3DPhase%2520I%2520study%2520of%2520an%2520oral%2520histone%2520deacetylase%2520inhibitor%252C%2520suberoylanilide%2520hydroxamic%2520acid%252C%2520in%2520patient%2520with%2520advanced%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D3923%26epage%3D3931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradei, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeppel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frechette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudette, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouchain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisburg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trachy-Bourget, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delorme, D.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4072</span><span class="NLM_x">–</span> <span class="NLM_lpage">4075</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800251w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4072-4075&author=N.+Zhouauthor=O.+Moradeiauthor=S.+Raeppelauthor=S.+Leitauthor=S.+Frechetteauthor=F.+Gaudetteauthor=I.+Paquinauthor=N.+Bernsteinauthor=G.+Bouchainauthor=A.+Vaisburgauthor=Z.+Jinauthor=J.+Gillespieauthor=J.+Wangauthor=M.+Fournelauthor=P.+T.+Yanauthor=M.-C.+Trachy-Bourgetauthor=A.+Kalitaauthor=A.+Luauthor=J.+Rahilauthor=A.+R.+MacLeodauthor=Z.+Liauthor=J.+M.+Bestermanauthor=D.+Delorme&title=Discovery+of+N-%282-aminophenyl%29-4-%5B%284-pyridin-3-ylpyrimidin-2-ylamino%29methyl%5Dbenzamide+%28MGCD0103%29%2C+an+orally+active+histone+deacetylase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjm800251w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800251w%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DMoradei%26aufirst%3DO.%26aulast%3DRaeppel%26aufirst%3DS.%26aulast%3DLeit%26aufirst%3DS.%26aulast%3DFrechette%26aufirst%3DS.%26aulast%3DGaudette%26aufirst%3DF.%26aulast%3DPaquin%26aufirst%3DI.%26aulast%3DBernstein%26aufirst%3DN.%26aulast%3DBouchain%26aufirst%3DG.%26aulast%3DVaisburg%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DGillespie%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DP.%2BT.%26aulast%3DTrachy-Bourget%26aufirst%3DM.-C.%26aulast%3DKalita%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DMacLeod%26aufirst%3DA.%2BR.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DDelorme%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520N-%25282-aminophenyl%2529-4-%255B%25284-pyridin-3-ylpyrimidin-2-ylamino%2529methyl%255Dbenzamide%2520%2528MGCD0103%2529%252C%2520an%2520orally%2520active%2520histone%2520deacetylase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4072%26epage%3D4075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Garcia-Manero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrov, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newsome, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martell, R.</span><span> </span><span class="NLM_article-title">Clinical activity and safety of the histone deacetylase inhibitor MGCD0103: results of a phase I study in patients with leukemia or myelodysplastic syndromes (MDS)</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">337S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=337S&author=G.+Garcia-Maneroauthor=M.+Mindenauthor=Z.+Estrovauthor=S.+Verstovsekauthor=W.+M.+Newsomeauthor=G.+Reidauthor=J.+Bestermanauthor=Z.+Liauthor=L.+Pearceauthor=R.+Martell&title=Clinical+activity+and+safety+of+the+histone+deacetylase+inhibitor+MGCD0103%3A+results+of+a+phase+I+study+in+patients+with+leukemia+or+myelodysplastic+syndromes+%28MDS%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Manero%26aufirst%3DG.%26aulast%3DMinden%26aufirst%3DM.%26aulast%3DEstrov%26aufirst%3DZ.%26aulast%3DVerstovsek%26aufirst%3DS.%26aulast%3DNewsome%26aufirst%3DW.%2BM.%26aulast%3DReid%26aufirst%3DG.%26aulast%3DBesterman%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DPearce%26aufirst%3DL.%26aulast%3DMartell%26aufirst%3DR.%26atitle%3DClinical%2520activity%2520and%2520safety%2520of%2520the%2520histone%2520deacetylase%2520inhibitor%2520MGCD0103%253A%2520results%2520of%2520a%2520phase%2520I%2520study%2520in%2520patients%2520with%2520leukemia%2520or%2520myelodysplastic%2520syndromes%2520%2528MDS%2529%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D337S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Fournel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonfils, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trachy-Bourget, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, A.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, M.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ste-Croix, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradei, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delorme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span> </span><span class="NLM_article-title">MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1158%2F1535-7163.MCT-07-2026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=18413790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1Gms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=759-768&author=M.+Fournelauthor=C.+Bonfilsauthor=Y.+Houauthor=T.+Yanauthor=M.-C.+Trachy-Bourgetauthor=A.+Kalitaauthor=J.+Liuauthor=A.-H.+Luauthor=N.+Z.+Zhouauthor=M.-F.+Robertauthor=J.+Gillespieauthor=J.+J.+Wangauthor=H.+Ste-Croixauthor=J.+Rahilauthor=S.+Lefebvreauthor=O.+Moradeiauthor=D.+Delormeauthor=A.+R.+MacLeodauthor=J.+M.+Bestermanauthor=Z.+Li&title=MGCD0103%2C+a+novel+isotype-selective+histone+deacetylase+inhibitor%2C+has+broad+spectrum+antitumor+activity+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo</span></div><div class="casAuthors">Fournel, Marielle; Bonfils, Claire; Hou, Yu; Yan, Pu Theresa; Trachy-Bourget, Marie-Claude; Kalita, Ann; Liu, Jianhong; Lu, Ai-Hua; Zhou, Nancy Z.; Robert, Marie-France; Gillespie, Jeffrey; Wang, James J.; Ste-Croix, Helene; Rahil, Jubrail; Lefebvre, Sylvain; Moradei, Oscar; Delorme, Daniel; MacLeod, A. Robert; Besterman, Jeffrey M.; Li, Zuomei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">759-768</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Nonselective inhibitors of human histone deacetylases (HDAC) are known to have antitumor activity in mice in vivo, and several of them are under clin. investigation.  The first of these, Vorinostat (SAHA), has been approved for treatment of cutaneous T-cell lymphoma.  Questions remain concerning which HDAC isotype(s) are the best to target for anticancer activity and whether increased efficacy and safety will result with an isotype-selective HDAC inhibitor.  We have developed an isotype-selective HDAC inhibitor, MGCD0103, which potently targets human HDAC1 but also has inhibitory activity against HDAC2, HDAC3, and HDAC11 in vitro.  In intact cells, MGCD0103 inhibited only a fraction of the total HDAC activity and showed long-lasting inhibitory activity even upon drug removal.  MGCD0103 induced hyperacetylation of histones, selectively induced apoptosis, and caused cell cycle blockade in various human cancer cell lines in a dose-dependent manner.  MGCD0103 exhibited potent and selective antiproliferative activities against a broad spectrum of human cancer cell lines in vitro, and HDAC inhibitory activity was required for these effects.  In vivo, MGCD0103 significantly inhibited growth of human tumor xenografts in nude mice in a dose-dependent manner and the antitumor activity correlated with induction of histone acetylation in tumors.  Our findings suggest that the isotype-selective HDAC inhibition by MGCD0103 is sufficient for antitumor activity in vivo and that further clin. investigation is warranted. [Mol Cancer Ther 2008;7(4):759-68].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokegpWTxBJyrVg90H21EOLACvtfcHk0lh1TLMPxtGKVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1Gms70%253D&md5=48604f141d969585efaa71c4005496cf</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2026%26sid%3Dliteratum%253Aachs%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DBonfils%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DT.%26aulast%3DTrachy-Bourget%26aufirst%3DM.-C.%26aulast%3DKalita%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DA.-H.%26aulast%3DZhou%26aufirst%3DN.%2BZ.%26aulast%3DRobert%26aufirst%3DM.-F.%26aulast%3DGillespie%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%2BJ.%26aulast%3DSte-Croix%26aufirst%3DH.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DMoradei%26aufirst%3DO.%26aulast%3DDelorme%26aufirst%3DD.%26aulast%3DMacLeod%26aufirst%3DA.%2BR.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DMGCD0103%252C%2520a%2520novel%2520isotype-selective%2520histone%2520deacetylase%2520inhibitor%252C%2520has%2520broad%2520spectrum%2520antitumor%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D759%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Saito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariko, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, O.</span><span> </span><span class="NLM_article-title">A synthetic inhibitor of histone deacetylase, MS-275, with marked in vivo antitumor activity against human tumors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">4592</span><span class="NLM_x">–</span> <span class="NLM_lpage">4597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=4592-4597&author=A.+Saitoauthor=T.+Yamasitaauthor=Y.+Marikoauthor=Y.+Nosakaauthor=K.+Tsuchiyaauthor=T.+Andoauthor=T.+Suzukiauthor=T.+Tsuruoauthor=O.+Nakanishi&title=A+synthetic+inhibitor+of+histone+deacetylase%2C+MS-275%2C+with+marked+in+vivo+antitumor+activity+against+human+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DA.%26aulast%3DYamasita%26aufirst%3DT.%26aulast%3DMariko%26aufirst%3DY.%26aulast%3DNosaka%26aufirst%3DY.%26aulast%3DTsuchiya%26aufirst%3DK.%26aulast%3DAndo%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DTsuruo%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DO.%26atitle%3DA%2520synthetic%2520inhibitor%2520of%2520histone%2520deacetylase%252C%2520MS-275%252C%2520with%2520marked%2520in%2520vivo%2520antitumor%2520activity%2520against%2520human%2520tumors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D4592%26epage%3D4597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Knipstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, L.</span><span> </span><span class="NLM_article-title">Entinostat for treatment of solid tumors and hematologic malignancies</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1455</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1455-1467&author=J.+Knipsteinauthor=L.+Gore&title=Entinostat+for+treatment+of+solid+tumors+and+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnipstein%26aufirst%3DJ.%26aulast%3DGore%26aufirst%3DL.%26atitle%3DEntinostat%2520for%2520treatment%2520of%2520solid%2520tumors%2520and%2520hematologic%2520malignancies%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D1455%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Piekarz, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayastha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdeldaim, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrico, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">4636</span><span class="NLM_x">–</span> <span class="NLM_lpage">4643</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=4636-4643&author=R.+L.+Piekarzauthor=R.+W.+Robeyauthor=Z.+Zhanauthor=G.+Kayasthaauthor=A.+Sayahauthor=A.+H.+Abdeldaimauthor=S.+Torricoauthor=S.+E.+Bates&title=T-cell+lymphoma+as+a+model+for+the+use+of+histone+deacetylase+inhibitors+in+cancer+therapy%3A+impact+of+depsipeptide+on+molecular+markers%2C+therapeutic+targets%2C+and+mechanisms+of+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiekarz%26aufirst%3DR.%2BL.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DZhan%26aufirst%3DZ.%26aulast%3DKayastha%26aufirst%3DG.%26aulast%3DSayah%26aufirst%3DA.%26aulast%3DAbdeldaim%26aufirst%3DA.%2BH.%26aulast%3DTorrico%26aufirst%3DS.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DT-cell%2520lymphoma%2520as%2520a%2520model%2520for%2520the%2520use%2520of%2520histone%2520deacetylase%2520inhibitors%2520in%2520cancer%2520therapy%253A%2520impact%2520of%2520depsipeptide%2520on%2520molecular%2520markers%252C%2520therapeutic%2520targets%252C%2520and%2520mechanisms%2520of%2520resistance%26jtitle%3DBlood%26date%3D2004%26volume%3D103%26spage%3D4636%26epage%3D4643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Piekarz, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschbaum, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geskin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joske, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetler-Stevenson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5410</span><span class="NLM_x">–</span> <span class="NLM_lpage">5417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1200%2FJCO.2008.21.6150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=19826128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFKkt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=5410-5417&author=R.+L.+Piekarzauthor=R.+Fryeauthor=M.+Turnerauthor=J.+Wrightauthor=S.+Allenauthor=M.+Kirschbaumauthor=J.+Zainauthor=H.+Princeauthor=J.+Leonardauthor=L.+Geskinauthor=D.+Joskeauthor=W.+Figgauthor=E.+Gardnerauthor=S.+Steinbergauthor=E.+Jaffeauthor=M.+Stetler-Stevensonauthor=S.+Ladeauthor=A.+Fojoauthor=S.+E.+Bates&title=T-cell+lymphoma+as+a+model+for+the+use+of+histone+deacetylase+inhibitors+in+cancer+therapy%3A+impact+of+depsipeptide+on+molecular+markers%2C+therapeutic+targets%2C+and+mechanisms+of+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma</span></div><div class="casAuthors">Piekarz, Richard L.; Frye, Robin; Turner, Maria; Wright, John J.; Allen, Steven L.; Kirschbaum, Mark H.; Zain, Jasmine; Prince, H. Miles; Leonard, John P.; Geskin, Larisa J.; Reeder, Craig; Joske, David; Figg, William D.; Gardner, Erin R.; Steinberg, Seth M.; Jaffe, Elaine S.; Stetler-Stevenson, Maryalice; Lade, Stephen; Fojo, A. Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">5410-5417</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Romidepsin (depsipeptide or FK228) is a member of a new class of antineoplastic agents active in T-cell lymphoma, the histone deacetylase inhibitors.  On the basis of obsd. responses in a phase I trial, a phase II trial of romidepsin in patients with T-cell lymphoma was initiated.  The initial cohort was limited to patients with cutaneous T-cell lymphoma (CTCL), or subtypes mycosis fungoides or Sezary syndrome, who had received no more than two prior cytotoxic regimens.  There were no limits on other types of therapy.  Subsequently, the protocol was expanded to enroll patients who had received more than two prior cytotoxic regimens.  Twenty-seven patients were enrolled onto the first cohort, and a total of 71 patients are included in this anal.  These patients had undergone a median of four prior treatments, and 62 patients (87%) had advanced-stage disease (stage IIB, n = 15; stage III, n= 6; or stage IV, n = 41).  Toxicities included nausea, vomiting, fatigue, and transient thrombocytopenia and granulocytopenia.  Pharmacokinetics were evaluated with the first administration of romidepsin.  Complete responses were obsd. in four patients, and partial responses were obsd. in 20 patients for an overall response rate of 34% (95% CI, 23% to 46%).  The median duration of response was 13.7 mo.  The histone deacetylase inhibitor romidepsin has single-agent clin. activity with significant and durable responses in patients with CTCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUzt-4ptTta7Vg90H21EOLACvtfcHk0ljEiWfBuyZKAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFKkt7vO&md5=e99b3bf6b987b6cb5ed3d2cbefcbd259</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2008.21.6150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2008.21.6150%26sid%3Dliteratum%253Aachs%26aulast%3DPiekarz%26aufirst%3DR.%2BL.%26aulast%3DFrye%26aufirst%3DR.%26aulast%3DTurner%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DKirschbaum%26aufirst%3DM.%26aulast%3DZain%26aufirst%3DJ.%26aulast%3DPrince%26aufirst%3DH.%26aulast%3DLeonard%26aufirst%3DJ.%26aulast%3DGeskin%26aufirst%3DL.%26aulast%3DJoske%26aufirst%3DD.%26aulast%3DFigg%26aufirst%3DW.%26aulast%3DGardner%26aufirst%3DE.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DJaffe%26aufirst%3DE.%26aulast%3DStetler-Stevenson%26aufirst%3DM.%26aulast%3DLade%26aufirst%3DS.%26aulast%3DFojo%26aufirst%3DA.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DT-cell%2520lymphoma%2520as%2520a%2520model%2520for%2520the%2520use%2520of%2520histone%2520deacetylase%2520inhibitors%2520in%2520cancer%2520therapy%253A%2520impact%2520of%2520depsipeptide%2520on%2520molecular%2520markers%252C%2520therapeutic%2520targets%252C%2520and%2520mechanisms%2520of%2520resistance%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2009%26volume%3D27%26spage%3D5410%26epage%3D5417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Chou, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesfeld, J. M.</span><span> </span><span class="NLM_article-title">Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I histone deacetylases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">35402</span><span class="NLM_x">–</span> <span class="NLM_lpage">35409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1074%2Fjbc.M807045200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=18953021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVylsr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=35402-35409&author=C.+J.+Chouauthor=D.+Hermanauthor=J.+M.+Gottesfeld&title=Pimelic+diphenylamide+106+is+a+slow%2C+tight-binding+inhibitor+of+class+I+histone+deacetylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pimelic Diphenylamide 106 Is a Slow, Tight-binding Inhibitor of Class I Histone Deacetylases</span></div><div class="casAuthors">Chou, C. James; Herman, David; Gottesfeld, Joel M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">35402-35409</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) inhibitors, including various benzamides and hydroxamates, are currently in clin. development for a broad range of human diseases, including cancer and neurodegenerative diseases.  We recently reported the identification of a family of benzamide-type HDAC inhibitors that are relatively non-toxic compared with the hydroxamates.  Members of this class of compds. have shown efficacy in cell-based and mouse models for the neurodegenerative diseases Friedreich ataxia and Huntington disease.  Considerable differences in IC50 values for the various HDAC enzymes have been reported for many of the HDAC inhibitors, leading to confusion as to the HDAC isotype specificities of these compds.  Here we show that a benzamide HDAC inhibitor, a pimelic diphenylamide (106), is a class I HDAC inhibitor, demonstrating no activity against class II HDACs.  106 Is a slow, tight-binding inhibitor of HDACs 1, 2, and 3, although inhibition for these enzymes occurs through different mechanisms.  Inhibitor 106 also has preference toward HDAC3 with Ki of ∼14 nM, 15 times lower than the Ki for HDAC1.  In comparison, the hydroxamate suberoylanilide hydroxamic acid does not discriminate between these enzymes and exhibits a fast-on/fast-off inhibitory mechanism.  These observations may explain a paradox involving the relative activities of pimelic diphenylamides vs. hydroxamates as gene activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeaJtDFGy6MbVg90H21EOLACvtfcHk0ljEiWfBuyZKAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVylsr3L&md5=ffcdd2b6a6884d7fa48076c9bf228011</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M807045200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M807045200%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DC.%2BJ.%26aulast%3DHerman%26aufirst%3DD.%26aulast%3DGottesfeld%26aufirst%3DJ.%2BM.%26atitle%3DPimelic%2520diphenylamide%2520106%2520is%2520a%2520slow%252C%2520tight-binding%2520inhibitor%2520of%2520class%2520I%2520histone%2520deacetylases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D35402%26epage%3D35409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bonfils, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carducci, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span> </span><span class="NLM_article-title">Evaluation of the pharmacodynamic effects of MGCD0103 from preclinical models to human using a novel HDAC enzyme assay</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3441</span><span class="NLM_x">–</span> <span class="NLM_lpage">3449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1158%2F1078-0432.CCR-07-4427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=18519775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslygsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3441-3449&author=C.+Bonfilsauthor=A.+Kalitaauthor=M.+Dubayauthor=L.+L.+Siuauthor=M.+A.+Carducciauthor=G.+Reidauthor=R.+E.+Martellauthor=J.+M.+Bestermanauthor=Z.+Li&title=Evaluation+of+the+pharmacodynamic+effects+of+MGCD0103+from+preclinical+models+to+human+using+a+novel+HDAC+enzyme+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Pharmacodynamic Effects of MGCD0103 from Preclinical Models to Human Using a Novel HDAC Enzyme Assay</span></div><div class="casAuthors">Bonfils, Claire; Kalita, Ann; Dubay, Marja; Siu, Lillian L.; Carducci, Michael A.; Reid, Gregory; Martell, Robert E.; Besterman, Jeffrey M.; Li, Zuomei</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3441-3449</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The pharmacodynamic properties of MGCD0103, an isotype-selective inhibitor of histone deacetylase (HDAC), were evaluated in preclin. models and patients with a novel whole-cell HDAC enzyme assay.  Exptl. Design: Boc-Lys(.vepsiln.-Ac)-AMC, a HDAC substrate with fluorescent readout, was found to be cell permeable and was used to monitor MGCD0103-mediated HDAC inhibition in cultured cancer cells in vitro, in peripheral WBC ex vivo, in mice in vivo, and in human patients.  RESULTS: MGCD0103 inhibited HDAC activity in several human cancer cell lines in vitro and in human peripheral WBC ex vivo in a dose-dependent manner.  Unlike suberoylanilide hydroxamic acid, the HDAC inhibitory activity of MGCD0103 was time dependent and sustained for at least 24 h following drug removal in peripheral WBC ex vivo.  Inhibitory activity of MGCD0103 was sustained for at least 8 h in vivo in mice and 48 h in patients with solid tumors.  HDAC inhibitory activity of MGCD0103 in peripheral WBC correlated with induction of histone acetylation in blood and in implanted tumors in mice.  In cancer patients, sustained pharmacodynamic effect of MGCD0103 was visualized only by dose-dependent enzyme inhibition in peripheral WBC but not by histone acetylation anal.  CONCLUSIONS: This study shows that MGCD0103 has sustained pharmacodynamic effects that can be monitored both in vitro and in vivo with a cell-based HDAC enzyme assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrReZVYYRQ0YbVg90H21EOLACvtfcHk0ljEiWfBuyZKAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslygsbk%253D&md5=29b048a8a7c72caa67b9e68e5604e1df</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-4427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-4427%26sid%3Dliteratum%253Aachs%26aulast%3DBonfils%26aufirst%3DC.%26aulast%3DKalita%26aufirst%3DA.%26aulast%3DDubay%26aufirst%3DM.%26aulast%3DSiu%26aufirst%3DL.%2BL.%26aulast%3DCarducci%26aufirst%3DM.%2BA.%26aulast%3DReid%26aufirst%3DG.%26aulast%3DMartell%26aufirst%3DR.%2BE.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEvaluation%2520of%2520the%2520pharmacodynamic%2520effects%2520of%2520MGCD0103%2520from%2520preclinical%2520models%2520to%2520human%2520using%2520a%2520novel%2520HDAC%2520enzyme%2520assay%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D3441%26epage%3D3449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Peh, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assem, E-S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marson, C. M.</span><span> </span><span class="NLM_article-title">Effect of a selection of histone deacetylase inhibitors on mast cell activation and airway and colonic smooth muscle contraction</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1801</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1016%2Fj.intimp.2008.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=18805511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGht7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1793-1801&author=K.+H.+Pehauthor=B.+Y.+Wanauthor=E-S.+K.+Assemauthor=C.+M.+Marson&title=Effect+of+a+selection+of+histone+deacetylase+inhibitors+on+mast+cell+activation+and+airway+and+colonic+smooth+muscle+contraction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a selection of histone deacetylase inhibitors on mast cell activation and airway and colonic smooth muscle contraction</span></div><div class="casAuthors">Assem, El-Sayed K.; Peh, Kheng H.; Wan, Beatrice Y. C.; Middleton, Brian J.; Dines, Jon; Marson, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">1793-1801</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Studies of histone deacetylase (HDAC) inhibitors, novel anticancer drugs, in models of autoimmune diseases, asthma, and inflammatory bowel disease suggest that HDAC inhibitors may also have useful anti-inflammatory effects.  Accordingly, in vitro studies relevant to asthma and inflammatory bowel disease were conducted using a selection of HDAC inhibitors: suberoylanilide hydroxamic acid (SAHA, Vorinostat), and a related branched hydroxamic acid, diamide (1), MGCD0103 and two short chain fatty acid derivs.: sodium butyrate (of use in inflammatory bowel disease) and sodium valproate.  The ability of those HDAC inhibitors to modulate antigen- or agonist-induced contraction of isolated guinea pig tracheal rings and colon, agonist-induced contraction of rat colon, and histamine release from rat peritoneal mast cells was examd.  Pre-incubation (up to 6 h) with 10-40 μM of SAHA, diamide (1), or MGCD0103 caused significant inhibition of the antigen-induced contraction of sensitized guinea pig tracheal rings as well as inhibition of the contraction induced by histamine, 5-hydroxytryptamine and carbachol (G-protein coupled receptor agonists), while sodium butyrate (1 mM) and sodium valproate (100 μM) were weak inhibitors.  Contraction of tracheal rings by sodium fluoride (NaF, a non-selective G-protein activator), KCl and a peroxyl radical generator was blocked by MGCD0103.  Addnl., MGCD0103 significantly inhibited antigen-induced histamine release from IgE antibody-sensitized rat peritoneal mast cells, and NaF-induced histamine release, as well as inhibiting NaF-induced colon contraction.  Those various effects appear to involve modulation of cell signaling, probably involving G-protein coupled pathways, and further support the development of HDAC inhibitors as anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-LCroFTT4LVg90H21EOLACvtfcHk0lhOdqpqtA1paA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGht7nI&md5=006b66dd39c2245e2a6ea2632182c971</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2008.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2008.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DPeh%26aufirst%3DK.%2BH.%26aulast%3DWan%26aufirst%3DB.%2BY.%26aulast%3DAssem%26aufirst%3DE-S.%2BK.%26aulast%3DMarson%26aufirst%3DC.%2BM.%26atitle%3DEffect%2520of%2520a%2520selection%2520of%2520histone%2520deacetylase%2520inhibitors%2520on%2520mast%2520cell%2520activation%2520and%2520airway%2520and%2520colonic%2520smooth%2520muscle%2520contraction%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2008%26volume%3D8%26spage%3D1793%26epage%3D1801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Dedes, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedes, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imesch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bueren, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedier, A.</span><span> </span><span class="NLM_article-title">Acquired vorinostat resistance shows partial cross-resistance to “second-generation” HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=321-333&author=K.+J.+Dedesauthor=I.+Dedesauthor=P.+Imeschauthor=A.+O.+von+Buerenauthor=D.+Finkauthor=A.+Fedier&title=Acquired+vorinostat+resistance+shows+partial+cross-resistance+to+%E2%80%9Csecond-generation%E2%80%9D+HDAC+inhibitors+and+correlates+with+loss+of+histone+acetylation+and+apoptosis+but+not+with+altered+HDAC+and+HAT+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDedes%26aufirst%3DK.%2BJ.%26aulast%3DDedes%26aufirst%3DI.%26aulast%3DImesch%26aufirst%3DP.%26aulast%3Dvon%2BBueren%26aufirst%3DA.%2BO.%26aulast%3DFink%26aufirst%3DD.%26aulast%3DFedier%26aufirst%3DA.%26atitle%3DAcquired%2520vorinostat%2520resistance%2520shows%2520partial%2520cross-resistance%2520to%2520%25E2%2580%259Csecond-generation%25E2%2580%259D%2520HDAC%2520inhibitors%2520and%2520correlates%2520with%2520loss%2520of%2520histone%2520acetylation%2520and%2520apoptosis%2520but%2520not%2520with%2520altered%2520HDAC%2520and%2520HAT%2520activities%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2009%26volume%3D20%26spage%3D321%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Delorme, D.; Vaisburg, A.; Moradei, O.; Leit, S.; Frechette, S.; Zhou, Z.; Paquin, I.; Gaudette, F.; Isakovic, L.; Bouchain, G.; Raeppel, S.</span><span> </span><span class="NLM_article-title">Inhibitors of Histone Deacetylase</span>. Patent CA 2559733<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>MethylGene.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=D.+Delorme&author=A.+Vaisburg&author=O.+Moradei&author=S.+Leit&author=S.+Frechette&author=Z.+Zhou&author=I.+Paquin&author=F.+Gaudette&author=L.+Isakovic&author=G.+Bouchain&author=S.+Raeppel&title=Inhibitors+of+Histone+Deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDelorme%26aufirst%3DD.%26atitle%3DInhibitors%2520of%2520Histone%2520Deacetylase%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Moradei, O.; Paquin, I.; Leit, S.; Frechette, S.; Vaisburg, A.; Besterman, J. M.; Tessier, P.; Mallais, T. C.</span><span> </span><span class="NLM_article-title">Inhibitors of Histone Deacetylase</span>. Patent WO 2005030704<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>MethylGene.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=O.+Moradei&author=I.+Paquin&author=S.+Leit&author=S.+Frechette&author=A.+Vaisburg&author=J.+M.+Besterman&author=P.+Tessier&author=T.+C.+Mallais&title=Inhibitors+of+Histone+Deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMoradei%26aufirst%3DO.%26atitle%3DInhibitors%2520of%2520Histone%2520Deacetylase%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Reyes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, K.</span><span> </span><span class="NLM_article-title">On formation of thiohydantoins from amino acids under acylation conditions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">2507</span><span class="NLM_x">–</span> <span class="NLM_lpage">2509</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo052576i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=2507-2509&author=S.+Reyesauthor=K.+Burgess&title=On+formation+of+thiohydantoins+from+amino+acids+under+acylation+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo052576i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052576i%26sid%3Dliteratum%253Aachs%26aulast%3DReyes%26aufirst%3DS.%26aulast%3DBurgess%26aufirst%3DK.%26atitle%3DOn%2520formation%2520of%2520thiohydantoins%2520from%2520amino%2520acids%2520under%2520acylation%2520conditions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D2507%26epage%3D2509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Samyn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardeman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Eycken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Beeumen, J.</span><span> </span><span class="NLM_article-title">Applicability of the alkylation chemistry for chemical C-terminal protein sequence analysis</span> <span class="citation_source-journal">Anal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1389</span><span class="NLM_x">–</span> <span class="NLM_lpage">1399</span></span><div class="citationLinks">[<a href="/doi/10.1021/ac991049u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2000&pages=1389-1399&author=B.+Samynauthor=K.+Hardemanauthor=J.+Van+der+Eyckenauthor=J.+Van+Beeumen&title=Applicability+of+the+alkylation+chemistry+for+chemical+C-terminal+protein+sequence+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fac991049u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac991049u%26sid%3Dliteratum%253Aachs%26aulast%3DSamyn%26aufirst%3DB.%26aulast%3DHardeman%26aufirst%3DK.%26aulast%3DVan%2Bder%2BEycken%26aufirst%3DJ.%26aulast%3DVan%2BBeeumen%26aufirst%3DJ.%26atitle%3DApplicability%2520of%2520the%2520alkylation%2520chemistry%2520for%2520chemical%2520C-terminal%2520protein%2520sequence%2520analysis%26jtitle%3DAnal.%2520Chem.%26date%3D2000%26volume%3D72%26spage%3D1389%26epage%3D1399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Yoshii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirashima, A.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of 2-aminothiazolines and 2-mercaptothiazolines as octopaminergic agonists</span> <span class="citation_source-journal">Agric. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2537</span><span class="NLM_x">–</span> <span class="NLM_lpage">2545</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1271%2Fbbb1961.55.2537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADyaK38XmsVGq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1991&pages=2537-2545&author=Y.+Yoshiiauthor=M.+Etoauthor=A.+Hirashima&title=Synthesis+and+biological+activity+of+2-aminothiazolines+and+2-mercaptothiazolines+as+octopaminergic+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activity of 2-aminothiazolines and 2-mercaptothiazolines as octopaminergic agonists</span></div><div class="casAuthors">Hirashima, Akinori; Yoshii, Yutaka; Eto, Morifusa</div><div class="citationInfo"><span class="NLM_cas:title">Agricultural and Biological Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2537-45</span>CODEN:
                <span class="NLM_cas:coden">ABCHA6</span>;
        ISSN:<span class="NLM_cas:issn">0002-1369</span>.
    </div><div class="casAbstract">The title compds., e.g., I (R = H, Me, Ph, Et, CH2CH2SMe; R1 = alkyl- or arylamino, SH, EtO2CCH2S) were prepd. by the cyclocondensation of the corresponding isothiocyanates or CS2 with ethanolamines or their sulfates.  I [R = H, R1 = 2-Me-4-ClC6H3NH (II)] was 33% as effective as octopamine at 100 μM in stimulating adenylate cyclase of Periplaneta americana ventral-nerve-cord homogenates.  Its activity was nonadditive to the activity of octopamine.  Stimulation of nerve-cord adenylate-cyclase activity by II was inhibited by several antagonists, including mianserin, cyproheptadine, chlorpromazine and gramine.  The rank-order ability of these antagonists to block the activation by II was identical to the rank-order ability of the same antagonists to block enzyme activation by octopamine.  The β-adrenergic antagonist propranolol was less potent.  These data suggest that II is a potent and selective agonist of octopamine-activated adenylate cyclase.  Aminothiazolines, which activated adenylate cyclase by 10-87% relative to octopamine also had acaricidal activity at 300 ppm, indicating a correlation between the in vitro octopaminergic-agonist activity and in vivo acaricidal activity of aminothiazolines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyepnJwRhIvLVg90H21EOLACvtfcHk0ljeD96131bCxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XmsVGq&md5=bc232025173db1f389b21b57fcd9df36</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1271%2Fbbb1961.55.2537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1271%252Fbbb1961.55.2537%26sid%3Dliteratum%253Aachs%26aulast%3DYoshii%26aufirst%3DY.%26aulast%3DEto%26aufirst%3DM.%26aulast%3DHirashima%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%25202-aminothiazolines%2520and%25202-mercaptothiazolines%2520as%2520octopaminergic%2520agonists%26jtitle%3DAgric.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D55%26spage%3D2537%26epage%3D2545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Kim, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cha, M.-H.</span><span> </span><span class="NLM_article-title">Efficient synthesis of 2-methylaminothiazolines via Mitsunobu reaction of <i>N</i>-(2-hydroxyethyl)-<i>N′</i>-methylthioureas</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">3125</span><span class="NLM_x">–</span> <span class="NLM_lpage">3128</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=3125-3128&author=T.+H.+Kimauthor=M.-H.+Cha&title=Efficient+synthesis+of+2-methylaminothiazolines+via+Mitsunobu+reaction+of+N-%282-hydroxyethyl%29-N%E2%80%B2-methylthioureas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DT.%2BH.%26aulast%3DCha%26aufirst%3DM.-H.%26atitle%3DEfficient%2520synthesis%2520of%25202-methylaminothiazolines%2520via%2520Mitsunobu%2520reaction%2520of%2520N-%25282-hydroxyethyl%2529-N%25E2%2580%25B2-methylthioureas%26jtitle%3DTetrahedron%2520Lett.%26date%3D1999%26volume%3D40%26spage%3D3125%26epage%3D3128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Fréchette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapointe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeannotte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradei, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouchain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeppel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudette, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisburg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trachy-Bourget, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, M.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delorme, D.</span><span> </span><span class="NLM_article-title">4-(Heteroarylaminomethyl)-<i>N</i>-(2-aminophenyl)-benzamides and their analogs as a novel class of histone deacetylase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1502</span><span class="NLM_x">–</span> <span class="NLM_lpage">1506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1502-1506&author=S.+Fr%C3%A9chetteauthor=S.+Leitauthor=S.+H.+Wooauthor=G.+Lapointeauthor=G.+Jeannotteauthor=O.+Moradeiauthor=I.+Paquinauthor=G.+Bouchainauthor=S.+Raeppelauthor=F.+Gaudetteauthor=N.+Zhouauthor=A.+Vaisburgauthor=M.+Fournelauthor=P.+T.+Yanauthor=M.-C.+Trachy-Bourgetauthor=A.+Kalitaauthor=M.-F.+Robertauthor=A.+Luauthor=J.+Rahilauthor=A.+R.+MacLeodauthor=J.+M.+Bestermanauthor=Z.+Liauthor=D.+Delorme&title=4-%28Heteroarylaminomethyl%29-N-%282-aminophenyl%29-benzamides+and+their+analogs+as+a+novel+class+of+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFr%25C3%25A9chette%26aufirst%3DS.%26aulast%3DLeit%26aufirst%3DS.%26aulast%3DWoo%26aufirst%3DS.%2BH.%26aulast%3DLapointe%26aufirst%3DG.%26aulast%3DJeannotte%26aufirst%3DG.%26aulast%3DMoradei%26aufirst%3DO.%26aulast%3DPaquin%26aufirst%3DI.%26aulast%3DBouchain%26aufirst%3DG.%26aulast%3DRaeppel%26aufirst%3DS.%26aulast%3DGaudette%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DVaisburg%26aufirst%3DA.%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DP.%2BT.%26aulast%3DTrachy-Bourget%26aufirst%3DM.-C.%26aulast%3DKalita%26aufirst%3DA.%26aulast%3DRobert%26aufirst%3DM.-F.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DMacLeod%26aufirst%3DA.%2BR.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DDelorme%26aufirst%3DD.%26atitle%3D4-%2528Heteroarylaminomethyl%2529-N-%25282-aminophenyl%2529-benzamides%2520and%2520their%2520analogs%2520as%2520a%2520novel%2520class%2520of%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1502%26epage%3D1506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Raeppel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudette, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larouche, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradei, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fréchette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakovic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delorme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trachy-Bourget, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisburg, A.</span><span> </span><span class="NLM_article-title">SAR and biological evaluation of analogues of a small histone deacetylase inhibitor <i>N</i>-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">644</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=644-649&author=S.+Raeppelauthor=N.+Zhouauthor=F.+Gaudetteauthor=S.+Leitauthor=I.+Paquinauthor=G.+Laroucheauthor=O.+Moradeiauthor=S.+Fr%C3%A9chetteauthor=L.+Isakovicauthor=D.+Delormeauthor=M.+Fournelauthor=A.+Kalitaauthor=A.+Luauthor=M.-C.+Trachy-Bourgetauthor=P.+T.+Yanauthor=J.+Liuauthor=J.+Rahilauthor=J.+Wangauthor=J.+M.+Bestermanauthor=K.+Murakamiauthor=Z.+Liauthor=A.+Vaisburg&title=SAR+and+biological+evaluation+of+analogues+of+a+small+histone+deacetylase+inhibitor+N-%282-aminophenyl%29-4-%28%284-%28pyridin-3-yl%29pyrimidin-2-ylamino%29methyl%29benzamide+%28MGCD0103%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaeppel%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DGaudette%26aufirst%3DF.%26aulast%3DLeit%26aufirst%3DS.%26aulast%3DPaquin%26aufirst%3DI.%26aulast%3DLarouche%26aufirst%3DG.%26aulast%3DMoradei%26aufirst%3DO.%26aulast%3DFr%25C3%25A9chette%26aufirst%3DS.%26aulast%3DIsakovic%26aufirst%3DL.%26aulast%3DDelorme%26aufirst%3DD.%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DKalita%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DTrachy-Bourget%26aufirst%3DM.-C.%26aulast%3DYan%26aufirst%3DP.%2BT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DVaisburg%26aufirst%3DA.%26atitle%3DSAR%2520and%2520biological%2520evaluation%2520of%2520analogues%2520of%2520a%2520small%2520histone%2520deacetylase%2520inhibitor%2520N-%25282-aminophenyl%2529-4-%2528%25284-%2528pyridin-3-yl%2529pyrimidin-2-ylamino%2529methyl%2529benzamide%2520%2528MGCD0103%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D644%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Moradei, O.; Paquin, I.; Leit, S.; Fréchette, S.; Vaisburg, A.; Besterman, J. M.; Tessier, P.; Mallais, T. C.</span><span> </span><span class="NLM_article-title">Inhibitors of Histone Deacetylase</span>. U.S. Patent 0307005<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>MethylGene Inc.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=O.+Moradei&author=I.+Paquin&author=S.+Leit&author=S.+Fr%C3%A9chette&author=A.+Vaisburg&author=J.+M.+Besterman&author=P.+Tessier&author=T.+C.+Mallais&title=Inhibitors+of+Histone+Deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMoradei%26aufirst%3DO.%26atitle%3DInhibitors%2520of%2520Histone%2520Deacetylase%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Kattar, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surdi, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabierek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Methot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlberg, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozerova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secrist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harsch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamill, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenific, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berk, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempest, P.</span><span> </span><span class="NLM_article-title">Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1168</span><span class="NLM_x">–</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1168-1172&author=S.+D.+Kattarauthor=L.+M.+Surdiauthor=A.+Zabierekauthor=J.+L.+Methotauthor=R.+E.+Middletonauthor=B.+Hughesauthor=A.+A.+Szewczakauthor=W.+K.+Dahlbergauthor=A.+M.+Kralauthor=N.+Ozerovaauthor=J.+C.+Flemingauthor=H.+Wangauthor=P.+Secristauthor=A.+Harschauthor=J.+E.+Hamillauthor=J.+C.+Cruzauthor=C.+M.+Kenificauthor=M.+Chenardauthor=T.+A.+Millerauthor=S.+C.+Berkauthor=P.+Tempest&title=Parallel+medicinal+chemistry+approaches+to+selective+HDAC1%2FHDAC2+inhibitor+%28SHI-1%3A2%29+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKattar%26aufirst%3DS.%2BD.%26aulast%3DSurdi%26aufirst%3DL.%2BM.%26aulast%3DZabierek%26aufirst%3DA.%26aulast%3DMethot%26aufirst%3DJ.%2BL.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DHughes%26aufirst%3DB.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DDahlberg%26aufirst%3DW.%2BK.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DOzerova%26aufirst%3DN.%26aulast%3DFleming%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DSecrist%26aufirst%3DP.%26aulast%3DHarsch%26aufirst%3DA.%26aulast%3DHamill%26aufirst%3DJ.%2BE.%26aulast%3DCruz%26aufirst%3DJ.%2BC.%26aulast%3DKenific%26aufirst%3DC.%2BM.%26aulast%3DChenard%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DT.%2BA.%26aulast%3DBerk%26aufirst%3DS.%2BC.%26aulast%3DTempest%26aufirst%3DP.%26atitle%3DParallel%2520medicinal%2520chemistry%2520approaches%2520to%2520selective%2520HDAC1%252FHDAC2%2520inhibitor%2520%2528SHI-1%253A2%2529%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1168%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Bieliauskas, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pflum, M. K. H.</span><span> </span><span class="NLM_article-title">Isoform-selective histone deacetylase inhibitors</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1402</span><span class="NLM_x">–</span> <span class="NLM_lpage">1413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1039%2Fb703830p" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=18568166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsFejsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2008&pages=1402-1413&author=A.+V.+Bieliauskasauthor=M.+K.+H.+Pflum&title=Isoform-selective+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-selective histone deacetylase inhibitors</span></div><div class="casAuthors">Bieliauskas, Anton V.; Pflum, Mary Kay H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1402-1413</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase (HDAC) proteins are transcription regulators linked to cancer.  As a result, multiple small mol. HDAC inhibitors are in various phases of clin. trials as anti-cancer drugs.  The majority of HDAC inhibitors non-selectively influence the activities of eleven human HDAC isoforms, which are divided into distinct classes.  This tutorial review focuses on the recent progress toward the identification of class-selective and isoform-selective HDAC inhibitors.  The emerging trends suggest that subtle differences in the active sites of the HDAC isoforms can be exploited to dictate selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXOB_YFWaeZrVg90H21EOLACvtfcHk0lhUzqvYM5Ho7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsFejsbs%253D&md5=326e20da0623a00114f43e5c459c9920</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2Fb703830p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb703830p%26sid%3Dliteratum%253Aachs%26aulast%3DBieliauskas%26aufirst%3DA.%2BV.%26aulast%3DPflum%26aufirst%3DM.%2BK.%2BH.%26atitle%3DIsoform-selective%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2008%26volume%3D37%26spage%3D1402%26epage%3D1413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Trott, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0lhUzqvYM5Ho7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luscombe, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A. P.</span><span> </span><span class="NLM_article-title">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1016%2Fj.drudis.2011.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=21704184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=822-830&author=R.+J.+Youngauthor=D.+V.+S.+Greenauthor=C.+N.+Luscombeauthor=A.+P.+Hill&title=Getting+physical+in+drug+discovery+II%3A+the+impact+of+chromatographic+hydrophobicity+measurements+and+aromaticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span></div><div class="casAuthors">Young, Robert J.; Green, Darren V. S.; Luscombe, Christopher N.; Hill, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17/18</span>),
    <span class="NLM_cas:pages">822-830</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here, we review the performance of chromatog. hydrophobicity measurements in a data set of 100 000 GlaxoSmithKline compds., demonstrating the advantages of the method over octanol-water partitioning and highlighting new insights for drug discovery.  The value of chromatog. measurements, vs. other hydrophobicity ests., was supported by improved relationships with soly., permeation, cytochrome P450s, intrinsic clearance, hERG binding and promiscuity.  We also obsd. marked differentiation of the relative influence of intrinsic and effective hydrophobicity.  The summing of hydrophobicity values plus arom. ring count [log D pH7.4 (or log P) + #Ar], indicated a wide relevance for simplistic property forecast indexes' in developability assays, clearly enhanced by chromatog. values; therefore establishing new foundations for enriching property-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmIJyWi-DBW7Vg90H21EOLACvtfcHk0lhUzqvYM5Ho7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF&md5=22788603a45aa77537e8666433473d14</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DGreen%26aufirst%3DD.%2BV.%2BS.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DHill%26aufirst%3DA.%2BP.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%2520II%253A%2520the%2520impact%2520of%2520chromatographic%2520hydrophobicity%2520measurements%2520and%2520aromaticity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D822%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">–</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0lhUzqvYM5Ho7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Hill, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span> </span><span class="NLM_article-title">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1016%2Fj.drudis.2010.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=20570751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=648-655&author=A.+P.+Hillauthor=R.+J.+Young&title=Getting+physical+in+drug+discovery%3A+a+contemporary+perspective+on+solubility+and+hydrophobicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span></div><div class="casAuthors">Hill, Alan P.; Young, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15/16</span>),
    <span class="NLM_cas:pages">648-655</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Suboptimal phys. properties have been identified as a particular shortcoming of compds. in contemporary drug discovery, contributing to high attrition levels.  An anal. of the relationship between hydrophobicity (calcd. and measured) and ∼100 k measured kinetic soly. values has been undertaken.  In line with the General Soly. Equation, ests. of hydrophobicity, particularly ACD c log D pH7.4, give a useful indication of the likely soly. classification of particular mols.  Taking ACD c log D pH7.4 values together with the no. of arom. rings in a given mol. provides enhanced prediction.  The Soly. Forecast Index' (SFI = c log D pH7.4 + #Ar) is proposed as a simple, yet effective, guide to predicting soly.  Moreover, anal. of measured distribution/partition coeff. values highlighted statistically significant shortcomings in the applicability of octanol/water as a model system for hydrophobicity detn. with poorly sol. compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdtQyfNjbFUrVg90H21EOLACvtfcHk0liHXfMCl2Jtcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P&md5=7b201081c5586a6ea4b7af00d507d462</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DA.%2BP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%253A%2520a%2520contemporary%2520perspective%2520on%2520solubility%2520and%2520hydrophobicity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D648%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0liHXfMCl2Jtcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Chia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beamish, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jafferi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielli, B.</span><span> </span><span class="NLM_article-title">The histone deacetylase inhibitor MGCD0103 has both deacetylase and microtuble activity</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">436</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=436-443&author=K.+Chiaauthor=H.+Beamishauthor=K.+Jafferiauthor=B.+Gabrielli&title=The+histone+deacetylase+inhibitor+MGCD0103+has+both+deacetylase+and+microtuble+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChia%26aufirst%3DK.%26aulast%3DBeamish%26aufirst%3DH.%26aulast%3DJafferi%26aufirst%3DK.%26aulast%3DGabrielli%26aufirst%3DB.%26atitle%3DThe%2520histone%2520deacetylase%2520inhibitor%2520MGCD0103%2520has%2520both%2520deacetylase%2520and%2520microtuble%2520activity%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26spage%3D436%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Charrier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span> </span><span class="NLM_article-title">Synthesis of indoles: efficient functionalisation of the 7-position</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">3467</span><span class="NLM_x">–</span> <span class="NLM_lpage">3477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1055%2Fs-2006-950223" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=3467-3477&author=N.+Charrierauthor=E.+Demontauthor=R.+Dunsdonauthor=G.+Maileauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=P.+Theobaldauthor=D.+Veseyauthor=D.+Walter&title=Synthesis+of+indoles%3A+efficient+functionalisation+of+the+7-position"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-950223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-950223%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DN.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DP.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DD.%26atitle%3DSynthesis%2520of%2520indoles%253A%2520efficient%2520functionalisation%2520of%2520the%25207-position%26jtitle%3DSynthesis%26date%3D2006%26volume%3D2006%26spage%3D3467%26epage%3D3477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Ogino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtake, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagae, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanesaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitobe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwaasa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanatani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, T.</span><span> </span><span class="NLM_article-title">Syntheses and structure–activity relationships of novel, potent, and selective <i>trans</i>-2-[3-oxospiro[isobenzofuran-1(3<i>H</i>),1′-cyclohexan]-4′-yl]benzimidazole NPY Y5 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4997</span><span class="NLM_x">–</span> <span class="NLM_lpage">5001</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4997-5001&author=Y.+Oginoauthor=N.+Ohtakeauthor=Y.+Nagaeauthor=K.+Matsudaauthor=M.+Ishikawaauthor=M.+Moriyaauthor=M.+Kanesakaauthor=Y.+Mitobeauthor=J.+Itoauthor=T.+Kannoauthor=A.+Ishiharaauthor=H.+Iwaasaauthor=T.+Oheauthor=A.+Kanataniauthor=T.+Fukami&title=Syntheses+and+structure%E2%80%93activity+relationships+of+novel%2C+potent%2C+and+selective+trans-2-%5B3-oxospiro%5Bisobenzofuran-1%283H%29%2C1%E2%80%B2-cyclohexan%5D-4%E2%80%B2-yl%5Dbenzimidazole+NPY+Y5+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOgino%26aufirst%3DY.%26aulast%3DOhtake%26aufirst%3DN.%26aulast%3DNagae%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DK.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DMoriya%26aufirst%3DM.%26aulast%3DKanesaka%26aufirst%3DM.%26aulast%3DMitobe%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DJ.%26aulast%3DKanno%26aufirst%3DT.%26aulast%3DIshihara%26aufirst%3DA.%26aulast%3DIwaasa%26aufirst%3DH.%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DKanatani%26aufirst%3DA.%26aulast%3DFukami%26aufirst%3DT.%26atitle%3DSyntheses%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520novel%252C%2520potent%252C%2520and%2520selective%2520trans-2-%255B3-oxospiro%255Bisobenzofuran-1%25283H%2529%252C1%25E2%2580%25B2-cyclohexan%255D-4%25E2%2580%25B2-yl%255Dbenzimidazole%2520NPY%2520Y5%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4997%26epage%3D5001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Kerr, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read de Alaniz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovis, T.</span><span> </span><span class="NLM_article-title">An efficient synthesis of achiral and chiral 1,2,4-triazolium salts: bench stable precursors for N-heterocyclic carbenes</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">5725</span><span class="NLM_x">–</span> <span class="NLM_lpage">5728</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo050645n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVymtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=5725-5728&author=M.+S.+Kerrauthor=J.+Read+de+Alanizauthor=T.+Rovis&title=An+efficient+synthesis+of+achiral+and+chiral+1%2C2%2C4-triazolium+salts%3A+bench+stable+precursors+for+N-heterocyclic+carbenes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">An Efficient Synthesis of Achiral and Chiral 1,2,4-Triazolium Salts: Bench Stable Precursors for N-Heterocyclic Carbenes</span></div><div class="casAuthors">Kerr, Mark S.; Read de Alaniz, Javier; Rovis, Tomislav</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5725-5728</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A variety of 1,2,4-triazolium salts I (R1 = Ph, 4-F3CC6H4, C6F5; R2 = H, PhCH2; X = Cl, BF4) and II (R3 = Ph, 4-MeOC6H4, C6F5; Y = BF4) was synthesized as stable precursors for N-heterocyclic carbenes.  The reactions commence from com. available amino acids and proceed in 44-68% overall yields.  The 1,2,4-triazolium salts obtained are air-stable cryst. solids that can be stored with no special precaution and can generate the active catalyst when treated with an appropriate base.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJvKHyGW1A77Vg90H21EOLACvtfcHk0lgH4W7EpbHJjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVymtb4%253D&md5=16fcdd58d923ebb82f4e754a2ea85b87</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjo050645n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo050645n%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DM.%2BS.%26aulast%3DRead%2Bde%2BAlaniz%26aufirst%3DJ.%26aulast%3DRovis%26aufirst%3DT.%26atitle%3DAn%2520efficient%2520synthesis%2520of%2520achiral%2520and%2520chiral%25201%252C2%252C4-triazolium%2520salts%253A%2520bench%2520stable%2520precursors%2520for%2520N-heterocyclic%2520carbenes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D5725%26epage%3D5728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Appleton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babcock, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copp, B. R.</span><span> </span><span class="NLM_article-title">Novel tryptophan-derived dipeptides and bioactive metabolites from the sea hare <i>Aplysia dactylomela</i></span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10181</span><span class="NLM_x">–</span> <span class="NLM_lpage">10189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=10181-10189&author=D.+R.+Appletonauthor=R.+C.+Babcockauthor=B.+R.+Copp&title=Novel+tryptophan-derived+dipeptides+and+bioactive+metabolites+from+the+sea+hare+Aplysia+dactylomela"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppleton%26aufirst%3DD.%2BR.%26aulast%3DBabcock%26aufirst%3DR.%2BC.%26aulast%3DCopp%26aufirst%3DB.%2BR.%26atitle%3DNovel%2520tryptophan-derived%2520dipeptides%2520and%2520bioactive%2520metabolites%2520from%2520the%2520sea%2520hare%2520Aplysia%2520dactylomela%26jtitle%3DTetrahedron%26date%3D2001%26volume%3D57%26spage%3D10181%26epage%3D10189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Pearson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chelliah, M. V.</span><span> </span><span class="NLM_article-title">Synthesis of a model bicyclic CDE ring system of ristocetin A and observation of a facile inversion of configuration in a 16-membered DE ring model</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">3087</span><span class="NLM_x">–</span> <span class="NLM_lpage">3098</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo980060b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=3087-3098&author=A.+J.+Pearsonauthor=M.+V.+Chelliah&title=Synthesis+of+a+model+bicyclic+CDE+ring+system+of+ristocetin+A+and+observation+of+a+facile+inversion+of+configuration+in+a+16-membered+DE+ring+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjo980060b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo980060b%26sid%3Dliteratum%253Aachs%26aulast%3DPearson%26aufirst%3DA.%2BJ.%26aulast%3DChelliah%26aufirst%3DM.%2BV.%26atitle%3DSynthesis%2520of%2520a%2520model%2520bicyclic%2520CDE%2520ring%2520system%2520of%2520ristocetin%2520A%2520and%2520observation%2520of%2520a%2520facile%2520inversion%2520of%2520configuration%2520in%2520a%252016-membered%2520DE%2520ring%2520model%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D3087%26epage%3D3098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Chandra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, D. K.</span><span> </span><span class="NLM_article-title">Design of photocleavable lipids and their application in liposomal “uncorking”</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_fpage">3021</span><span class="NLM_x">–</span> <span class="NLM_lpage">3023</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=3021-3023&author=B.+Chandraauthor=S.+Mallikauthor=D.+K.+Srivastava&title=Design+of+photocleavable+lipids+and+their+application+in+liposomal+%E2%80%9Cuncorking%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChandra%26aufirst%3DB.%26aulast%3DMallik%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DD.%2BK.%26atitle%3DDesign%2520of%2520photocleavable%2520lipids%2520and%2520their%2520application%2520in%2520liposomal%2520%25E2%2580%259Cuncorking%25E2%2580%259D%26jtitle%3DChem.%2520Commun.%26date%3D2005%26spage%3D3021%26epage%3D3023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Petasis, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, Z. D.</span><span> </span><span class="NLM_article-title">Synthesis of piperazinones and benzopiperazinones from 1,2-diamines and organoboronic acids</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">9607</span><span class="NLM_x">–</span> <span class="NLM_lpage">9611</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=9607-9611&author=N.+A.+Petasisauthor=Z.+D.+Patel&title=Synthesis+of+piperazinones+and+benzopiperazinones+from+1%2C2-diamines+and+organoboronic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetasis%26aufirst%3DN.%2BA.%26aulast%3DPatel%26aufirst%3DZ.%2BD.%26atitle%3DSynthesis%2520of%2520piperazinones%2520and%2520benzopiperazinones%2520from%25201%252C2-diamines%2520and%2520organoboronic%2520acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D9607%26epage%3D9611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Suzuki, T.; Ando, T.; Tsuchiya, K.; Nakanishi, O.; Saito, A.; Yamashita, T.; Shiraishi, Y.; Tanaka, E.</span><span> </span><span class="NLM_article-title">Cell Differentiation Inducer</span>. U.S. Patent 6174905,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">; </span>Mitsui Chemicals Inc.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=T.+Suzuki&author=T.+Ando&author=K.+Tsuchiya&author=O.+Nakanishi&author=A.+Saito&author=T.+Yamashita&author=Y.+Shiraishi&author=E.+Tanaka&title=Cell+Differentiation+Inducer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DCell%2520Differentiation%2520Inducer%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Humljan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, S.</span><span> </span><span class="NLM_article-title">Synthesis of <i>N</i>-phthalimido β-aminoethanesulfonyl chlorides: the use of thionyl chloride for a simple and efficient synthesis of new peptidosulfonamide building blocks</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4069</span><span class="NLM_x">–</span> <span class="NLM_lpage">4072</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=4069-4072&author=J.+Humljanauthor=S.+Gobec&title=Synthesis+of+N-phthalimido+%CE%B2-aminoethanesulfonyl+chlorides%3A+the+use+of+thionyl+chloride+for+a+simple+and+efficient+synthesis+of+new+peptidosulfonamide+building+blocks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHumljan%26aufirst%3DJ.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520N-phthalimido%2520%25CE%25B2-aminoethanesulfonyl%2520chlorides%253A%2520the%2520use%2520of%2520thionyl%2520chloride%2520for%2520a%2520simple%2520and%2520efficient%2520synthesis%2520of%2520new%2520peptidosulfonamide%2520building%2520blocks%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D4069%26epage%3D4072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">McKennon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drauz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarm, M.</span><span> </span><span class="NLM_article-title">A convenient reduction of amino acids and their derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3568</span><span class="NLM_x">–</span> <span class="NLM_lpage">3571</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00065a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADyaK3sXksV2rtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=3568-3571&author=M.+J.+McKennonauthor=A.+I.+Meyersauthor=K.+Drauzauthor=M.+Schwarm&title=A+convenient+reduction+of+amino+acids+and+their+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient reduction of amino acids and their derivatives</span></div><div class="casAuthors">McKennon, Marc J.; Meyers, A. I.; Drauz, Karlheinz; Schwarm, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3568-71</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Amino acids were reduced by NaBH4 in the presence of iodine to give the corresponding amino alcs.  Thus, amino acids I (R = CMe3, CHMe2, CH2Ph, CHEtMe, CH2CH2SMe, C6H4OH-4) were reduced by NaBH4-iodine in THF to give amino alcs. II.  N-acyl amino acids III [R = CH2Ph, R1 = H, R2 = H, Me; RR1 = (CH2)3 R2 = Me; R = R1 = H, R2 = Ph] were also reduced by NaBH4-iodine in THF to give N-acyl amino alcs. IV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnnqE3R204brVg90H21EOLACvtfcHk0lizM7oNddctHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksV2rtL8%253D&md5=d79a74af1c20e79ceee5c61ed977bccb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjo00065a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00065a020%26sid%3Dliteratum%253Aachs%26aulast%3DMcKennon%26aufirst%3DM.%2BJ.%26aulast%3DMeyers%26aufirst%3DA.%2BI.%26aulast%3DDrauz%26aufirst%3DK.%26aulast%3DSchwarm%26aufirst%3DM.%26atitle%3DA%2520convenient%2520reduction%2520of%2520amino%2520acids%2520and%2520their%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1993%26volume%3D58%26spage%3D3568%26epage%3D3571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span> </span><span class="NLM_article-title">A versatile synthesis of various substituted taurines from vicinal amino alcohols and aziridines</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">5841</span><span class="NLM_x">–</span> <span class="NLM_lpage">5846</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2009&publication_year=2009&pages=5841-5846&author=N.+Chenauthor=W.+Jiaauthor=J.+Xu&title=A+versatile+synthesis+of+various+substituted+taurines+from+vicinal+amino+alcohols+and+aziridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DN.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DA%2520versatile%2520synthesis%2520of%2520various%2520substituted%2520taurines%2520from%2520vicinal%2520amino%2520alcohols%2520and%2520aziridines%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2009%26volume%3D2009%26spage%3D5841%26epage%3D5846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Nasim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P. A.</span><span> </span><span class="NLM_article-title">Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in culture</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4879</span><span class="NLM_x">–</span> <span class="NLM_lpage">4883</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4879-4883&author=S.+Nasimauthor=M.+L.+Guzmanauthor=C.+T.+Jordanauthor=P.+A.+Crooks&title=Discovery+of+1%2C2%2C4-thiadiazolidine-3%2C5-dione+analogs+that+exhibit+unusual+and+selective+rapid+cell+death+kinetics+against+acute+myelogenous+leukemia+cells+in+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNasim%26aufirst%3DS.%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DJordan%26aufirst%3DC.%2BT.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%25201%252C2%252C4-thiadiazolidine-3%252C5-dione%2520analogs%2520that%2520exhibit%2520unusual%2520and%2520selective%2520rapid%2520cell%2520death%2520kinetics%2520against%2520acute%2520myelogenous%2520leukemia%2520cells%2520in%2520culture%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4879%26epage%3D4883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Hoffman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brosch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loidl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">First non-radioactive assay for in vitro screening of histone deacetylase inhibitors</span> <span class="citation_source-journal">Pharmazie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2000&pages=601-606&author=K.+Hoffmanauthor=G.+Broschauthor=P.+Loidlauthor=M.+Jung&title=First+non-radioactive+assay+for+in+vitro+screening+of+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DK.%26aulast%3DBrosch%26aufirst%3DG.%26aulast%3DLoidl%26aufirst%3DP.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DFirst%2520non-radioactive%2520assay%2520for%2520in%2520vitro%2520screening%2520of%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DPharmazie%26date%3D2000%26volume%3D55%26spage%3D601%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Wegener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirsching, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riester, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwienhorst, A.</span><span> </span><span class="NLM_article-title">A fluorogenic histone deacetylase assay well suited for high-throughput activity screening</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1016%2FS1074-5521%2802%2900305-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=12573699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1Skuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=61-68&author=D.+Wegenerauthor=F.+Wirschingauthor=D.+Riesterauthor=A.+Schwienhorst&title=A+fluorogenic+histone+deacetylase+assay+well+suited+for+high-throughput+activity+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A Fluorogenic Histone Deacetylase Assay Well Suited for High-Throughput Activity Screening</span></div><div class="casAuthors">Wegener, Dennis; Wirsching, Frank; Riester, Daniel; Schwienhorst, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-68</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are important enzymes for the transcriptional regulation of gene expression in eukaryotic cells.  Recent findings suggest that HDACs could be key targets for chemotherapeutic intervention in malignant diseases.  A convenient and sensitive fluorogenic assay for HDAC activity would therefore expedite studies of HDAC in transcriptional regulation and in vitro screening for drug discovery.  In this study, novel fluorogenic substrates of HDACs were synthesized with an ε-acetylated lysyl moiety and an adjacent MCA moiety at the C terminus of the peptide chain.  Upon deacetylation of the acetylated lysyl moiety, mols. became substrates for trypsin, which released highly fluorescent AMC mols. in a subsequent step of the assay.  The fluorescence increased in direct proportion to the amt. of deacetylated substrate mols., i.e., HDAC activity.  The nonisotopic, homogeneous assay is well suited for high-throughput HDAC inhibitor screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5ogyqEBSC3bVg90H21EOLACvtfcHk0lizM7oNddctHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1Skuw%253D%253D&md5=eea350d8066f6ebd773ba50cc0211fdc</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2802%2900305-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252802%252900305-8%26sid%3Dliteratum%253Aachs%26aulast%3DWegener%26aufirst%3DD.%26aulast%3DWirsching%26aufirst%3DF.%26aulast%3DRiester%26aufirst%3DD.%26aulast%3DSchwienhorst%26aufirst%3DA.%26atitle%3DA%2520fluorogenic%2520histone%2520deacetylase%2520assay%2520well%2520suited%2520for%2520high-throughput%2520activity%2520screening%26jtitle%3DChem.%2520Biol.%26date%3D2003%26volume%3D10%26spage%3D61%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Lea, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mufti, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, N. S. B.</span><span> </span><span class="NLM_article-title">Commitment, point during Go to G1 that controls entry into the cell cycle</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2351</span><span class="NLM_x">–</span> <span class="NLM_lpage">2361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1128%2FMCB.23.7.2351-2361.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=12640120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFensbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=2351-2361&author=N.+C.+Leaauthor=S.+J.+Orrauthor=K.+Stoeberauthor=G.+H.+Williamsauthor=E.+W.+Lamauthor=M.+A.+Ibrahimauthor=G.+J.+Muftiauthor=N.+S.+B.+Thomas&title=Commitment%2C+point+during+Go+to+G1+that+controls+entry+into+the+cell+cycle"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Commitment point during G0→G1 that controls entry into the cell cycle</span></div><div class="casAuthors">Lea, Nicholas C.; Orr, Stephen J.; Stoeber, Kai; Williams, Gareth H.; Lam, Eric W.-F.; Ibrahim, Mohammad A. A.; Mufti, Ghulam J.; Thomas, N. Shaun B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2351-2361</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Initiation of T-lymphocyte-mediated immune responses involves two cellular processes: entry into the cell cycle (G0→G1) for clonal proliferation and coordinated changes in surface and secreted mols. that mediate effector functions.  However, a point during G0→G1 beyond which T cells are committed to enter the cell cycle has not been defined.  We define here a G0→G1 commitment point that occurs 3 to 5 h after CD3 and CD28 stimulation of human CD4 or CD8 T cells.  Transition through this point requires cdk6/4-cyclin D, since inhibition with TAT-p16INK4A during the first 3 to 5 h prevents cell cycle entry and maintains both naive and memory T cells in G0.  Transition through the G0→G1 commitment point is also necessary for T cells to increase in size, i.e., to enter the cellular growth cycle.  However, transition through this point is not required for the induction of effector functions.  These can be initiated while cells are maintained in G0 with TAT-p16INK4A.  We have termed this quiescent, activated state G0(A).  Our data provide proof of the principle that entry of T cells into the cell cycle and cellular growth cycles are coupled at the G0→G1 commitment point but that these processes can be uncoupled from the early expression of mols. of effector functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWTDtobHcVrbVg90H21EOLACvtfcHk0lizM7oNddctHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFensbs%253D&md5=458dfd0326c14bbc5d41f67112da20f7</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.7.2351-2361.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.7.2351-2361.2003%26sid%3Dliteratum%253Aachs%26aulast%3DLea%26aufirst%3DN.%2BC.%26aulast%3DOrr%26aufirst%3DS.%2BJ.%26aulast%3DStoeber%26aufirst%3DK.%26aulast%3DWilliams%26aufirst%3DG.%2BH.%26aulast%3DLam%26aufirst%3DE.%2BW.%26aulast%3DIbrahim%26aufirst%3DM.%2BA.%26aulast%3DMufti%26aufirst%3DG.%2BJ.%26aulast%3DThomas%26aufirst%3DN.%2BS.%2BB.%26atitle%3DCommitment%252C%2520point%2520during%2520Go%2520to%2520G1%2520that%2520controls%2520entry%2520into%2520the%2520cell%2520cycle%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D2351%26epage%3D2361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15a','cit15b'],'ref16':['cit16a','cit16b','cit16c'],'ref17':['cit17a','cit17b'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 40 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Nilanjan Adhikari, Tarun Jha, <span class="NLM_string-name hlFld-ContribAuthor">Balaram Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 8827-8869. <a href="https://doi.org/10.1021/acs.jmedchem.0c01676" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01676</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01676%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDissecting%252BHistone%252BDeacetylase%252B3%252Bin%252BMultiple%252BDisease%252BConditions%25253A%252BSelective%252BInhibition%252Bas%252Ba%252BPromising%252BTherapeutic%252BStrategy%26aulast%3DAdhikari%26aufirst%3DNilanjan%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D24092020%26date%3D23062021%26volume%3D64%26issue%3D13%26spage%3D8827%26epage%3D8869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles M.  Marson</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Matthews</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Atkinson</span>, <span class="hlFld-ContribAuthor ">Nermina  Lamadema</span>, and <span class="hlFld-ContribAuthor ">N. Shaun B.  Thomas</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (17)
                                     , 6803-6818. <a href="https://doi.org/10.1021/acs.jmedchem.5b00545" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00545</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00545%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%252Band%252BSelective%252BInhibitors%252Bof%252BHistone%252BDeacetylase-3%252BContaining%252BChiral%252BOxazoline%252BCapping%252BGroups%252Band%252Ba%252BN-%2525282-Aminophenyl%252529-benzamide%252BBinding%252BUnit%26aulast%3DMarson%26aufirst%3DCharles%2BM.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D06042015%26date%3D27082015%26date%3D10092015%26date%3D19082015%26volume%3D58%26issue%3D17%26spage%3D6803%26epage%3D6818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuben  Hou</span>, <span class="hlFld-ContribAuthor ">Jintong  Du</span>, <span class="hlFld-ContribAuthor ">Renshuai  Liu</span>, <span class="hlFld-ContribAuthor ">Yi  Zhou</span>, <span class="hlFld-ContribAuthor ">Minyong  Li</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>, and <span class="hlFld-ContribAuthor ">Hao  Fang</span>  . </span><span class="cited-content_cbyCitation_article-title">Enhancing the Sensitivity of Pharmacophore-Based Virtual Screening by Incorporating Customized ZBG Features: A Case Study Using Histone Deacetylase 8. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (4)
                                     , 861-871. <a href="https://doi.org/10.1021/ci500762z" title="DOI URL">https://doi.org/10.1021/ci500762z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500762z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500762z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DEnhancing%252Bthe%252BSensitivity%252Bof%252BPharmacophore-Based%252BVirtual%252BScreening%252Bby%252BIncorporating%252BCustomized%252BZBG%252BFeatures%25253A%252BA%252BCase%252BStudy%252BUsing%252BHistone%252BDeacetylase%252B8%26aulast%3DHou%26aufirst%3DXuben%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D24122014%26date%3D16032015%26date%3D27042015%26date%3D10032015%26volume%3D55%26issue%3D4%26spage%3D861%26epage%3D871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Xia</span>, <span class="hlFld-ContribAuthor ">Ermias Lemma  Tilahun</span>, <span class="hlFld-ContribAuthor ">Eyob Hailu  Kebede</span>, <span class="hlFld-ContribAuthor ">Terry-Elinor  Reid</span>, <span class="hlFld-ContribAuthor ">Liangren  Zhang</span>, and <span class="hlFld-ContribAuthor ">Xiang Simon  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Comparative Modeling and Benchmarking Data Sets for Human Histone Deacetylases and Sirtuin Families. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (2)
                                     , 374-388. <a href="https://doi.org/10.1021/ci5005515" title="DOI URL">https://doi.org/10.1021/ci5005515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci5005515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci5005515%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DComparative%252BModeling%252Band%252BBenchmarking%252BData%252BSets%252Bfor%252BHuman%252BHistone%252BDeacetylases%252Band%252BSirtuin%252BFamilies%26aulast%3DXia%26aufirst%3DJie%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D10092014%26date%3D09022015%26date%3D23022015%26date%3D29012015%26volume%3D55%26issue%3D2%26spage%3D374%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Micha B. A.  Kunze</span>, <span class="hlFld-ContribAuthor ">David W.  Wright</span>, <span class="hlFld-ContribAuthor ">Nicolas D.  Werbeck</span>, <span class="hlFld-ContribAuthor ">John  Kirkpatrick</span>, <span class="hlFld-ContribAuthor ">Peter V.  Coveney</span>, and <span class="hlFld-ContribAuthor ">D. Flemming  Hansen</span>  . </span><span class="cited-content_cbyCitation_article-title">Loop Interactions and Dynamics Tune the Enzymatic Activity of the Human Histone Deacetylase 8. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2013,</strong> <em>135 </em>
                                    (47)
                                     , 17862-17868. <a href="https://doi.org/10.1021/ja408184x" title="DOI URL">https://doi.org/10.1021/ja408184x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja408184x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja408184x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DLoop%252BInteractions%252Band%252BDynamics%252BTune%252Bthe%252BEnzymatic%252BActivity%252Bof%252Bthe%252BHuman%252BHistone%252BDeacetylase%252B8%26aulast%3DKunze%26aufirst%3DMicha%2BB.%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D07082013%26date%3D15112013%26date%3D27112013%26date%3D30102013%26volume%3D135%26issue%3D47%26spage%3D17862%26epage%3D17868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ganesh  Routholla</span>, <span class="hlFld-ContribAuthor ">Sravani  Pulya</span>, <span class="hlFld-ContribAuthor ">Tarun  Patel</span>, <span class="hlFld-ContribAuthor ">Sk.  Abdul Amin</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Swati  Biswas</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>, <span class="hlFld-ContribAuthor ">Balaram  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation, and molecular docking analysis of novel linker-less benzamide based potent and selective HDAC3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105050. <a href="https://doi.org/10.1016/j.bioorg.2021.105050" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bmolecular%252Bdocking%252Banalysis%252Bof%252Bnovel%252Blinker-less%252Bbenzamide%252Bbased%252Bpotent%252Band%252Bselective%252BHDAC3%252Binhibitors%26aulast%3DRoutholla%26aufirst%3DGanesh%26date%3D2021%26volume%3D114%26spage%3D105050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jelena  Melesina</span>, <span class="hlFld-ContribAuthor ">Conrad V.  Simoben</span>, <span class="hlFld-ContribAuthor ">Lucas  Praetorius</span>, <span class="hlFld-ContribAuthor ">Emre F.  Bülbül</span>, <span class="hlFld-ContribAuthor ">Dina  Robaa</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies To Design Selective Histone Deacetylase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (9)
                                     , 1336-1359. <a href="https://doi.org/10.1002/cmdc.202000934" title="DOI URL">https://doi.org/10.1002/cmdc.202000934</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000934%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStrategies%252BTo%252BDesign%252BSelective%252BHistone%252BDeacetylase%252BInhibitors%26aulast%3DMelesina%26aufirst%3DJelena%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D9%26spage%3D1336%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arshdeep  Singh</span>, <span class="hlFld-ContribAuthor ">Ting-Yu  Chang</span>, <span class="hlFld-ContribAuthor ">Navdeep  Kaur</span>, <span class="hlFld-ContribAuthor ">Kai-Cheng  Hsu</span>, <span class="hlFld-ContribAuthor ">Yun  Yen</span>, <span class="hlFld-ContribAuthor ">Tony Eight  Lin</span>, <span class="hlFld-ContribAuthor ">Mei-Jung  Lai</span>, <span class="hlFld-ContribAuthor ">Sung-Bau  Lee</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">CAP rigidification of MS-275 and chidamide leads to enhanced antiproliferative effects mediated through HDAC1, 2 and tubulin polymerization inhibition. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>215 </em>, 113169. <a href="https://doi.org/10.1016/j.ejmech.2021.113169" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113169%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCAP%252Brigidification%252Bof%252BMS-275%252Band%252Bchidamide%252Bleads%252Bto%252Benhanced%252Bantiproliferative%252Beffects%252Bmediated%252Bthrough%252BHDAC1%25252C%252B2%252Band%252Btubulin%252Bpolymerization%252Binhibition%26aulast%3DSingh%26aufirst%3DArshdeep%26date%3D2021%26volume%3D215%26spage%3D113169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sachin S.  Wazalwar</span>, <span class="hlFld-ContribAuthor ">Anita R.  Banpurkar</span>, <span class="hlFld-ContribAuthor ">Franc  Perdih</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Characterization, Crystal Structure and Biological Study of Carboxamides Obtained from 2-Aminothiazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Crystallography</span><span> <strong>2020,</strong> <em>50 </em>
                                    (4)
                                     , 319-329. <a href="https://doi.org/10.1007/s10870-019-00800-w" title="DOI URL">https://doi.org/10.1007/s10870-019-00800-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10870-019-00800-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10870-019-00800-w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Crystallography%26atitle%3DSynthesis%25252C%252BCharacterization%25252C%252BCrystal%252BStructure%252Band%252BBiological%252BStudy%252Bof%252BCarboxamides%252BObtained%252Bfrom%252B2-Aminothiazole%252BDerivatives%26aulast%3DWazalwar%26aufirst%3DSachin%2BS.%26date%3D2020%26date%3D2019%26volume%3D50%26issue%3D4%26spage%3D319%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuxiang  Luo</span>, <span class="hlFld-ContribAuthor ">Huilin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs). </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (22)
                                     , 8828. <a href="https://doi.org/10.3390/ijms21228828" title="DOI URL">https://doi.org/10.3390/ijms21228828</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21228828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21228828%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DStructure-Based%252BInhibitor%252BDiscovery%252Bof%252BClass%252BI%252BHistone%252BDeacetylases%252B%252528HDACs%252529%26aulast%3DLuo%26aufirst%3DYuxiang%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D22%26spage%3D8828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan-An  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhong  Ding</span>, <span class="hlFld-ContribAuthor ">Peng  Liu</span>, <span class="hlFld-ContribAuthor ">Wei-Si  Guo</span>, <span class="hlFld-ContribAuthor ">Li-Rong  Wen</span>, <span class="hlFld-ContribAuthor ">Ming  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Access to SCN-containing thiazolines
              via
              electrochemical regioselective thiocyanothiocyclization of
              N
              -allylthioamides. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (11)
                                     , 1321-1326. <a href="https://doi.org/10.1039/D0QO00300J" title="DOI URL">https://doi.org/10.1039/D0QO00300J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00300J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00300J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DAccess%252Bto%252BSCN-containing%252Bthiazolines%252Bvia%252Belectrochemical%252Bregioselective%252Bthiocyanothiocyclization%252Bof%252BN%252B-allylthioamides%26aulast%3DZhang%26aufirst%3DYan-An%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D11%26spage%3D1321%26epage%3D1326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kunal  Nepali</span>, <span class="hlFld-ContribAuthor ">Ting-Yu  Chang</span>, <span class="hlFld-ContribAuthor ">Mei-Jung  Lai</span>, <span class="hlFld-ContribAuthor ">Kai-Cheng  Hsu</span>, <span class="hlFld-ContribAuthor ">Yun  Yen</span>, <span class="hlFld-ContribAuthor ">Tony Eight  Lin</span>, <span class="hlFld-ContribAuthor ">Sung-Bau  Lee</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>196 </em>, 112291. <a href="https://doi.org/10.1016/j.ejmech.2020.112291" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112291</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112291%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPurine%25252Fpurine%252Bisoster%252Bbased%252Bscaffolds%252Bas%252Bnew%252Bderivatives%252Bof%252Bbenzamide%252Bclass%252Bof%252BHDAC%252Binhibitors%26aulast%3DNepali%26aufirst%3DKunal%26date%3D2020%26volume%3D196%26spage%3D112291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajat  Sarkar</span>, <span class="hlFld-ContribAuthor ">Suvankar  Banerjee</span>, <span class="hlFld-ContribAuthor ">Sk Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112171. <a href="https://doi.org/10.1016/j.ejmech.2020.112171" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112171%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHistone%252Bdeacetylase%252B3%252B%252528HDAC3%252529%252Binhibitors%252Bas%252Banticancer%252Bagents%25253A%252BA%252Breview%26aulast%3DSarkar%26aufirst%3DRajat%26date%3D2020%26volume%3D192%26spage%3D112171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon O.R.  Greenwood</span>, <span class="hlFld-ContribAuthor ">A.W. Edith  Chan</span>, <span class="hlFld-ContribAuthor ">D. Flemming  Hansen</span>, <span class="hlFld-ContribAuthor ">Charles M.  Marson</span>. </span><span class="cited-content_cbyCitation_article-title">Potent non-hydroxamate inhibitors of histone deacetylase-8: Role and scope of an isoindolin-2-yl linker with an α-amino amide as the zinc-binding unit. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (5)
                                     , 126926. <a href="https://doi.org/10.1016/j.bmcl.2019.126926" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126926</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126926%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%252Bnon-hydroxamate%252Binhibitors%252Bof%252Bhistone%252Bdeacetylase-8%25253A%252BRole%252Band%252Bscope%252Bof%252Ban%252Bisoindolin-2-yl%252Blinker%252Bwith%252Ban%252B%2525CE%2525B1-amino%252Bamide%252Bas%252Bthe%252Bzinc-binding%252Bunit%26aulast%3DGreenwood%26aufirst%3DSimon%2BO.R.%26date%3D2020%26volume%3D30%26issue%3D5%26spage%3D126926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Efraín  Polo</span>, <span class="hlFld-ContribAuthor ">Alejandro  Morales-Bayuelo</span>, <span class="hlFld-ContribAuthor ">Mauricio E.  Orozco-Ugarriza</span>, <span class="hlFld-ContribAuthor ">José A.  Henao</span>, <span class="hlFld-ContribAuthor ">Antonio  Galdámez</span>, <span class="hlFld-ContribAuthor ">Margarita  Gutierrez</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure and theoretical studies of 2-bromo-N-(2,4-difluorobenzyl)benzamide; intermediate for the synthesis of phenanthridinone. </span><span class="cited-content_cbyCitation_journal-name">Chemical Data Collections</span><span> <strong>2019,</strong> <em>21 </em>, 100218. <a href="https://doi.org/10.1016/j.cdc.2019.100218" title="DOI URL">https://doi.org/10.1016/j.cdc.2019.100218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cdc.2019.100218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cdc.2019.100218%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Data%2520Collections%26atitle%3DCrystal%252Bstructure%252Band%252Btheoretical%252Bstudies%252Bof%252B2-bromo-N-%2525282%25252C4-difluorobenzyl%252529benzamide%25253B%252Bintermediate%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bphenanthridinone%26aulast%3DPolo%26aufirst%3DEfra%25C3%25ADn%26date%3D2019%26volume%3D21%26spage%3D100218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sk. Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>, <span class="hlFld-ContribAuthor ">Balaram  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">Designing potential HDAC3 inhibitors to improve memory and learning. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2019,</strong> <em>37 </em>
                                    (8)
                                     , 2133-2142. <a href="https://doi.org/10.1080/07391102.2018.1477625" title="DOI URL">https://doi.org/10.1080/07391102.2018.1477625</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2018.1477625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2018.1477625%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDesigning%252Bpotential%252BHDAC3%252Binhibitors%252Bto%252Bimprove%252Bmemory%252Band%252Blearning%26aulast%3DAmin%26aufirst%3DSk.%2BAbdul%26date%3D2019%26date%3D2018%26volume%3D37%26issue%3D8%26spage%3D2133%26epage%3D2142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noor U.  Din Reshi</span>, <span class="hlFld-ContribAuthor ">Dineshchakravarthy  Senthurpandi</span>, <span class="hlFld-ContribAuthor ">Ashoka G.  Samuelson</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric transfer hydrogenation of ketones using Ru(0) nanoparticles modified by Chiral Thiones. </span><span class="cited-content_cbyCitation_journal-name">Applied Organometallic Chemistry</span><span> <strong>2019,</strong> <em>33 </em>
                                    (5)
                                     , e4885. <a href="https://doi.org/10.1002/aoc.4885" title="DOI URL">https://doi.org/10.1002/aoc.4885</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/aoc.4885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Faoc.4885%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Organometallic%2520Chemistry%26atitle%3DAsymmetric%252Btransfer%252Bhydrogenation%252Bof%252Bketones%252Busing%252BRu%2525280%252529%252Bnanoparticles%252Bmodified%252Bby%252BChiral%252BThiones%26aulast%3DDin%2BReshi%26aufirst%3DNoor%2BU.%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D5%26spage%3De4885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yahia N.  Mabkhot</span>, <span class="hlFld-ContribAuthor ">H.  Algarni</span>, <span class="hlFld-ContribAuthor ">Abdulrhman  Alsayari</span>, <span class="hlFld-ContribAuthor ">Abdullatif  Bin Muhsinah</span>, <span class="hlFld-ContribAuthor ">Nabila A.  Kheder</span>, <span class="hlFld-ContribAuthor ">Zainab M.  Almarhoon</span>, <span class="hlFld-ContribAuthor ">Faiz A.  Al-aizari</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, X-ray Analysis, Biological Evaluation and Molecular Docking Study of New Thiazoline Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (9)
                                     , 1654. <a href="https://doi.org/10.3390/molecules24091654" title="DOI URL">https://doi.org/10.3390/molecules24091654</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24091654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24091654%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BX-ray%252BAnalysis%25252C%252BBiological%252BEvaluation%252Band%252BMolecular%252BDocking%252BStudy%252Bof%252BNew%252BThiazoline%252BDerivatives%26aulast%3DMabkhot%26aufirst%3DYahia%2BN.%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D9%26spage%3D1654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sk. Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Sonali  Kotagiri</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>, <span class="hlFld-ContribAuthor ">Balaram  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>166 </em>, 369-380. <a href="https://doi.org/10.1016/j.ejmech.2019.01.077" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.077%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHistone%252Bdeacetylase%252B3%252Binhibitors%252Bin%252Blearning%252Band%252Bmemory%252Bprocesses%252Bwith%252Bspecial%252Bemphasis%252Bon%252Bbenzamides%26aulast%3DAmin%26aufirst%3DSk.%2BAbdul%26date%3D2019%26volume%3D166%26spage%3D369%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Islam H.  El Azab</span>, <span class="hlFld-ContribAuthor ">Ola A.  Abu Ali</span>, <span class="hlFld-ContribAuthor ">Aishah H.  El‐Zahrani</span>, <span class="hlFld-ContribAuthor ">Adil A.  Gobouri</span>, <span class="hlFld-ContribAuthor ">Tariq A.  Altalhi</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazole‐1‐carbothioamide as a Potent Precursor for Synthesis of Some New
              N
              ‐heterocycles of Potential Biological Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2019,</strong> <em>56 </em>
                                    (1)
                                     , 18-31. <a href="https://doi.org/10.1002/jhet.3350" title="DOI URL">https://doi.org/10.1002/jhet.3350</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3350%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DPyrazole%2525E2%252580%2525901%2525E2%252580%252590carbothioamide%252Bas%252Ba%252BPotent%252BPrecursor%252Bfor%252BSynthesis%252Bof%252BSome%252BNew%252BN%252B%2525E2%252580%252590heterocycles%252Bof%252BPotential%252BBiological%252BActivity%26aulast%3DEl%2BAzab%26aufirst%3DIslam%2BH.%26date%3D2019%26date%3D2018%26volume%3D56%26issue%3D1%26spage%3D18%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahrzad  Movafagh</span>, <span class="hlFld-ContribAuthor ">Amanda  Munson</span>. </span><span class="cited-content_cbyCitation_article-title">Histone Deacetylase Inhibitors in Cancer Prevention and Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 75-105. <a href="https://doi.org/10.1016/B978-0-12-812494-9.00004-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-812494-9.00004-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-812494-9.00004-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-812494-9.00004-4%26sid%3Dliteratum%253Aachs%26atitle%3DHistone%252BDeacetylase%252BInhibitors%252Bin%252BCancer%252BPrevention%252Band%252BTherapy%26aulast%3DMovafagh%26aufirst%3DShahrzad%26date%3D2019%26spage%3D75%26epage%3D105%26pub%3DElsevier%26atitle%3DEpigenetics%252Bof%252BCancer%252BPrevention%26date%3D2019%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prakruti  Trivedi</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Sk. Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>, <span class="hlFld-ContribAuthor ">Balaram  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological screening of 2-aminobenzamides as selective HDAC3 inhibitors with promising anticancer effects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2018,</strong> <em>124 </em>, 165-181. <a href="https://doi.org/10.1016/j.ejps.2018.08.030" title="DOI URL">https://doi.org/10.1016/j.ejps.2018.08.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2018.08.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2018.08.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bscreening%252Bof%252B2-aminobenzamides%252Bas%252Bselective%252BHDAC3%252Binhibitors%252Bwith%252Bpromising%252Banticancer%252Beffects%26aulast%3DTrivedi%26aufirst%3DPrakruti%26date%3D2018%26volume%3D124%26spage%3D165%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rekha  Sangwan</span>, <span class="hlFld-ContribAuthor ">Remya  Rajan</span>, <span class="hlFld-ContribAuthor ">Pintu Kumar  Mandal</span>. </span><span class="cited-content_cbyCitation_article-title">HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 620-706. <a href="https://doi.org/10.1016/j.ejmech.2018.08.073" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.073%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHDAC%252Bas%252Bonco%252Btarget%25253A%252BReviewing%252Bthe%252Bsynthetic%252Bapproaches%252Bwith%252BSAR%252Bstudy%252Bof%252Btheir%252Binhibitors%26aulast%3DSangwan%26aufirst%3DRekha%26date%3D2018%26volume%3D158%26spage%3D620%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Sk. Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Prakruti  Trivedi</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>, <span class="hlFld-ContribAuthor ">Balaram  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 1127-1142. <a href="https://doi.org/10.1016/j.ejmech.2018.08.081" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.081%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHDAC3%252Bis%252Ba%252Bpotential%252Bvalidated%252Btarget%252Bfor%252Bcancer%25253A%252BAn%252Boverview%252Bon%252Bthe%252Bbenzamide-based%252Bselective%252BHDAC3%252Binhibitors%252Bthrough%252Bcomparative%252BSAR%25252FQSAR%25252FQAAR%252Bapproaches%26aulast%3DAdhikari%26aufirst%3DNilanjan%26date%3D2018%26volume%3D157%26spage%3D1127%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangyuan  Cao</span>, <span class="hlFld-ContribAuthor ">Martijn  Zwinderman</span>, <span class="hlFld-ContribAuthor ">Frank  Dekker</span>. </span><span class="cited-content_cbyCitation_article-title">The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (3)
                                     , 551. <a href="https://doi.org/10.3390/molecules23030551" title="DOI URL">https://doi.org/10.3390/molecules23030551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23030551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23030551%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BProcess%252Band%252BStrategy%252Bfor%252BDeveloping%252BSelective%252BHistone%252BDeacetylase%252B3%252BInhibitors%26aulast%3DCao%26aufirst%3DFangyuan%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D3%26spage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gülhan  Turan-Zitouni</span>, <span class="hlFld-ContribAuthor ">Leyla  Yurttaş</span>, <span class="hlFld-ContribAuthor ">Aouatef  Tabbi</span>, <span class="hlFld-ContribAuthor ">Gülşen  Akalın Çiftçi</span>, <span class="hlFld-ContribAuthor ">Halide  Temel</span>, <span class="hlFld-ContribAuthor ">Zafer  Kaplancıklı</span>. </span><span class="cited-content_cbyCitation_article-title">New Thiazoline-Tetralin Derivatives and Biological Activity Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (1)
                                     , 135. <a href="https://doi.org/10.3390/molecules23010135" title="DOI URL">https://doi.org/10.3390/molecules23010135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23010135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23010135%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNew%252BThiazoline-Tetralin%252BDerivatives%252Band%252BBiological%252BActivity%252BEvaluation%26aulast%3DTuran-Zitouni%26aufirst%3DG%25C3%25BClhan%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D1%26spage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanyu  Chen</span>, <span class="hlFld-ContribAuthor ">Rong  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiujun  Peng</span>, <span class="hlFld-ContribAuthor ">Lanting  Xu</span>, <span class="hlFld-ContribAuthor ">XianHua  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium(III)-Catalyzed Directed C−H Amidation of
              N
              -Nitrosoanilines and Subsequent Formation of 1,2-Disubstituted Benzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - An Asian Journal</span><span> <strong>2017,</strong> <em>12 </em>
                                    (21)
                                     , 2804-2808. <a href="https://doi.org/10.1002/asia.201701287" title="DOI URL">https://doi.org/10.1002/asia.201701287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.201701287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.201701287%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520An%2520Asian%2520Journal%26atitle%3DRhodium%252528III%252529-Catalyzed%252BDirected%252BC%2525E2%252588%252592H%252BAmidation%252Bof%252BN%252B-Nitrosoanilines%252Band%252BSubsequent%252BFormation%252Bof%252B1%25252C2-Disubstituted%252BBenzimidazoles%26aulast%3DChen%26aufirst%3DYanyu%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D21%26spage%3D2804%26epage%3D2808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joëlle  Roche</span>, <span class="hlFld-ContribAuthor ">Philippe  Bertrand</span>. </span><span class="cited-content_cbyCitation_article-title">Inside HDACs with more selective HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>121 </em>, 451-483. <a href="https://doi.org/10.1016/j.ejmech.2016.05.047" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.05.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.05.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInside%252BHDACs%252Bwith%252Bmore%252Bselective%252BHDAC%252Binhibitors%26aulast%3DRoche%26aufirst%3DJo%25C3%25ABlle%26date%3D2016%26volume%3D121%26spage%3D451%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niek GJ  Leus</span>, <span class="hlFld-ContribAuthor ">Martijn RH  Zwinderman</span>, <span class="hlFld-ContribAuthor ">Frank J  Dekker</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2016,</strong> <em>33 </em>, 160-168. <a href="https://doi.org/10.1016/j.cbpa.2016.06.019" title="DOI URL">https://doi.org/10.1016/j.cbpa.2016.06.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2016.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2016.06.019%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DHistone%252Bdeacetylase%252B3%252B%252528HDAC%252B3%252529%252Bas%252Bemerging%252Bdrug%252Btarget%252Bin%252BNF-%2525CE%2525BAB-mediated%252Binflammation%26aulast%3DLeus%26aufirst%3DNiek%2BGJ%26date%3D2016%26volume%3D33%26spage%3D160%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yellaiah  Tangella </span>, <span class="hlFld-ContribAuthor ">Kesari Lakshmi  Manasa</span>, <span class="hlFld-ContribAuthor ">Manda  Sathish</span>, <span class="hlFld-ContribAuthor ">Abdullah  Alarifi</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal </span>. </span><span class="cited-content_cbyCitation_article-title">Phenyliodonium Diacetate Mediated One-Pot Synthesis of Benzimidazoles and Quinazolinones from Benzylamines. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2016,</strong> <em>1 </em>
                                    (11)
                                     , 2895-2899. <a href="https://doi.org/10.1002/slct.201600772" title="DOI URL">https://doi.org/10.1002/slct.201600772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201600772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201600772%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DPhenyliodonium%252BDiacetate%252BMediated%252BOne-Pot%252BSynthesis%252Bof%252BBenzimidazoles%252Band%252BQuinazolinones%252Bfrom%252BBenzylamines%26aulast%3DTangella%25E2%2580%2589%26aufirst%3DYellaiah%26date%3D2016%26date%3D2016%26volume%3D1%26issue%3D11%26spage%3D2895%26epage%3D2899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Sudhakar</span>, <span class="hlFld-ContribAuthor ">G.  Thirupathi</span>, <span class="hlFld-ContribAuthor ">A.  Balakishan</span>, <span class="hlFld-ContribAuthor ">S.  Narsima chary</span>, <span class="hlFld-ContribAuthor ">S.  Ravi</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis of novel (1-Aryl/alkyl-1H-1,2,3-triazol- 4-yl)methyl-2-bromo-4-methylthiazole-5-carboxylates by Cu(I) catalyzed click reaction. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2016,</strong> <em>86 </em>
                                    (7)
                                     , 1722-1729. <a href="https://doi.org/10.1134/S1070363216070306" title="DOI URL">https://doi.org/10.1134/S1070363216070306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363216070306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363216070306%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DFacile%252Bsynthesis%252Bof%252Bnovel%252B%2525281-Aryl%25252Falkyl-1H-1%25252C2%25252C3-triazol-%252B4-yl%252529methyl-2-bromo-4-methylthiazole-5-carboxylates%252Bby%252BCu%252528I%252529%252Bcatalyzed%252Bclick%252Breaction%26aulast%3DSudhakar%26aufirst%3DK.%26date%3D2016%26date%3D2016%26volume%3D86%26issue%3D7%26spage%3D1722%26epage%3D1729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thea  van den Bosch</span>, <span class="hlFld-ContribAuthor ">Niek G.J.  Leus</span>, <span class="hlFld-ContribAuthor ">Tirza  Timmerman</span>, <span class="hlFld-ContribAuthor ">Frank J.  Dekker</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitors of Histone Deacetylases and Acetyltransferases as Potential Therapeutics in Oncology. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 191-208. <a href="https://doi.org/10.1016/B978-0-12-802208-5.00008-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-802208-5.00008-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-802208-5.00008-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-802208-5.00008-4%26sid%3Dliteratum%253Aachs%26atitle%3DSmall%252BMolecule%252BInhibitors%252Bof%252BHistone%252BDeacetylases%252Band%252BAcetyltransferases%252Bas%252BPotential%252BTherapeutics%252Bin%252BOncology%26aulast%3Dvan%2Bden%2BBosch%26aufirst%3DThea%26date%3D2016%26spage%3D191%26epage%3D208%26pub%3DElsevier%26atitle%3DDrug%252BDiscovery%252Bin%252BCancer%252BEpigenetics%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simiao  Gao</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Jun  Dong</span>, <span class="hlFld-ContribAuthor ">Ning  Chen</span>, <span class="hlFld-ContribAuthor ">Jiaxi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of functionalized 5-substituted thiazolidine-2-thiones via adscititious xanthate-promoted radical cyclization of allyl(alkyl/aryl)dithiocarbamates. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (3)
                                     , 1002-1012. <a href="https://doi.org/10.1039/C5OB02297E" title="DOI URL">https://doi.org/10.1039/C5OB02297E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB02297E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB02297E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bfunctionalized%252B5-substituted%252Bthiazolidine-2-thiones%252Bvia%252Badscititious%252Bxanthate-promoted%252Bradical%252Bcyclization%252Bof%252Ballyl%252528alkyl%25252Faryl%252529dithiocarbamates%26aulast%3DGao%26aufirst%3DSimiao%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D3%26spage%3D1002%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zainab  Noor</span>, <span class="hlFld-ContribAuthor ">Noreen  Afzal</span>, <span class="hlFld-ContribAuthor ">Sajid  Rashid</span>, . </span><span class="cited-content_cbyCitation_article-title">Exploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation Assays. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (10)
                                     , e0139588. <a href="https://doi.org/10.1371/journal.pone.0139588" title="DOI URL">https://doi.org/10.1371/journal.pone.0139588</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0139588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0139588%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DExploration%252Bof%252BNovel%252BInhibitors%252Bfor%252BClass%252BI%252BHistone%252BDeacetylase%252BIsoforms%252Bby%252BQSAR%252BModeling%252Band%252BMolecular%252BDynamics%252BSimulation%252BAssays%26aulast%3DNoor%26aufirst%3DZainab%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D10%26spage%3De0139588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Peng-Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Dong-Dong  Li</span>, <span class="hlFld-ContribAuthor ">Wei-Ming  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Navigating into the chemical space between MGCD0103 and SAHA: novel histone deacetylase inhibitors as a promising lead. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (10)
                                     , 1816-1825. <a href="https://doi.org/10.1039/C5MD00247H" title="DOI URL">https://doi.org/10.1039/C5MD00247H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00247H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00247H%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DNavigating%252Binto%252Bthe%252Bchemical%252Bspace%252Bbetween%252BMGCD0103%252Band%252BSAHA%25253A%252Bnovel%252Bhistone%252Bdeacetylase%252Binhibitors%252Bas%252Ba%252Bpromising%252Blead%26aulast%3DZhang%26aufirst%3DXin%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D10%26spage%3D1816%26epage%3D1825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiwu  Yao</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>, <span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Qiao  Sun</span>, <span class="hlFld-ContribAuthor ">Chunping  Liu</span>, <span class="hlFld-ContribAuthor ">Yang  Yang</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Sheng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of 1, 3-disubstituted-pyrazole derivatives as new class I and IIb histone deacetylase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>86 </em>, 639-652. <a href="https://doi.org/10.1016/j.ejmech.2014.09.024" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.09.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.09.024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B1%25252C%252B3-disubstituted-pyrazole%252Bderivatives%252Bas%252Bnew%252Bclass%252BI%252Band%252BIIb%252Bhistone%252Bdeacetylase%252Binhibitors%26aulast%3DYao%26aufirst%3DYiwu%26date%3D2014%26volume%3D86%26spage%3D639%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan Ling  Wu</span>, <span class="hlFld-ContribAuthor ">Li Wen  Shen</span>, <span class="hlFld-ContribAuthor ">Yan Ping  Ding</span>, <span class="hlFld-ContribAuthor ">Yoshimasa  Tanaka</span>, <span class="hlFld-ContribAuthor ">Wen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Tumor Cell Proliferation In Vitro by Benzamide Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials Research</span><span> <strong>2014,</strong> <em>997 </em>, 225-228. <a href="https://doi.org/10.4028/www.scientific.net/AMR.997.225" title="DOI URL">https://doi.org/10.4028/www.scientific.net/AMR.997.225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4028/www.scientific.net/AMR.997.225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4028%2Fwww.scientific.net%2FAMR.997.225%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%2520Research%26atitle%3DInhibition%252Bof%252BTumor%252BCell%252BProliferation%252BIn%252BVitro%252Bby%252BBenzamide%252BDerivatives%26aulast%3DWu%26aufirst%3DYan%2BLing%26date%3D2014%26date%3D2014%26volume%3D997%26spage%3D225%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florian  Thaler</span>, <span class="hlFld-ContribAuthor ">Ciro  Mercurio</span>. </span><span class="cited-content_cbyCitation_article-title">Towards Selective Inhibition of Histone Deacetylase Isoforms: What Has Been Achieved, Where We Are and What Will Be Next. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (3)
                                     , 523-536. <a href="https://doi.org/10.1002/cmdc.201300413" title="DOI URL">https://doi.org/10.1002/cmdc.201300413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300413%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTowards%252BSelective%252BInhibition%252Bof%252BHistone%252BDeacetylase%252BIsoforms%25253A%252BWhat%252BHas%252BBeen%252BAchieved%25252C%252BWhere%252BWe%252BAre%252Band%252BWhat%252BWill%252BBe%252BNext%26aulast%3DThaler%26aufirst%3DFlorian%26date%3D2014%26date%3D2013%26volume%3D9%26issue%3D3%26spage%3D523%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ge  Meng</span>, <span class="hlFld-ContribAuthor ">Mei  Wang</span>, <span class="hlFld-ContribAuthor ">Aqun  Zheng</span>, <span class="hlFld-ContribAuthor ">Jianwei  Dou</span>, <span class="hlFld-ContribAuthor ">Zengjun  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient one-pot synthesis of ethyl 2-substitued-4-methylthiazole-5-carboxylates. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry Letters and Reviews</span><span> <strong>2014,</strong> <em>7 </em>
                                    (1)
                                     , 46-49. <a href="https://doi.org/10.1080/17518253.2014.895858" title="DOI URL">https://doi.org/10.1080/17518253.2014.895858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17518253.2014.895858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17518253.2014.895858%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%2520Letters%2520and%2520Reviews%26atitle%3DEfficient%252Bone-pot%252Bsynthesis%252Bof%252Bethyl%252B2-substitued-4-methylthiazole-5-carboxylates%26aulast%3DMeng%26aufirst%3DGe%26date%3D2014%26date%3D2014%26volume%3D7%26issue%3D1%26spage%3D46%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajeev R.  Jha</span>, <span class="hlFld-ContribAuthor ">Rakesh K.  Saunthwal</span>, <span class="hlFld-ContribAuthor ">Akhilesh K.  Verma</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective tandem synthesis of thiazolo fused naphthyridines and thienopyridines from o-alkynylaldehydes via Au(
              iii
              )-catalyzed regioselective 6-endo-dig ring closure. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2014,</strong> <em>12 </em>
                                    (4)
                                     , 552-556. <a href="https://doi.org/10.1039/C3OB42035C" title="DOI URL">https://doi.org/10.1039/C3OB42035C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3OB42035C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3OB42035C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DStereoselective%252Btandem%252Bsynthesis%252Bof%252Bthiazolo%252Bfused%252Bnaphthyridines%252Band%252Bthienopyridines%252Bfrom%252Bo-alkynylaldehydes%252Bvia%252BAu%252528%252Biii%252B%252529-catalyzed%252Bregioselective%252B6-endo-dig%252Bring%252Bclosure%26aulast%3DJha%26aufirst%3DRajeev%2BR.%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D4%26spage%3D552%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of clinical HDAC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SOCl<sub>2</sub>, MeOH, reflux, 16 h; (b) PhCH<sub>2</sub>Br, Na<sub>2</sub>CO<sub>3</sub>, DMF, 20 °C, 18 h; (c) <b>2a</b>, DIBAL, THF–CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 1 h, then 20 °C, 1 h, then 20 °C, 3 h; (d) TBSCl, imidazole, DMF, 20 °C, 16 h; (e) PhB(OH)<sub>2</sub>, (Ph<sub>3</sub>P)<sub>4</sub>Pd, Na<sub>2</sub>CO<sub>3</sub>, aqueous 1,2-dimethoxyetjame, 80 °C, 48 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SOCl<sub>2</sub>, reflux, 3 h; (ii) naphthalene-2,3-diamine, Et<sub>2</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, DMF, 0 °C, 30 min, then 20 °C, 1 h; (b) BOP, <b>6</b>, pyridine, then NaH, 20 °C, 7 h; (c) H<sub>2</sub>, 10% Pd/C, MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C, 6 h; (d) <b>5</b>, NaH, BOP, pyridine, Et<sub>3</sub>N,20 °C 2.5 h; (e) FeSO<sub>4</sub>·7H<sub>2</sub>O, aqueous NH<sub>3</sub>, EtOH, 60 °C, 4 h; (f) 3-methoxyphenylene-1,2-diamine, BOP, Et<sub>3</sub>N, DMF, 20 °C, 27 h; (g) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C h; (h) BOP, <b>4</b>, pyridine, then NaH, 20 °C, 2.5 h; (i) H<sub>2</sub>, 10% Pd/C, MeOH, CHCl<sub>3</sub>, 20 °C, 7 h; (j) SnCl<sub>2</sub>·2H<sub>2</sub>O, OAc, 1:1:1 THF/MeOH/H<sub>2</sub>O, 20 °C, 21 h, then 50 °C, 1 h; (k) NaH and <b>2b</b>, anhydrous pyridine, −10 °C, 5 min; then addition of acid chloride (<b>7</b>, SOCl<sub>2</sub>, toluene, reflux, 3 h), 20 °C, 2 h; (l) H<sub>2</sub>, 10% Pd/C, MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C, 5.5 h; (m) H<sub>2</sub>, 10% Pd/C, MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C, 45 h; (n) phenylene-1,2-diamine, BOP, DMF, 20 °C, 24 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NH<sub>4</sub>SCN, Ac<sub>2</sub>O, 100 °C (1 h, <b>9a</b>; 10 min, <b>9b</b>); (b) Mel, K<sub>2</sub>CO<sub>3</sub>, MeCN, 20 °C, 2.5 h; (c) 4-(methylamino)benzoic acid, ethanol, reflux, 16 h; (d) BOP, Et<sub>3</sub>N, phenylene-1,2-diamine, DMF, 20 °C, 3.5 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethoxycarbonyl isothiocyanate, pyridine, MeCN, 20 °C, 18 h; (b) Mel, K<sub>2</sub>CO<sub>3</sub>, MeCN, 20 °C, 2.5 h; (c) 4-(methylamino)benzoic acid, ethanol, reflux, 4 h (18 h for <b>17a</b>); (d) BOP, Et<sub>3</sub>N, phenylene-1,2-diamine, DMF, 20 °C, 3 h; (e)TFA, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C, 3 h.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>3</sub>N, (COCl)<sub>2</sub>, DMF, CH<sub>2</sub>Cl<sub>2</sub>; then <i>N</i>-Boc-phenylene-1,2-diamine, 20 °C, 20 h; (b) K<sub>2</sub>CO<sub>3</sub>, aqueous MeOH, 70 °C, 4 h; (c) CS<sub>2</sub>, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C, 10 min, then 0 °C and TsCl, 10 min; (d) 1,2-amino alcohol, MeCN, 20 °C, 16 h; (e) concentrated HCl, 90 °C (for all <b>23</b> except <b>23c</b>); (f) diethyl azodicarboxylate, Ph<sub>3</sub>P, THF, 20 °C, 75 min, then HCl in Et<sub>2</sub>O, 20 °C, 5 h (for <b>23c</b>).</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CS<sub>2</sub>, aqueous KOH, reflux, 20 h; (b) <i>N</i>-Boc-phenylene-1,2-diamine, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, −10 to 20 °C, 2 h; (c) <b>28a</b>, Nal, acetone, reflux, 2 h; then <b>26a</b>, 20 °C, 28 h; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C, 2.5 h; (e) <b>26b/26c</b>, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 17 h.</p></p></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Molecular modeling of thiazoline <b>24a</b> (turquoise) bound to HDAC3 (derived by modification of PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A69">4A69</a> using AutoDockTools 1.5.4) and docked using AutoDock Vina.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> A side-on view of <b>24a</b> is depicted in PyMOL with residues bound to zinc and other residues near <b>24a</b> shown in pink.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Analysis of histone H3 acetylation by Western blotting: Jurkat and HeLa cells cultured for 24 h with DMSO control and mocetinostat and <b>19c</b> and <b>24a</b> (each at 10 and 1 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Analysis of DNA and protein content using compounds at 10 μM. Samples cultured as described in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> were stained with dyes to identify protein and DNA, followed by flow cytometry. Shown is the percentage of cells in G<sub>0</sub>/G<sub>1</sub>, S, and G<sub>2</sub>/M cell cycle phases and with sub-G<sub>1</sub> DNA content and low protein content characteristic of apoptotic cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/medium/jm-2013-00634n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Analysis of DNA and protein content using compounds at 1 μM. Samples cultured as described in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> were stained with dyes to identify protein and DNA, followed by flow cytometry. Shown is the percentage of cells in G<sub>0</sub>/G<sub>1</sub>, S, and G<sub>2</sub>/M cell cycle phases and with sub-G<sub>1</sub> DNA content and low protein content characteristic of apoptotic cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-15/jm400634n/production/images/large/jm-2013-00634n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400634n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 54 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Marson, C. M.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors: design, structure–activity relationships and therapeutic implications for cancer</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=661-692&author=C.+M.+Marson&title=Histone+deacetylase+inhibitors%3A+design%2C+structure%E2%80%93activity+relationships+and+therapeutic+implications+for+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarson%26aufirst%3DC.%2BM.%26atitle%3DHistone%2520deacetylase%2520inhibitors%253A%2520design%252C%2520structure%25E2%2580%2593activity%2520relationships%2520and%2520therapeutic%2520implications%2520for%2520cancer%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D661%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelicci, G.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors and the promise of epigenetic (and more) treatment for cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1038%2Fnrc1779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=16397526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=38-51&author=S.+Minucciauthor=G.+Pelicci&title=Histone+deacetylase+inhibitors+and+the+promise+of+epigenetic+%28and+more%29+treatment+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer</span></div><div class="casAuthors">Minucci, Saverio; Pelicci, Pier Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-51</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are considered to be among the most promising targets in drug development for cancer therapy, and first-generation histone deacetylase inhibitors (HDACi) are currently being tested in phase I/II clin. trials.  A wide-ranging knowledge of the role of HDACs in tumorigenesis, and of the action of HDACi, has been achieved.  However, several basic aspects are not yet fully understood.  Investigating these aspects in the context of what we now understand about HDACi action both in vitro and in vivo will further improve the design of optimized clin. protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxXiACZV1sK7Vg90H21EOLACvtfcHk0lgswcAtiMl62w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GgsA%253D%253D&md5=384e1f8d676d61531e46843c060a9380</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc1779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1779%26sid%3Dliteratum%253Aachs%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DPelicci%26aufirst%3DG.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520and%2520the%2520promise%2520of%2520epigenetic%2520%2528and%2520more%2529%2520treatment%2520for%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D38%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Strahl, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">The language of covalent histone modifications</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">403</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1038%2F47412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=10638745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=2000&pages=41-45&author=B.+D.+Strahlauthor=C.+D.+Allis&title=The+language+of+covalent+histone+modifications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The language of covalent histone modifications</span></div><div class="casAuthors">Strahl B D; Allis C D</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">403</span>
        (<span class="NLM_cas:issue">6765</span>),
    <span class="NLM_cas:pages">41-5</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Histone proteins and the nucleosomes they form with DNA are the fundamental building blocks of eukaryotic chromatin.  A diverse array of post-translational modifications that often occur on tail domains of these proteins has been well documented.  Although the function of these highly conserved modifications has remained elusive, converging biochemical and genetic evidence suggests functions in several chromatin-based processes.  We propose that distinct histone modifications, on one or more tails, act sequentially or in combination to form a 'histone code' that is, read by other proteins to bring about distinct downstream events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyzhdlYh9sX7t7lRqEFUJVfW6udTcc2eYuowt4elK1f7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D&md5=2eb7d093151c6122ccd70fa2adcfd94b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F47412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F47412%26sid%3Dliteratum%253Aachs%26aulast%3DStrahl%26aufirst%3DB.%2BD.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DThe%2520language%2520of%2520covalent%2520histone%2520modifications%26jtitle%3DNature%26date%3D2000%26volume%3D403%26spage%3D41%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Jenuwein, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">Translating the histone code</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">1074</span><span class="NLM_x">–</span> <span class="NLM_lpage">1080</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1126%2Fscience.1063127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=11498575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtVWltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2001&pages=1074-1080&author=T.+Jenuweinauthor=C.+D.+Allis&title=Translating+the+histone+code"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Translating the histone code</span></div><div class="casAuthors">Jenuwein, Thomas; Allis, C. David</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">5532</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The review.  Chromatin, the physiol. template of all eukaryotic genetic information, is subject to a diverse array of posttranslational modifications that largely impinge on histone amino termini, thereby regulating access to the underlying DNA.  Distinct histone amino-terminal modifications can generate synergistic or antagonistic interaction affinities for chromatin-assocd. proteins, which in turn dictate dynamic transitions between transcriptionally active or transcriptionally silent chromatin states.  The combinatorial nature of histone amino-terminal modifications thus reveals a "histone code" that considerably extends the information potential of the genetic code.  We propose that this epigenetic marking system represents a fundamental regulatory mechanism that has an impact on most, if not all; chromatin-templated processes, with far-reaching consequences for cell fate decisions and both normal and pathol. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUFyHNepKcUbVg90H21EOLACvtfcHk0lgio3QP0o5-Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtVWltro%253D&md5=021dcd98a5e5bf2ed7eedef1897b2269</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1063127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1063127%26sid%3Dliteratum%253Aachs%26aulast%3DJenuwein%26aufirst%3DT.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DTranslating%2520the%2520histone%2520code%26jtitle%3DScience%26date%3D2001%26volume%3D293%26spage%3D1074%26epage%3D1080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Taunton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassig, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span> </span><span class="NLM_article-title">A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1126%2Fscience.272.5260.408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=8602529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADyaK28XisVegsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1996&pages=408-411&author=J.+Tauntonauthor=C.+A.+Hassigauthor=S.+L.+Schreiber&title=A+mammalian+histone+deacetylase+related+to+the+yeast+transcriptional+regulator+Rpd3p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p</span></div><div class="casAuthors">Taunton, Jack; Hassig, Christian A.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">5260</span>),
    <span class="NLM_cas:pages">408-11</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Trapoxin is a microbially derived cyclotetrapeptide that inhibits histone deacetylation in vivo and causes mammalian cells to arrest in the cell cycle.  A trapoxin affinity matrix was used to isolate two nuclear proteins that copurified with histone deacetylase activity.  Both proteins were identified by peptide microsequencing, and a complementary DNA encoding the histone deacetylase catalytic subunit (HD1) was cloned from a human Jurkat T cell library.  As the predicted protein is very similar to the yeast transcriptional regulator Rpd3p, these results support a role for histone deacetylase as a key regulator of eukaryotic transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBh4pS_nPMRLVg90H21EOLACvtfcHk0lgio3QP0o5-Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisVegsr8%253D&md5=fda244b40a10d5bc75f94fcc6fae189f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.272.5260.408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.272.5260.408%26sid%3Dliteratum%253Aachs%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DHassig%26aufirst%3DC.%2BA.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DA%2520mammalian%2520histone%2520deacetylase%2520related%2520to%2520the%2520yeast%2520transcriptional%2520regulator%2520Rpd3p%26jtitle%3DScience%26date%3D1996%26volume%3D272%26spage%3D408%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hassig, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span> </span><span class="NLM_article-title">Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1016%2FS1367-5931%2897%2980066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=9667866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADyaK2sXnt12mtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1997&pages=300-308&author=C.+A.+Hassigauthor=S.+L.+Schreiber&title=Nuclear+histone+acetylases+and+deacetylases+and+transcriptional+regulation%3A+HATs+off+to+HDACs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs</span></div><div class="casAuthors">Hassig, Christian A.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">300-308</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review with 60 refs.  Reversible acetylation of lysines on the amino-terminal tails of nucleosomal histones is correlated with changes in chromatin structure and transcription.  The recent characterization of enzymes directly responsible for regulating histone acetylation and deacetylation and the cloning of their encoding cDNAs have provided insights into the possible functional and regulatory mechanisms of these classes of mols.  Nuclear histone acetylases have been shown to be transcriptional coactivators and coactivator-assocd. proteins, while histone deacetylases have been identified as components of nuclear co-repressor complexes.  These findings confirm previous studies linking histone acetylation and transcriptional regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD9X5m19_84rVg90H21EOLACvtfcHk0lgio3QP0o5-Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt12mtL4%253D&md5=d6fb2f8ee6a4ab770c1a722dc895bddb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1367-5931%2897%2980066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1367-5931%252897%252980066-X%26sid%3Dliteratum%253Aachs%26aulast%3DHassig%26aufirst%3DC.%2BA.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DNuclear%2520histone%2520acetylases%2520and%2520deacetylases%2520and%2520transcriptional%2520regulation%253A%2520HATs%2520off%2520to%2520HDACs%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D1997%26volume%3D1%26spage%3D300%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Mahlknecht, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelzner, D.</span><span> </span><span class="NLM_article-title">Histone acetylation modifiers in the pathogenesis of malignant disease</span> <span class="citation_source-journal">Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=11055583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1Klsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=623-644&author=U.+Mahlknechtauthor=D.+Hoelzner&title=Histone+acetylation+modifiers+in+the+pathogenesis+of+malignant+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Histone acetylation modifiers in the pathogenesis of malignant disease</span></div><div class="casAuthors">Mahlknecht, Ulrich; Hoelzer, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">623-644</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Johns Hopkins University Press</span>)
        </div><div class="casAbstract">A review with 248 refs.  Chromatin structure is gaining increasing attention as a potential target in the treatment of cancer.  Relaxation of the chromatin fiber facilitates transcription and is regulated by 2 competing enzymic activities, histone acetyltransferases (HATs) and histone deacetylases (HDACs), which modify the acetylation state of histone proteins and other promoter-bound transcription factors.  While HATs, which are frequently part of multisubunit coactivator complexes, lead to the relaxation of chromatin structure and transcriptional activation, HDACs tend to assoc. with multisubunit corepressor complexes, which result in chromating condensation and transcriptional repression of specific target genes.  HATs and HDACs are known to be involved both in the pathogenesis as well as in the suppression of cancer.  Some of the genes encoding these enzymes have been shown to be rearranged in the context of chromosomal translocations in human acute leukemias and solid tumors, where fusions of regulatory and coding regions of a variety of transcription factor genes result in completely new gene products that may interfere with regulatory cascades controlling cell growth and differentiation.  On the other hand, some histone acetylation-modifying enzymes were located within chromosomal regions that are particularly prone to chromosomal breaks.  In these cases gains and losses of chromosomal material may effect the availability of functionally active HATs and HDACs, which in turn disturbs the tightly controlled equil. of histone acetylation.  The authors review herein the recent achievements, which further help to elucidate the biol. role of histone acetylation modifying enzymes and their potential impact on the current understanding of the mol. changes involved in the development of solid tumors and leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokkAo1pVT1sbVg90H21EOLACvtfcHk0ljmsMXMkPxWwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1Klsr4%253D&md5=ae8ccd70bde1c4af065380f9d7aed0d8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahlknecht%26aufirst%3DU.%26aulast%3DHoelzner%26aufirst%3DD.%26atitle%3DHistone%2520acetylation%2520modifiers%2520in%2520the%2520pathogenesis%2520of%2520malignant%2520disease%26jtitle%3DMol.%2520Med.%26date%3D2000%26volume%3D6%26spage%3D623%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Gayther, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batley, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorpe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowter, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delhanty, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponder, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas, C.</span><span> </span><span class="NLM_article-title">Mutations truncating the EP300 acetylase in human cancers</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1038%2F73536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=10700188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2000&pages=300-303&author=S.+A.+Gaytherauthor=S.+J.+Batleyauthor=L.+Lingerauthor=A.+Bannisterauthor=K.+Thorpeauthor=S.+F.+Chinauthor=Y.+Daigoauthor=P.+Russellauthor=A.+Wilsonauthor=H.+M.+Sowterauthor=J.+D.+Delhantyauthor=B.+A.+Ponderauthor=T.+Kouzaridesauthor=C.+Caldas&title=Mutations+truncating+the+EP300+acetylase+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations truncating the EP300 acetylase in human cancers</span></div><div class="casAuthors">Gayther, Simon A.; Batley, Sarah J.; Linger, Lori; Bannister, Andy; Thorpe, Karen; Chin, Suet-Feung; Daigo, Yataro; Russell, Paul; Wilson, Annie; Sowter, Heidi M.; Delhanty, Joy D. A.; Ponder, Bruce A. J.; Kouzarides, Tony; Caldas, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">300-303</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">The EP300 protein is a histone acetyltransferase that regulates transcription via chromatin remodelling and is important in the processes of cell proliferation and differentiation.  EP300 acetylation of TP53 in response to DNA damage regulates its DNA-binding and transcription functions.  A role for EP300 in cancer has been implied by the fact that it is targeted by viral oncoproteins, it is fused to MLL in leukemia and two missense sequence alterations in EP300 were identified in epithelial malignancies.  Nevertheless, direct demonstration of the role of EP300 in tumorigenesis by inactivating mutations in human cancers has been lacking.  Here the authors describe EP300 mutations, which predict a truncated protein, in 6 (3%) of 193 epithelial cancers analyzed.  Of these six mutations, two were in primary tumors (a colorectal cancer and a breast cancer) and four were in cancer cell lines (colorectal, breast and pancreatic).  In addn., the authors identified a somatic in-frame insertion in a primary breast cancer and missense alterations in a primary colorectal cancer and two cell lines (breast and pancreatic).  Inactivation of the second allele was demonstrated in five of six cases with truncating mutations and in two other cases.  The authors' data show that EP300 is mutated in epithelial cancers and provide the first evidence that it behaves as a classical tumor-suppressor gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmG241Ii2EyrVg90H21EOLACvtfcHk0ljmsMXMkPxWwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtL4%253D&md5=3bd677467a94dfa7dc29825f1d92ad59</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F73536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F73536%26sid%3Dliteratum%253Aachs%26aulast%3DGayther%26aufirst%3DS.%2BA.%26aulast%3DBatley%26aufirst%3DS.%2BJ.%26aulast%3DLinger%26aufirst%3DL.%26aulast%3DBannister%26aufirst%3DA.%26aulast%3DThorpe%26aufirst%3DK.%26aulast%3DChin%26aufirst%3DS.%2BF.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DRussell%26aufirst%3DP.%26aulast%3DWilson%26aufirst%3DA.%26aulast%3DSowter%26aufirst%3DH.%2BM.%26aulast%3DDelhanty%26aufirst%3DJ.%2BD.%26aulast%3DPonder%26aufirst%3DB.%2BA.%26aulast%3DKouzarides%26aufirst%3DT.%26aulast%3DCaldas%26aufirst%3DC.%26atitle%3DMutations%2520truncating%2520the%2520EP300%2520acetylase%2520in%2520human%2520cancers%26jtitle%3DNat.%2520Genet.%26date%3D2000%26volume%3D24%26spage%3D300%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Sambucetti, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabludoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trogani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, D.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">34940</span><span class="NLM_x">–</span> <span class="NLM_lpage">34947</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=34940-34947&author=L.+C.+Sambucettiauthor=D.+D.+Fischerauthor=S.+Zabludoffauthor=P.+O.+Kwonauthor=H.+Chamberlinauthor=N.+Troganiauthor=H.+Xuauthor=D.+Cohen&title=Histone+deacetylase+inhibition+selectively+alters+the+activity+and+expression+of+cell+cycle+proteins+leading+to+specific+chromatin+acetylation+and+antiproliferative+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSambucetti%26aufirst%3DL.%2BC.%26aulast%3DFischer%26aufirst%3DD.%2BD.%26aulast%3DZabludoff%26aufirst%3DS.%26aulast%3DKwon%26aufirst%3DP.%2BO.%26aulast%3DChamberlin%26aufirst%3DH.%26aulast%3DTrogani%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DCohen%26aufirst%3DD.%26atitle%3DHistone%2520deacetylase%2520inhibition%2520selectively%2520alters%2520the%2520activity%2520and%2520expression%2520of%2520cell%2520cycle%2520proteins%2520leading%2520to%2520specific%2520chromatin%2520acetylation%2520and%2520antiproliferative%2520effects%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D34940%26epage%3D34947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslow, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, W. K.</span><span> </span><span class="NLM_article-title">Histone deacetylases and cancer: causes and therapies</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1038%2F35106079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=11902574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=194-202&author=P.+A.+Marksauthor=R.+A.+Rifkindauthor=V.+M.+Richonauthor=R.+Breslowauthor=T.+Millerauthor=W.+K.+Kelly&title=Histone+deacetylases+and+cancer%3A+causes+and+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases and cancer: causes and therapies</span></div><div class="casAuthors">Marks, Paul A.; Rifkind, Richard A.; Richon, Victoria M.; Breslow, Ronald; Miller, Thomas; Kelly, William K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-202</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Together, histone acetyltransferases and histone deacetylases (HDACs) det. the acetylation status of histones.  This acetylation affects the regulation of gene expression, and inhibitors of HDACs have been found to cause growth arrest, differentiation and/or apoptosis of many tumors cells by altering the transcription of a small no. of genes.  HDAC inhibitors are proving to be an exciting therapeutic approach to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNXyL8yvd0OrVg90H21EOLACvtfcHk0liujg8h_OyD0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qtr0%253D&md5=ea50a1a72a6df9ea3a0e1a6a0d5cda5e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F35106079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35106079%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DBreslow%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DKelly%26aufirst%3DW.%2BK.%26atitle%3DHistone%2520deacetylases%2520and%2520cancer%253A%2520causes%2520and%2520therapies%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26spage%3D194%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ruefli, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ausserlechner, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tainton, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kofler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span> </span><span class="NLM_article-title">The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">10833</span><span class="NLM_x">–</span> <span class="NLM_lpage">10838</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=10833-10838&author=A.+A.+Ruefliauthor=M.+J.+Ausserlechnerauthor=D.+Bernhardauthor=V.+R.+Suttonauthor=K.+M.+Taintonauthor=R.+Koflerauthor=M.+J.+Smythauthor=R.+W.+Johnstone&title=The+histone+deacetylase+inhibitor+and+chemotherapeutic+agent+suberoylanilide+hydroxamic+acid+%28SAHA%29+induces+a+cell-death+pathway+characterized+by+cleavage+of+Bid+and+production+of+reactive+oxygen+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuefli%26aufirst%3DA.%2BA.%26aulast%3DAusserlechner%26aufirst%3DM.%2BJ.%26aulast%3DBernhard%26aufirst%3DD.%26aulast%3DSutton%26aufirst%3DV.%2BR.%26aulast%3DTainton%26aufirst%3DK.%2BM.%26aulast%3DKofler%26aufirst%3DR.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DThe%2520histone%2520deacetylase%2520inhibitor%2520and%2520chemotherapeutic%2520agent%2520suberoylanilide%2520hydroxamic%2520acid%2520%2528SAHA%2529%2520induces%2520a%2520cell-death%2520pathway%2520characterized%2520by%2520cleavage%2520of%2520Bid%2520and%2520production%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D10833%26epage%3D10838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Rosato, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almenara, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span> </span><span class="NLM_article-title">The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">3637</span><span class="NLM_x">–</span> <span class="NLM_lpage">3645</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=3637-3645&author=R.+R.+Rosatoauthor=J.+A.+Almenaraauthor=S.+Grant&title=The+histone+deacetylase+inhibitor+MS-275+promotes+differentiation+or+apoptosis+in+human+leukemia+cells+through+a+process+regulated+by+generation+of+reactive+oxygen+species+and+induction+of+p21"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosato%26aufirst%3DR.%2BR.%26aulast%3DAlmenara%26aufirst%3DJ.%2BA.%26aulast%3DGrant%26aufirst%3DS.%26atitle%3DThe%2520histone%2520deacetylase%2520inhibitor%2520MS-275%2520promotes%2520differentiation%2520or%2520apoptosis%2520in%2520human%2520leukemia%2520cells%2520through%2520a%2520process%2520regulated%2520by%2520generation%2520of%2520reactive%2520oxygen%2520species%2520and%2520induction%2520of%2520p21%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D3637%26epage%3D3645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Xu, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dokmanovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span> </span><span class="NLM_article-title">Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">15540</span><span class="NLM_x">–</span> <span class="NLM_lpage">15545</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=15540-15545&author=W.+S.+Xuauthor=L.+Ngoauthor=G.+Perezauthor=M.+Dokmanovicauthor=P.+A.+Marks&title=Intrinsic+apoptotic+and+thioredoxin+pathways+in+human+prostate+cancer+cell+response+to+histone+deacetylase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%2BS.%26aulast%3DNgo%26aufirst%3DL.%26aulast%3DPerez%26aufirst%3DG.%26aulast%3DDokmanovic%26aufirst%3DM.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DIntrinsic%2520apoptotic%2520and%2520thioredoxin%2520pathways%2520in%2520human%2520prostate%2520cancer%2520cell%2520response%2520to%2520histone%2520deacetylase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D15540%26epage%3D15545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Zain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, O. A.</span><span> </span><span class="NLM_article-title">Targeting histone deacetyalses in the treatment of B- and T-cell malignancies</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">S58</span><span class="NLM_x">–</span> <span class="NLM_lpage">S78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=S58-S78&author=J.+Zainauthor=O.+A.+O%E2%80%99Connor&title=Targeting+histone+deacetyalses+in+the+treatment+of+B-+and+T-cell+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZain%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DO.%2BA.%26atitle%3DTargeting%2520histone%2520deacetyalses%2520in%2520the%2520treatment%2520of%2520B-%2520and%2520T-cell%2520malignancies%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2010%26volume%3D28%26spage%3DS58%26epage%3DS78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Vargas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardwick, J. S.</span><span> </span><span class="NLM_article-title">Development of vorinostat: current applications and future perspectives for cancer therapy</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1016%2Fj.canlet.2009.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=19181442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsF2jt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2009&pages=201-210&author=V.+M.+Richonauthor=J.+Garcia-Vargasauthor=J.+S.+Hardwick&title=Development+of+vorinostat%3A+current+applications+and+future+perspectives+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Development of vorinostat: Current applications and future perspectives for cancer therapy</span></div><div class="casAuthors">Richon, Victoria M.; Garcia-Vargas, Jose; Hardwick, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-210</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Vorinostat is a potent histone deacetylase inhibitor that blocks the catalytic site of these enzymes.  A large no. of cellular proteins are modified post-translationally by acetylation, leading to altered structure and/or function.  Many of these proteins, such as core nucleosomal histones and transcription factors, function in key cellular processes and signal transduction pathways that regulate cell growth, migration, and differentiation.  At concns. that are non-toxic to normal cells, vorinostat dramatically alters cellular acetylation patterns and causes growth arrest and death and in a wide range of transformed cells, both in vitro and in animal tumor models.  Vorinostat has shown promising clin. activity against hematol. and solid tumors at doses that have been well tolerated by patients.  Recent non-clin. expts. that explored the effects of vorinostat in combination with other chemotherapeutic agents have begun to illuminate potential mechanisms of action for this histone deacetylase inhibitor and are providing guidance for new avenues of clin. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLaRS24LfvvbVg90H21EOLACvtfcHk0lgHt7RzafQc7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsF2jt7k%253D&md5=c14a4b9ad3c37c5eb1e89c9f549040de</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2009.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2009.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DGarcia-Vargas%26aufirst%3DJ.%26aulast%3DHardwick%26aufirst%3DJ.%2BS.%26atitle%3DDevelopment%2520of%2520vorinostat%253A%2520current%2520applications%2520and%2520future%2520perspectives%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D280%26spage%3D201%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kelly, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krug, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiao, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGregore-Cortelli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secrist, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olgac, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span> </span><span class="NLM_article-title">Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patient with advanced cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3923</span><span class="NLM_x">–</span> <span class="NLM_lpage">3931</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1200%2FJCO.2005.14.167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=15897550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtVahtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=3923-3931&author=W.+K.+Kellyauthor=O.+A.+O%E2%80%99Connorauthor=L.+M.+Krugauthor=J.+H.+Chiaoauthor=M.+Heaneyauthor=T.+Curleyauthor=B.+MacGregore-Cortelliauthor=W.+Tongauthor=J.+P.+Secristauthor=L.+Schwartzauthor=S.+Richardsonauthor=E.+Chuauthor=S.+Olgacauthor=P.+A.+Marksauthor=H.+Scherauthor=V.+M.+Richon&title=Phase+I+study+of+an+oral+histone+deacetylase+inhibitor%2C+suberoylanilide+hydroxamic+acid%2C+in+patient+with+advanced+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer</span></div><div class="casAuthors">Kelly, William Kevin; O'Connor, Owen A.; Krug, Lee M.; Chiao, Judy H.; Heaney, Mark; Curley, Tracy; MacGregore-Cortelli, Barbara; Tong, William; Secrist, J. Paul; Schwartz, Lawrence; Richardson, Stacy; Chu, Elaina; Olgac, Semra; Marks, Paul A.; Scher, Howard; Richon, Victoria M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3923-3931</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To det. the safety, dosing schedules, pharmacokinetic profile, and biol. effect of orally administered histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) in patients with advanced cancer.  Patients and Methods: Patients with solid and hematol. malignancies were treated with oral SAHA administered once or twice a day on a continuous basis or twice daily for 3 consecutive days per wk.  Pharmacokinetic profile and bioavailability of oral SAHA were detd.  Western blots and enzyme-linked immunosorbent assays of histones isolated from peripheral-blood mononuclear cells (PBMNCs) pre and post-therapy were performed to evaluate target inhibition.  Results: Seventy-three patients were treated with oral SAHA and major dose-limiting toxicities were anorexia, dehydration, diarrhea, and fatigue.  The max. tolerated dose was 400 mg qd and 200 mg bid for continuous daily dosing and 300 mg bid for 3 consecutive days per wk dosing.  Oral SAHA had linear pharmacokinetics from 200 to 600 mg, with an apparent half-life ranging from 91 to 127 min and 43% oral bioavailability.  Histones isolated from PBMNCs showed consistent accumulation of acetylated histones post-therapy, and ELISA demonstrated a trend towards a dose-dependent accumulation of acetylated histones from 200 to 600 mg of oral SAHA.  There was one complete response, three partial responses, two unconfirmed partial responses, and 22 (30%) patients remained on study for 4 to 37+ months.  Conclusions: Oral SAHA has linear pharmacokinetics and good bioavailability, inhibits histone deacetylase activity in PBMNCs, can be safely administered chronically, and has a broad range of antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfHYxcbfdZ3LVg90H21EOLACvtfcHk0lgYGFDH1pJ7yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtVahtLw%253D&md5=b16db863c77bc6d45e355bd75b7a8f93</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.14.167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.14.167%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DW.%2BK.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DO.%2BA.%26aulast%3DKrug%26aufirst%3DL.%2BM.%26aulast%3DChiao%26aufirst%3DJ.%2BH.%26aulast%3DHeaney%26aufirst%3DM.%26aulast%3DCurley%26aufirst%3DT.%26aulast%3DMacGregore-Cortelli%26aufirst%3DB.%26aulast%3DTong%26aufirst%3DW.%26aulast%3DSecrist%26aufirst%3DJ.%2BP.%26aulast%3DSchwartz%26aufirst%3DL.%26aulast%3DRichardson%26aufirst%3DS.%26aulast%3DChu%26aufirst%3DE.%26aulast%3DOlgac%26aufirst%3DS.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DScher%26aufirst%3DH.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26atitle%3DPhase%2520I%2520study%2520of%2520an%2520oral%2520histone%2520deacetylase%2520inhibitor%252C%2520suberoylanilide%2520hydroxamic%2520acid%252C%2520in%2520patient%2520with%2520advanced%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D3923%26epage%3D3931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradei, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeppel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frechette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudette, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouchain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisburg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trachy-Bourget, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delorme, D.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4072</span><span class="NLM_x">–</span> <span class="NLM_lpage">4075</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800251w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4072-4075&author=N.+Zhouauthor=O.+Moradeiauthor=S.+Raeppelauthor=S.+Leitauthor=S.+Frechetteauthor=F.+Gaudetteauthor=I.+Paquinauthor=N.+Bernsteinauthor=G.+Bouchainauthor=A.+Vaisburgauthor=Z.+Jinauthor=J.+Gillespieauthor=J.+Wangauthor=M.+Fournelauthor=P.+T.+Yanauthor=M.-C.+Trachy-Bourgetauthor=A.+Kalitaauthor=A.+Luauthor=J.+Rahilauthor=A.+R.+MacLeodauthor=Z.+Liauthor=J.+M.+Bestermanauthor=D.+Delorme&title=Discovery+of+N-%282-aminophenyl%29-4-%5B%284-pyridin-3-ylpyrimidin-2-ylamino%29methyl%5Dbenzamide+%28MGCD0103%29%2C+an+orally+active+histone+deacetylase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjm800251w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800251w%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DMoradei%26aufirst%3DO.%26aulast%3DRaeppel%26aufirst%3DS.%26aulast%3DLeit%26aufirst%3DS.%26aulast%3DFrechette%26aufirst%3DS.%26aulast%3DGaudette%26aufirst%3DF.%26aulast%3DPaquin%26aufirst%3DI.%26aulast%3DBernstein%26aufirst%3DN.%26aulast%3DBouchain%26aufirst%3DG.%26aulast%3DVaisburg%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DGillespie%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DP.%2BT.%26aulast%3DTrachy-Bourget%26aufirst%3DM.-C.%26aulast%3DKalita%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DMacLeod%26aufirst%3DA.%2BR.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DDelorme%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520N-%25282-aminophenyl%2529-4-%255B%25284-pyridin-3-ylpyrimidin-2-ylamino%2529methyl%255Dbenzamide%2520%2528MGCD0103%2529%252C%2520an%2520orally%2520active%2520histone%2520deacetylase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4072%26epage%3D4075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Garcia-Manero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrov, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newsome, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martell, R.</span><span> </span><span class="NLM_article-title">Clinical activity and safety of the histone deacetylase inhibitor MGCD0103: results of a phase I study in patients with leukemia or myelodysplastic syndromes (MDS)</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">337S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=337S&author=G.+Garcia-Maneroauthor=M.+Mindenauthor=Z.+Estrovauthor=S.+Verstovsekauthor=W.+M.+Newsomeauthor=G.+Reidauthor=J.+Bestermanauthor=Z.+Liauthor=L.+Pearceauthor=R.+Martell&title=Clinical+activity+and+safety+of+the+histone+deacetylase+inhibitor+MGCD0103%3A+results+of+a+phase+I+study+in+patients+with+leukemia+or+myelodysplastic+syndromes+%28MDS%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Manero%26aufirst%3DG.%26aulast%3DMinden%26aufirst%3DM.%26aulast%3DEstrov%26aufirst%3DZ.%26aulast%3DVerstovsek%26aufirst%3DS.%26aulast%3DNewsome%26aufirst%3DW.%2BM.%26aulast%3DReid%26aufirst%3DG.%26aulast%3DBesterman%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DPearce%26aufirst%3DL.%26aulast%3DMartell%26aufirst%3DR.%26atitle%3DClinical%2520activity%2520and%2520safety%2520of%2520the%2520histone%2520deacetylase%2520inhibitor%2520MGCD0103%253A%2520results%2520of%2520a%2520phase%2520I%2520study%2520in%2520patients%2520with%2520leukemia%2520or%2520myelodysplastic%2520syndromes%2520%2528MDS%2529%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D337S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Fournel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonfils, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trachy-Bourget, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, A.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, M.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ste-Croix, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradei, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delorme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span> </span><span class="NLM_article-title">MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1158%2F1535-7163.MCT-07-2026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=18413790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1Gms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=759-768&author=M.+Fournelauthor=C.+Bonfilsauthor=Y.+Houauthor=T.+Yanauthor=M.-C.+Trachy-Bourgetauthor=A.+Kalitaauthor=J.+Liuauthor=A.-H.+Luauthor=N.+Z.+Zhouauthor=M.-F.+Robertauthor=J.+Gillespieauthor=J.+J.+Wangauthor=H.+Ste-Croixauthor=J.+Rahilauthor=S.+Lefebvreauthor=O.+Moradeiauthor=D.+Delormeauthor=A.+R.+MacLeodauthor=J.+M.+Bestermanauthor=Z.+Li&title=MGCD0103%2C+a+novel+isotype-selective+histone+deacetylase+inhibitor%2C+has+broad+spectrum+antitumor+activity+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo</span></div><div class="casAuthors">Fournel, Marielle; Bonfils, Claire; Hou, Yu; Yan, Pu Theresa; Trachy-Bourget, Marie-Claude; Kalita, Ann; Liu, Jianhong; Lu, Ai-Hua; Zhou, Nancy Z.; Robert, Marie-France; Gillespie, Jeffrey; Wang, James J.; Ste-Croix, Helene; Rahil, Jubrail; Lefebvre, Sylvain; Moradei, Oscar; Delorme, Daniel; MacLeod, A. Robert; Besterman, Jeffrey M.; Li, Zuomei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">759-768</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Nonselective inhibitors of human histone deacetylases (HDAC) are known to have antitumor activity in mice in vivo, and several of them are under clin. investigation.  The first of these, Vorinostat (SAHA), has been approved for treatment of cutaneous T-cell lymphoma.  Questions remain concerning which HDAC isotype(s) are the best to target for anticancer activity and whether increased efficacy and safety will result with an isotype-selective HDAC inhibitor.  We have developed an isotype-selective HDAC inhibitor, MGCD0103, which potently targets human HDAC1 but also has inhibitory activity against HDAC2, HDAC3, and HDAC11 in vitro.  In intact cells, MGCD0103 inhibited only a fraction of the total HDAC activity and showed long-lasting inhibitory activity even upon drug removal.  MGCD0103 induced hyperacetylation of histones, selectively induced apoptosis, and caused cell cycle blockade in various human cancer cell lines in a dose-dependent manner.  MGCD0103 exhibited potent and selective antiproliferative activities against a broad spectrum of human cancer cell lines in vitro, and HDAC inhibitory activity was required for these effects.  In vivo, MGCD0103 significantly inhibited growth of human tumor xenografts in nude mice in a dose-dependent manner and the antitumor activity correlated with induction of histone acetylation in tumors.  Our findings suggest that the isotype-selective HDAC inhibition by MGCD0103 is sufficient for antitumor activity in vivo and that further clin. investigation is warranted. [Mol Cancer Ther 2008;7(4):759-68].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokegpWTxBJyrVg90H21EOLACvtfcHk0ljcDY4GwyELgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1Gms70%253D&md5=48604f141d969585efaa71c4005496cf</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2026%26sid%3Dliteratum%253Aachs%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DBonfils%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DT.%26aulast%3DTrachy-Bourget%26aufirst%3DM.-C.%26aulast%3DKalita%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DA.-H.%26aulast%3DZhou%26aufirst%3DN.%2BZ.%26aulast%3DRobert%26aufirst%3DM.-F.%26aulast%3DGillespie%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%2BJ.%26aulast%3DSte-Croix%26aufirst%3DH.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DMoradei%26aufirst%3DO.%26aulast%3DDelorme%26aufirst%3DD.%26aulast%3DMacLeod%26aufirst%3DA.%2BR.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DMGCD0103%252C%2520a%2520novel%2520isotype-selective%2520histone%2520deacetylase%2520inhibitor%252C%2520has%2520broad%2520spectrum%2520antitumor%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D759%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Saito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariko, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, O.</span><span> </span><span class="NLM_article-title">A synthetic inhibitor of histone deacetylase, MS-275, with marked in vivo antitumor activity against human tumors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">4592</span><span class="NLM_x">–</span> <span class="NLM_lpage">4597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=4592-4597&author=A.+Saitoauthor=T.+Yamasitaauthor=Y.+Marikoauthor=Y.+Nosakaauthor=K.+Tsuchiyaauthor=T.+Andoauthor=T.+Suzukiauthor=T.+Tsuruoauthor=O.+Nakanishi&title=A+synthetic+inhibitor+of+histone+deacetylase%2C+MS-275%2C+with+marked+in+vivo+antitumor+activity+against+human+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DA.%26aulast%3DYamasita%26aufirst%3DT.%26aulast%3DMariko%26aufirst%3DY.%26aulast%3DNosaka%26aufirst%3DY.%26aulast%3DTsuchiya%26aufirst%3DK.%26aulast%3DAndo%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DTsuruo%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DO.%26atitle%3DA%2520synthetic%2520inhibitor%2520of%2520histone%2520deacetylase%252C%2520MS-275%252C%2520with%2520marked%2520in%2520vivo%2520antitumor%2520activity%2520against%2520human%2520tumors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D4592%26epage%3D4597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Knipstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, L.</span><span> </span><span class="NLM_article-title">Entinostat for treatment of solid tumors and hematologic malignancies</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1455</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1455-1467&author=J.+Knipsteinauthor=L.+Gore&title=Entinostat+for+treatment+of+solid+tumors+and+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnipstein%26aufirst%3DJ.%26aulast%3DGore%26aufirst%3DL.%26atitle%3DEntinostat%2520for%2520treatment%2520of%2520solid%2520tumors%2520and%2520hematologic%2520malignancies%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D1455%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Piekarz, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayastha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdeldaim, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrico, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">4636</span><span class="NLM_x">–</span> <span class="NLM_lpage">4643</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=4636-4643&author=R.+L.+Piekarzauthor=R.+W.+Robeyauthor=Z.+Zhanauthor=G.+Kayasthaauthor=A.+Sayahauthor=A.+H.+Abdeldaimauthor=S.+Torricoauthor=S.+E.+Bates&title=T-cell+lymphoma+as+a+model+for+the+use+of+histone+deacetylase+inhibitors+in+cancer+therapy%3A+impact+of+depsipeptide+on+molecular+markers%2C+therapeutic+targets%2C+and+mechanisms+of+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiekarz%26aufirst%3DR.%2BL.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DZhan%26aufirst%3DZ.%26aulast%3DKayastha%26aufirst%3DG.%26aulast%3DSayah%26aufirst%3DA.%26aulast%3DAbdeldaim%26aufirst%3DA.%2BH.%26aulast%3DTorrico%26aufirst%3DS.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DT-cell%2520lymphoma%2520as%2520a%2520model%2520for%2520the%2520use%2520of%2520histone%2520deacetylase%2520inhibitors%2520in%2520cancer%2520therapy%253A%2520impact%2520of%2520depsipeptide%2520on%2520molecular%2520markers%252C%2520therapeutic%2520targets%252C%2520and%2520mechanisms%2520of%2520resistance%26jtitle%3DBlood%26date%3D2004%26volume%3D103%26spage%3D4636%26epage%3D4643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Piekarz, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschbaum, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geskin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joske, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetler-Stevenson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5410</span><span class="NLM_x">–</span> <span class="NLM_lpage">5417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1200%2FJCO.2008.21.6150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=19826128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFKkt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=5410-5417&author=R.+L.+Piekarzauthor=R.+Fryeauthor=M.+Turnerauthor=J.+Wrightauthor=S.+Allenauthor=M.+Kirschbaumauthor=J.+Zainauthor=H.+Princeauthor=J.+Leonardauthor=L.+Geskinauthor=D.+Joskeauthor=W.+Figgauthor=E.+Gardnerauthor=S.+Steinbergauthor=E.+Jaffeauthor=M.+Stetler-Stevensonauthor=S.+Ladeauthor=A.+Fojoauthor=S.+E.+Bates&title=T-cell+lymphoma+as+a+model+for+the+use+of+histone+deacetylase+inhibitors+in+cancer+therapy%3A+impact+of+depsipeptide+on+molecular+markers%2C+therapeutic+targets%2C+and+mechanisms+of+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma</span></div><div class="casAuthors">Piekarz, Richard L.; Frye, Robin; Turner, Maria; Wright, John J.; Allen, Steven L.; Kirschbaum, Mark H.; Zain, Jasmine; Prince, H. Miles; Leonard, John P.; Geskin, Larisa J.; Reeder, Craig; Joske, David; Figg, William D.; Gardner, Erin R.; Steinberg, Seth M.; Jaffe, Elaine S.; Stetler-Stevenson, Maryalice; Lade, Stephen; Fojo, A. Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">5410-5417</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Romidepsin (depsipeptide or FK228) is a member of a new class of antineoplastic agents active in T-cell lymphoma, the histone deacetylase inhibitors.  On the basis of obsd. responses in a phase I trial, a phase II trial of romidepsin in patients with T-cell lymphoma was initiated.  The initial cohort was limited to patients with cutaneous T-cell lymphoma (CTCL), or subtypes mycosis fungoides or Sezary syndrome, who had received no more than two prior cytotoxic regimens.  There were no limits on other types of therapy.  Subsequently, the protocol was expanded to enroll patients who had received more than two prior cytotoxic regimens.  Twenty-seven patients were enrolled onto the first cohort, and a total of 71 patients are included in this anal.  These patients had undergone a median of four prior treatments, and 62 patients (87%) had advanced-stage disease (stage IIB, n = 15; stage III, n= 6; or stage IV, n = 41).  Toxicities included nausea, vomiting, fatigue, and transient thrombocytopenia and granulocytopenia.  Pharmacokinetics were evaluated with the first administration of romidepsin.  Complete responses were obsd. in four patients, and partial responses were obsd. in 20 patients for an overall response rate of 34% (95% CI, 23% to 46%).  The median duration of response was 13.7 mo.  The histone deacetylase inhibitor romidepsin has single-agent clin. activity with significant and durable responses in patients with CTCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUzt-4ptTta7Vg90H21EOLACvtfcHk0lhYqc9uundgnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFKkt7vO&md5=e99b3bf6b987b6cb5ed3d2cbefcbd259</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2008.21.6150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2008.21.6150%26sid%3Dliteratum%253Aachs%26aulast%3DPiekarz%26aufirst%3DR.%2BL.%26aulast%3DFrye%26aufirst%3DR.%26aulast%3DTurner%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DKirschbaum%26aufirst%3DM.%26aulast%3DZain%26aufirst%3DJ.%26aulast%3DPrince%26aufirst%3DH.%26aulast%3DLeonard%26aufirst%3DJ.%26aulast%3DGeskin%26aufirst%3DL.%26aulast%3DJoske%26aufirst%3DD.%26aulast%3DFigg%26aufirst%3DW.%26aulast%3DGardner%26aufirst%3DE.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DJaffe%26aufirst%3DE.%26aulast%3DStetler-Stevenson%26aufirst%3DM.%26aulast%3DLade%26aufirst%3DS.%26aulast%3DFojo%26aufirst%3DA.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DT-cell%2520lymphoma%2520as%2520a%2520model%2520for%2520the%2520use%2520of%2520histone%2520deacetylase%2520inhibitors%2520in%2520cancer%2520therapy%253A%2520impact%2520of%2520depsipeptide%2520on%2520molecular%2520markers%252C%2520therapeutic%2520targets%252C%2520and%2520mechanisms%2520of%2520resistance%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2009%26volume%3D27%26spage%3D5410%26epage%3D5417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Chou, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesfeld, J. M.</span><span> </span><span class="NLM_article-title">Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I histone deacetylases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">35402</span><span class="NLM_x">–</span> <span class="NLM_lpage">35409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1074%2Fjbc.M807045200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=18953021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVylsr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=35402-35409&author=C.+J.+Chouauthor=D.+Hermanauthor=J.+M.+Gottesfeld&title=Pimelic+diphenylamide+106+is+a+slow%2C+tight-binding+inhibitor+of+class+I+histone+deacetylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pimelic Diphenylamide 106 Is a Slow, Tight-binding Inhibitor of Class I Histone Deacetylases</span></div><div class="casAuthors">Chou, C. James; Herman, David; Gottesfeld, Joel M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">35402-35409</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) inhibitors, including various benzamides and hydroxamates, are currently in clin. development for a broad range of human diseases, including cancer and neurodegenerative diseases.  We recently reported the identification of a family of benzamide-type HDAC inhibitors that are relatively non-toxic compared with the hydroxamates.  Members of this class of compds. have shown efficacy in cell-based and mouse models for the neurodegenerative diseases Friedreich ataxia and Huntington disease.  Considerable differences in IC50 values for the various HDAC enzymes have been reported for many of the HDAC inhibitors, leading to confusion as to the HDAC isotype specificities of these compds.  Here we show that a benzamide HDAC inhibitor, a pimelic diphenylamide (106), is a class I HDAC inhibitor, demonstrating no activity against class II HDACs.  106 Is a slow, tight-binding inhibitor of HDACs 1, 2, and 3, although inhibition for these enzymes occurs through different mechanisms.  Inhibitor 106 also has preference toward HDAC3 with Ki of ∼14 nM, 15 times lower than the Ki for HDAC1.  In comparison, the hydroxamate suberoylanilide hydroxamic acid does not discriminate between these enzymes and exhibits a fast-on/fast-off inhibitory mechanism.  These observations may explain a paradox involving the relative activities of pimelic diphenylamides vs. hydroxamates as gene activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeaJtDFGy6MbVg90H21EOLACvtfcHk0lhri4YzTM8uHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVylsr3L&md5=ffcdd2b6a6884d7fa48076c9bf228011</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M807045200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M807045200%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DC.%2BJ.%26aulast%3DHerman%26aufirst%3DD.%26aulast%3DGottesfeld%26aufirst%3DJ.%2BM.%26atitle%3DPimelic%2520diphenylamide%2520106%2520is%2520a%2520slow%252C%2520tight-binding%2520inhibitor%2520of%2520class%2520I%2520histone%2520deacetylases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D35402%26epage%3D35409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bonfils, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carducci, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span> </span><span class="NLM_article-title">Evaluation of the pharmacodynamic effects of MGCD0103 from preclinical models to human using a novel HDAC enzyme assay</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3441</span><span class="NLM_x">–</span> <span class="NLM_lpage">3449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1158%2F1078-0432.CCR-07-4427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=18519775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslygsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3441-3449&author=C.+Bonfilsauthor=A.+Kalitaauthor=M.+Dubayauthor=L.+L.+Siuauthor=M.+A.+Carducciauthor=G.+Reidauthor=R.+E.+Martellauthor=J.+M.+Bestermanauthor=Z.+Li&title=Evaluation+of+the+pharmacodynamic+effects+of+MGCD0103+from+preclinical+models+to+human+using+a+novel+HDAC+enzyme+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Pharmacodynamic Effects of MGCD0103 from Preclinical Models to Human Using a Novel HDAC Enzyme Assay</span></div><div class="casAuthors">Bonfils, Claire; Kalita, Ann; Dubay, Marja; Siu, Lillian L.; Carducci, Michael A.; Reid, Gregory; Martell, Robert E.; Besterman, Jeffrey M.; Li, Zuomei</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3441-3449</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The pharmacodynamic properties of MGCD0103, an isotype-selective inhibitor of histone deacetylase (HDAC), were evaluated in preclin. models and patients with a novel whole-cell HDAC enzyme assay.  Exptl. Design: Boc-Lys(.vepsiln.-Ac)-AMC, a HDAC substrate with fluorescent readout, was found to be cell permeable and was used to monitor MGCD0103-mediated HDAC inhibition in cultured cancer cells in vitro, in peripheral WBC ex vivo, in mice in vivo, and in human patients.  RESULTS: MGCD0103 inhibited HDAC activity in several human cancer cell lines in vitro and in human peripheral WBC ex vivo in a dose-dependent manner.  Unlike suberoylanilide hydroxamic acid, the HDAC inhibitory activity of MGCD0103 was time dependent and sustained for at least 24 h following drug removal in peripheral WBC ex vivo.  Inhibitory activity of MGCD0103 was sustained for at least 8 h in vivo in mice and 48 h in patients with solid tumors.  HDAC inhibitory activity of MGCD0103 in peripheral WBC correlated with induction of histone acetylation in blood and in implanted tumors in mice.  In cancer patients, sustained pharmacodynamic effect of MGCD0103 was visualized only by dose-dependent enzyme inhibition in peripheral WBC but not by histone acetylation anal.  CONCLUSIONS: This study shows that MGCD0103 has sustained pharmacodynamic effects that can be monitored both in vitro and in vivo with a cell-based HDAC enzyme assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrReZVYYRQ0YbVg90H21EOLACvtfcHk0lhri4YzTM8uHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslygsbk%253D&md5=29b048a8a7c72caa67b9e68e5604e1df</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-4427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-4427%26sid%3Dliteratum%253Aachs%26aulast%3DBonfils%26aufirst%3DC.%26aulast%3DKalita%26aufirst%3DA.%26aulast%3DDubay%26aufirst%3DM.%26aulast%3DSiu%26aufirst%3DL.%2BL.%26aulast%3DCarducci%26aufirst%3DM.%2BA.%26aulast%3DReid%26aufirst%3DG.%26aulast%3DMartell%26aufirst%3DR.%2BE.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEvaluation%2520of%2520the%2520pharmacodynamic%2520effects%2520of%2520MGCD0103%2520from%2520preclinical%2520models%2520to%2520human%2520using%2520a%2520novel%2520HDAC%2520enzyme%2520assay%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D3441%26epage%3D3449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Peh, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assem, E-S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marson, C. M.</span><span> </span><span class="NLM_article-title">Effect of a selection of histone deacetylase inhibitors on mast cell activation and airway and colonic smooth muscle contraction</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1801</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1016%2Fj.intimp.2008.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=18805511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGht7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1793-1801&author=K.+H.+Pehauthor=B.+Y.+Wanauthor=E-S.+K.+Assemauthor=C.+M.+Marson&title=Effect+of+a+selection+of+histone+deacetylase+inhibitors+on+mast+cell+activation+and+airway+and+colonic+smooth+muscle+contraction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a selection of histone deacetylase inhibitors on mast cell activation and airway and colonic smooth muscle contraction</span></div><div class="casAuthors">Assem, El-Sayed K.; Peh, Kheng H.; Wan, Beatrice Y. C.; Middleton, Brian J.; Dines, Jon; Marson, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">1793-1801</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Studies of histone deacetylase (HDAC) inhibitors, novel anticancer drugs, in models of autoimmune diseases, asthma, and inflammatory bowel disease suggest that HDAC inhibitors may also have useful anti-inflammatory effects.  Accordingly, in vitro studies relevant to asthma and inflammatory bowel disease were conducted using a selection of HDAC inhibitors: suberoylanilide hydroxamic acid (SAHA, Vorinostat), and a related branched hydroxamic acid, diamide (1), MGCD0103 and two short chain fatty acid derivs.: sodium butyrate (of use in inflammatory bowel disease) and sodium valproate.  The ability of those HDAC inhibitors to modulate antigen- or agonist-induced contraction of isolated guinea pig tracheal rings and colon, agonist-induced contraction of rat colon, and histamine release from rat peritoneal mast cells was examd.  Pre-incubation (up to 6 h) with 10-40 μM of SAHA, diamide (1), or MGCD0103 caused significant inhibition of the antigen-induced contraction of sensitized guinea pig tracheal rings as well as inhibition of the contraction induced by histamine, 5-hydroxytryptamine and carbachol (G-protein coupled receptor agonists), while sodium butyrate (1 mM) and sodium valproate (100 μM) were weak inhibitors.  Contraction of tracheal rings by sodium fluoride (NaF, a non-selective G-protein activator), KCl and a peroxyl radical generator was blocked by MGCD0103.  Addnl., MGCD0103 significantly inhibited antigen-induced histamine release from IgE antibody-sensitized rat peritoneal mast cells, and NaF-induced histamine release, as well as inhibiting NaF-induced colon contraction.  Those various effects appear to involve modulation of cell signaling, probably involving G-protein coupled pathways, and further support the development of HDAC inhibitors as anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-LCroFTT4LVg90H21EOLACvtfcHk0lgyp-Lq99Hn2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGht7nI&md5=006b66dd39c2245e2a6ea2632182c971</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2008.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2008.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DPeh%26aufirst%3DK.%2BH.%26aulast%3DWan%26aufirst%3DB.%2BY.%26aulast%3DAssem%26aufirst%3DE-S.%2BK.%26aulast%3DMarson%26aufirst%3DC.%2BM.%26atitle%3DEffect%2520of%2520a%2520selection%2520of%2520histone%2520deacetylase%2520inhibitors%2520on%2520mast%2520cell%2520activation%2520and%2520airway%2520and%2520colonic%2520smooth%2520muscle%2520contraction%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2008%26volume%3D8%26spage%3D1793%26epage%3D1801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Dedes, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedes, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imesch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bueren, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedier, A.</span><span> </span><span class="NLM_article-title">Acquired vorinostat resistance shows partial cross-resistance to “second-generation” HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=321-333&author=K.+J.+Dedesauthor=I.+Dedesauthor=P.+Imeschauthor=A.+O.+von+Buerenauthor=D.+Finkauthor=A.+Fedier&title=Acquired+vorinostat+resistance+shows+partial+cross-resistance+to+%E2%80%9Csecond-generation%E2%80%9D+HDAC+inhibitors+and+correlates+with+loss+of+histone+acetylation+and+apoptosis+but+not+with+altered+HDAC+and+HAT+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDedes%26aufirst%3DK.%2BJ.%26aulast%3DDedes%26aufirst%3DI.%26aulast%3DImesch%26aufirst%3DP.%26aulast%3Dvon%2BBueren%26aufirst%3DA.%2BO.%26aulast%3DFink%26aufirst%3DD.%26aulast%3DFedier%26aufirst%3DA.%26atitle%3DAcquired%2520vorinostat%2520resistance%2520shows%2520partial%2520cross-resistance%2520to%2520%25E2%2580%259Csecond-generation%25E2%2580%259D%2520HDAC%2520inhibitors%2520and%2520correlates%2520with%2520loss%2520of%2520histone%2520acetylation%2520and%2520apoptosis%2520but%2520not%2520with%2520altered%2520HDAC%2520and%2520HAT%2520activities%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2009%26volume%3D20%26spage%3D321%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Delorme, D.; Vaisburg, A.; Moradei, O.; Leit, S.; Frechette, S.; Zhou, Z.; Paquin, I.; Gaudette, F.; Isakovic, L.; Bouchain, G.; Raeppel, S.</span><span> </span><span class="NLM_article-title">Inhibitors of Histone Deacetylase</span>. Patent CA 2559733<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>MethylGene.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=D.+Delorme&author=A.+Vaisburg&author=O.+Moradei&author=S.+Leit&author=S.+Frechette&author=Z.+Zhou&author=I.+Paquin&author=F.+Gaudette&author=L.+Isakovic&author=G.+Bouchain&author=S.+Raeppel&title=Inhibitors+of+Histone+Deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDelorme%26aufirst%3DD.%26atitle%3DInhibitors%2520of%2520Histone%2520Deacetylase%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Moradei, O.; Paquin, I.; Leit, S.; Frechette, S.; Vaisburg, A.; Besterman, J. M.; Tessier, P.; Mallais, T. C.</span><span> </span><span class="NLM_article-title">Inhibitors of Histone Deacetylase</span>. Patent WO 2005030704<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>MethylGene.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=O.+Moradei&author=I.+Paquin&author=S.+Leit&author=S.+Frechette&author=A.+Vaisburg&author=J.+M.+Besterman&author=P.+Tessier&author=T.+C.+Mallais&title=Inhibitors+of+Histone+Deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMoradei%26aufirst%3DO.%26atitle%3DInhibitors%2520of%2520Histone%2520Deacetylase%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Reyes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, K.</span><span> </span><span class="NLM_article-title">On formation of thiohydantoins from amino acids under acylation conditions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">2507</span><span class="NLM_x">–</span> <span class="NLM_lpage">2509</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo052576i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=2507-2509&author=S.+Reyesauthor=K.+Burgess&title=On+formation+of+thiohydantoins+from+amino+acids+under+acylation+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo052576i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052576i%26sid%3Dliteratum%253Aachs%26aulast%3DReyes%26aufirst%3DS.%26aulast%3DBurgess%26aufirst%3DK.%26atitle%3DOn%2520formation%2520of%2520thiohydantoins%2520from%2520amino%2520acids%2520under%2520acylation%2520conditions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D2507%26epage%3D2509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Samyn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardeman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Eycken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Beeumen, J.</span><span> </span><span class="NLM_article-title">Applicability of the alkylation chemistry for chemical C-terminal protein sequence analysis</span> <span class="citation_source-journal">Anal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1389</span><span class="NLM_x">–</span> <span class="NLM_lpage">1399</span></span><div class="citationLinks">[<a href="/doi/10.1021/ac991049u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2000&pages=1389-1399&author=B.+Samynauthor=K.+Hardemanauthor=J.+Van+der+Eyckenauthor=J.+Van+Beeumen&title=Applicability+of+the+alkylation+chemistry+for+chemical+C-terminal+protein+sequence+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fac991049u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac991049u%26sid%3Dliteratum%253Aachs%26aulast%3DSamyn%26aufirst%3DB.%26aulast%3DHardeman%26aufirst%3DK.%26aulast%3DVan%2Bder%2BEycken%26aufirst%3DJ.%26aulast%3DVan%2BBeeumen%26aufirst%3DJ.%26atitle%3DApplicability%2520of%2520the%2520alkylation%2520chemistry%2520for%2520chemical%2520C-terminal%2520protein%2520sequence%2520analysis%26jtitle%3DAnal.%2520Chem.%26date%3D2000%26volume%3D72%26spage%3D1389%26epage%3D1399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Yoshii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirashima, A.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of 2-aminothiazolines and 2-mercaptothiazolines as octopaminergic agonists</span> <span class="citation_source-journal">Agric. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2537</span><span class="NLM_x">–</span> <span class="NLM_lpage">2545</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1271%2Fbbb1961.55.2537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADyaK38XmsVGq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1991&pages=2537-2545&author=Y.+Yoshiiauthor=M.+Etoauthor=A.+Hirashima&title=Synthesis+and+biological+activity+of+2-aminothiazolines+and+2-mercaptothiazolines+as+octopaminergic+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activity of 2-aminothiazolines and 2-mercaptothiazolines as octopaminergic agonists</span></div><div class="casAuthors">Hirashima, Akinori; Yoshii, Yutaka; Eto, Morifusa</div><div class="citationInfo"><span class="NLM_cas:title">Agricultural and Biological Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2537-45</span>CODEN:
                <span class="NLM_cas:coden">ABCHA6</span>;
        ISSN:<span class="NLM_cas:issn">0002-1369</span>.
    </div><div class="casAbstract">The title compds., e.g., I (R = H, Me, Ph, Et, CH2CH2SMe; R1 = alkyl- or arylamino, SH, EtO2CCH2S) were prepd. by the cyclocondensation of the corresponding isothiocyanates or CS2 with ethanolamines or their sulfates.  I [R = H, R1 = 2-Me-4-ClC6H3NH (II)] was 33% as effective as octopamine at 100 μM in stimulating adenylate cyclase of Periplaneta americana ventral-nerve-cord homogenates.  Its activity was nonadditive to the activity of octopamine.  Stimulation of nerve-cord adenylate-cyclase activity by II was inhibited by several antagonists, including mianserin, cyproheptadine, chlorpromazine and gramine.  The rank-order ability of these antagonists to block the activation by II was identical to the rank-order ability of the same antagonists to block enzyme activation by octopamine.  The β-adrenergic antagonist propranolol was less potent.  These data suggest that II is a potent and selective agonist of octopamine-activated adenylate cyclase.  Aminothiazolines, which activated adenylate cyclase by 10-87% relative to octopamine also had acaricidal activity at 300 ppm, indicating a correlation between the in vitro octopaminergic-agonist activity and in vivo acaricidal activity of aminothiazolines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyepnJwRhIvLVg90H21EOLACvtfcHk0lh6gBQu5Zj1Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XmsVGq&md5=bc232025173db1f389b21b57fcd9df36</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1271%2Fbbb1961.55.2537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1271%252Fbbb1961.55.2537%26sid%3Dliteratum%253Aachs%26aulast%3DYoshii%26aufirst%3DY.%26aulast%3DEto%26aufirst%3DM.%26aulast%3DHirashima%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%25202-aminothiazolines%2520and%25202-mercaptothiazolines%2520as%2520octopaminergic%2520agonists%26jtitle%3DAgric.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D55%26spage%3D2537%26epage%3D2545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Kim, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cha, M.-H.</span><span> </span><span class="NLM_article-title">Efficient synthesis of 2-methylaminothiazolines via Mitsunobu reaction of <i>N</i>-(2-hydroxyethyl)-<i>N′</i>-methylthioureas</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">3125</span><span class="NLM_x">–</span> <span class="NLM_lpage">3128</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=3125-3128&author=T.+H.+Kimauthor=M.-H.+Cha&title=Efficient+synthesis+of+2-methylaminothiazolines+via+Mitsunobu+reaction+of+N-%282-hydroxyethyl%29-N%E2%80%B2-methylthioureas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DT.%2BH.%26aulast%3DCha%26aufirst%3DM.-H.%26atitle%3DEfficient%2520synthesis%2520of%25202-methylaminothiazolines%2520via%2520Mitsunobu%2520reaction%2520of%2520N-%25282-hydroxyethyl%2529-N%25E2%2580%25B2-methylthioureas%26jtitle%3DTetrahedron%2520Lett.%26date%3D1999%26volume%3D40%26spage%3D3125%26epage%3D3128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Fréchette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapointe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeannotte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradei, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouchain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeppel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudette, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisburg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trachy-Bourget, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, M.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delorme, D.</span><span> </span><span class="NLM_article-title">4-(Heteroarylaminomethyl)-<i>N</i>-(2-aminophenyl)-benzamides and their analogs as a novel class of histone deacetylase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1502</span><span class="NLM_x">–</span> <span class="NLM_lpage">1506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1502-1506&author=S.+Fr%C3%A9chetteauthor=S.+Leitauthor=S.+H.+Wooauthor=G.+Lapointeauthor=G.+Jeannotteauthor=O.+Moradeiauthor=I.+Paquinauthor=G.+Bouchainauthor=S.+Raeppelauthor=F.+Gaudetteauthor=N.+Zhouauthor=A.+Vaisburgauthor=M.+Fournelauthor=P.+T.+Yanauthor=M.-C.+Trachy-Bourgetauthor=A.+Kalitaauthor=M.-F.+Robertauthor=A.+Luauthor=J.+Rahilauthor=A.+R.+MacLeodauthor=J.+M.+Bestermanauthor=Z.+Liauthor=D.+Delorme&title=4-%28Heteroarylaminomethyl%29-N-%282-aminophenyl%29-benzamides+and+their+analogs+as+a+novel+class+of+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFr%25C3%25A9chette%26aufirst%3DS.%26aulast%3DLeit%26aufirst%3DS.%26aulast%3DWoo%26aufirst%3DS.%2BH.%26aulast%3DLapointe%26aufirst%3DG.%26aulast%3DJeannotte%26aufirst%3DG.%26aulast%3DMoradei%26aufirst%3DO.%26aulast%3DPaquin%26aufirst%3DI.%26aulast%3DBouchain%26aufirst%3DG.%26aulast%3DRaeppel%26aufirst%3DS.%26aulast%3DGaudette%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DVaisburg%26aufirst%3DA.%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DP.%2BT.%26aulast%3DTrachy-Bourget%26aufirst%3DM.-C.%26aulast%3DKalita%26aufirst%3DA.%26aulast%3DRobert%26aufirst%3DM.-F.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DMacLeod%26aufirst%3DA.%2BR.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DDelorme%26aufirst%3DD.%26atitle%3D4-%2528Heteroarylaminomethyl%2529-N-%25282-aminophenyl%2529-benzamides%2520and%2520their%2520analogs%2520as%2520a%2520novel%2520class%2520of%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1502%26epage%3D1506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Raeppel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudette, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larouche, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradei, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fréchette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakovic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delorme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trachy-Bourget, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besterman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisburg, A.</span><span> </span><span class="NLM_article-title">SAR and biological evaluation of analogues of a small histone deacetylase inhibitor <i>N</i>-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">644</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=644-649&author=S.+Raeppelauthor=N.+Zhouauthor=F.+Gaudetteauthor=S.+Leitauthor=I.+Paquinauthor=G.+Laroucheauthor=O.+Moradeiauthor=S.+Fr%C3%A9chetteauthor=L.+Isakovicauthor=D.+Delormeauthor=M.+Fournelauthor=A.+Kalitaauthor=A.+Luauthor=M.-C.+Trachy-Bourgetauthor=P.+T.+Yanauthor=J.+Liuauthor=J.+Rahilauthor=J.+Wangauthor=J.+M.+Bestermanauthor=K.+Murakamiauthor=Z.+Liauthor=A.+Vaisburg&title=SAR+and+biological+evaluation+of+analogues+of+a+small+histone+deacetylase+inhibitor+N-%282-aminophenyl%29-4-%28%284-%28pyridin-3-yl%29pyrimidin-2-ylamino%29methyl%29benzamide+%28MGCD0103%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaeppel%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DGaudette%26aufirst%3DF.%26aulast%3DLeit%26aufirst%3DS.%26aulast%3DPaquin%26aufirst%3DI.%26aulast%3DLarouche%26aufirst%3DG.%26aulast%3DMoradei%26aufirst%3DO.%26aulast%3DFr%25C3%25A9chette%26aufirst%3DS.%26aulast%3DIsakovic%26aufirst%3DL.%26aulast%3DDelorme%26aufirst%3DD.%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DKalita%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DTrachy-Bourget%26aufirst%3DM.-C.%26aulast%3DYan%26aufirst%3DP.%2BT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DVaisburg%26aufirst%3DA.%26atitle%3DSAR%2520and%2520biological%2520evaluation%2520of%2520analogues%2520of%2520a%2520small%2520histone%2520deacetylase%2520inhibitor%2520N-%25282-aminophenyl%2529-4-%2528%25284-%2528pyridin-3-yl%2529pyrimidin-2-ylamino%2529methyl%2529benzamide%2520%2528MGCD0103%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D644%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Moradei, O.; Paquin, I.; Leit, S.; Fréchette, S.; Vaisburg, A.; Besterman, J. M.; Tessier, P.; Mallais, T. C.</span><span> </span><span class="NLM_article-title">Inhibitors of Histone Deacetylase</span>. U.S. Patent 0307005<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>MethylGene Inc.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=O.+Moradei&author=I.+Paquin&author=S.+Leit&author=S.+Fr%C3%A9chette&author=A.+Vaisburg&author=J.+M.+Besterman&author=P.+Tessier&author=T.+C.+Mallais&title=Inhibitors+of+Histone+Deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMoradei%26aufirst%3DO.%26atitle%3DInhibitors%2520of%2520Histone%2520Deacetylase%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Kattar, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surdi, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabierek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Methot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlberg, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozerova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secrist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harsch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamill, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenific, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berk, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempest, P.</span><span> </span><span class="NLM_article-title">Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1168</span><span class="NLM_x">–</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1168-1172&author=S.+D.+Kattarauthor=L.+M.+Surdiauthor=A.+Zabierekauthor=J.+L.+Methotauthor=R.+E.+Middletonauthor=B.+Hughesauthor=A.+A.+Szewczakauthor=W.+K.+Dahlbergauthor=A.+M.+Kralauthor=N.+Ozerovaauthor=J.+C.+Flemingauthor=H.+Wangauthor=P.+Secristauthor=A.+Harschauthor=J.+E.+Hamillauthor=J.+C.+Cruzauthor=C.+M.+Kenificauthor=M.+Chenardauthor=T.+A.+Millerauthor=S.+C.+Berkauthor=P.+Tempest&title=Parallel+medicinal+chemistry+approaches+to+selective+HDAC1%2FHDAC2+inhibitor+%28SHI-1%3A2%29+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKattar%26aufirst%3DS.%2BD.%26aulast%3DSurdi%26aufirst%3DL.%2BM.%26aulast%3DZabierek%26aufirst%3DA.%26aulast%3DMethot%26aufirst%3DJ.%2BL.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DHughes%26aufirst%3DB.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DDahlberg%26aufirst%3DW.%2BK.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DOzerova%26aufirst%3DN.%26aulast%3DFleming%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DSecrist%26aufirst%3DP.%26aulast%3DHarsch%26aufirst%3DA.%26aulast%3DHamill%26aufirst%3DJ.%2BE.%26aulast%3DCruz%26aufirst%3DJ.%2BC.%26aulast%3DKenific%26aufirst%3DC.%2BM.%26aulast%3DChenard%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DT.%2BA.%26aulast%3DBerk%26aufirst%3DS.%2BC.%26aulast%3DTempest%26aufirst%3DP.%26atitle%3DParallel%2520medicinal%2520chemistry%2520approaches%2520to%2520selective%2520HDAC1%252FHDAC2%2520inhibitor%2520%2528SHI-1%253A2%2529%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1168%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Bieliauskas, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pflum, M. K. H.</span><span> </span><span class="NLM_article-title">Isoform-selective histone deacetylase inhibitors</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1402</span><span class="NLM_x">–</span> <span class="NLM_lpage">1413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1039%2Fb703830p" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=18568166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsFejsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2008&pages=1402-1413&author=A.+V.+Bieliauskasauthor=M.+K.+H.+Pflum&title=Isoform-selective+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-selective histone deacetylase inhibitors</span></div><div class="casAuthors">Bieliauskas, Anton V.; Pflum, Mary Kay H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1402-1413</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase (HDAC) proteins are transcription regulators linked to cancer.  As a result, multiple small mol. HDAC inhibitors are in various phases of clin. trials as anti-cancer drugs.  The majority of HDAC inhibitors non-selectively influence the activities of eleven human HDAC isoforms, which are divided into distinct classes.  This tutorial review focuses on the recent progress toward the identification of class-selective and isoform-selective HDAC inhibitors.  The emerging trends suggest that subtle differences in the active sites of the HDAC isoforms can be exploited to dictate selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXOB_YFWaeZrVg90H21EOLACvtfcHk0lj5ZkxuqPAx3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsFejsbs%253D&md5=326e20da0623a00114f43e5c459c9920</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2Fb703830p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb703830p%26sid%3Dliteratum%253Aachs%26aulast%3DBieliauskas%26aufirst%3DA.%2BV.%26aulast%3DPflum%26aufirst%3DM.%2BK.%2BH.%26atitle%3DIsoform-selective%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2008%26volume%3D37%26spage%3D1402%26epage%3D1413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Trott, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0lj5ZkxuqPAx3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luscombe, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, A. P.</span><span> </span><span class="NLM_article-title">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1016%2Fj.drudis.2011.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=21704184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=822-830&author=R.+J.+Youngauthor=D.+V.+S.+Greenauthor=C.+N.+Luscombeauthor=A.+P.+Hill&title=Getting+physical+in+drug+discovery+II%3A+the+impact+of+chromatographic+hydrophobicity+measurements+and+aromaticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span></div><div class="casAuthors">Young, Robert J.; Green, Darren V. S.; Luscombe, Christopher N.; Hill, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17/18</span>),
    <span class="NLM_cas:pages">822-830</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here, we review the performance of chromatog. hydrophobicity measurements in a data set of 100 000 GlaxoSmithKline compds., demonstrating the advantages of the method over octanol-water partitioning and highlighting new insights for drug discovery.  The value of chromatog. measurements, vs. other hydrophobicity ests., was supported by improved relationships with soly., permeation, cytochrome P450s, intrinsic clearance, hERG binding and promiscuity.  We also obsd. marked differentiation of the relative influence of intrinsic and effective hydrophobicity.  The summing of hydrophobicity values plus arom. ring count [log D pH7.4 (or log P) + #Ar], indicated a wide relevance for simplistic property forecast indexes' in developability assays, clearly enhanced by chromatog. values; therefore establishing new foundations for enriching property-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmIJyWi-DBW7Vg90H21EOLACvtfcHk0ljme28i_Ks2UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF&md5=22788603a45aa77537e8666433473d14</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DGreen%26aufirst%3DD.%2BV.%2BS.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DHill%26aufirst%3DA.%2BP.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%2520II%253A%2520the%2520impact%2520of%2520chromatographic%2520hydrophobicity%2520measurements%2520and%2520aromaticity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D822%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">–</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0ljme28i_Ks2UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Hill, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span> </span><span class="NLM_article-title">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1016%2Fj.drudis.2010.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=20570751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=648-655&author=A.+P.+Hillauthor=R.+J.+Young&title=Getting+physical+in+drug+discovery%3A+a+contemporary+perspective+on+solubility+and+hydrophobicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span></div><div class="casAuthors">Hill, Alan P.; Young, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15/16</span>),
    <span class="NLM_cas:pages">648-655</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Suboptimal phys. properties have been identified as a particular shortcoming of compds. in contemporary drug discovery, contributing to high attrition levels.  An anal. of the relationship between hydrophobicity (calcd. and measured) and ∼100 k measured kinetic soly. values has been undertaken.  In line with the General Soly. Equation, ests. of hydrophobicity, particularly ACD c log D pH7.4, give a useful indication of the likely soly. classification of particular mols.  Taking ACD c log D pH7.4 values together with the no. of arom. rings in a given mol. provides enhanced prediction.  The Soly. Forecast Index' (SFI = c log D pH7.4 + #Ar) is proposed as a simple, yet effective, guide to predicting soly.  Moreover, anal. of measured distribution/partition coeff. values highlighted statistically significant shortcomings in the applicability of octanol/water as a model system for hydrophobicity detn. with poorly sol. compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdtQyfNjbFUrVg90H21EOLACvtfcHk0lgrLEeuq4_pYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P&md5=7b201081c5586a6ea4b7af00d507d462</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DA.%2BP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%253A%2520a%2520contemporary%2520perspective%2520on%2520solubility%2520and%2520hydrophobicity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D648%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0lgrLEeuq4_pYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Chia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beamish, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jafferi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielli, B.</span><span> </span><span class="NLM_article-title">The histone deacetylase inhibitor MGCD0103 has both deacetylase and microtuble activity</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">436</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=436-443&author=K.+Chiaauthor=H.+Beamishauthor=K.+Jafferiauthor=B.+Gabrielli&title=The+histone+deacetylase+inhibitor+MGCD0103+has+both+deacetylase+and+microtuble+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChia%26aufirst%3DK.%26aulast%3DBeamish%26aufirst%3DH.%26aulast%3DJafferi%26aufirst%3DK.%26aulast%3DGabrielli%26aufirst%3DB.%26atitle%3DThe%2520histone%2520deacetylase%2520inhibitor%2520MGCD0103%2520has%2520both%2520deacetylase%2520and%2520microtuble%2520activity%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26spage%3D436%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Charrier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span> </span><span class="NLM_article-title">Synthesis of indoles: efficient functionalisation of the 7-position</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">3467</span><span class="NLM_x">–</span> <span class="NLM_lpage">3477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1055%2Fs-2006-950223" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=3467-3477&author=N.+Charrierauthor=E.+Demontauthor=R.+Dunsdonauthor=G.+Maileauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=P.+Theobaldauthor=D.+Veseyauthor=D.+Walter&title=Synthesis+of+indoles%3A+efficient+functionalisation+of+the+7-position"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-950223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-950223%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DN.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DP.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DD.%26atitle%3DSynthesis%2520of%2520indoles%253A%2520efficient%2520functionalisation%2520of%2520the%25207-position%26jtitle%3DSynthesis%26date%3D2006%26volume%3D2006%26spage%3D3467%26epage%3D3477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Ogino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtake, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagae, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanesaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitobe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwaasa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanatani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, T.</span><span> </span><span class="NLM_article-title">Syntheses and structure–activity relationships of novel, potent, and selective <i>trans</i>-2-[3-oxospiro[isobenzofuran-1(3<i>H</i>),1′-cyclohexan]-4′-yl]benzimidazole NPY Y5 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4997</span><span class="NLM_x">–</span> <span class="NLM_lpage">5001</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4997-5001&author=Y.+Oginoauthor=N.+Ohtakeauthor=Y.+Nagaeauthor=K.+Matsudaauthor=M.+Ishikawaauthor=M.+Moriyaauthor=M.+Kanesakaauthor=Y.+Mitobeauthor=J.+Itoauthor=T.+Kannoauthor=A.+Ishiharaauthor=H.+Iwaasaauthor=T.+Oheauthor=A.+Kanataniauthor=T.+Fukami&title=Syntheses+and+structure%E2%80%93activity+relationships+of+novel%2C+potent%2C+and+selective+trans-2-%5B3-oxospiro%5Bisobenzofuran-1%283H%29%2C1%E2%80%B2-cyclohexan%5D-4%E2%80%B2-yl%5Dbenzimidazole+NPY+Y5+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOgino%26aufirst%3DY.%26aulast%3DOhtake%26aufirst%3DN.%26aulast%3DNagae%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DK.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DMoriya%26aufirst%3DM.%26aulast%3DKanesaka%26aufirst%3DM.%26aulast%3DMitobe%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DJ.%26aulast%3DKanno%26aufirst%3DT.%26aulast%3DIshihara%26aufirst%3DA.%26aulast%3DIwaasa%26aufirst%3DH.%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DKanatani%26aufirst%3DA.%26aulast%3DFukami%26aufirst%3DT.%26atitle%3DSyntheses%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520novel%252C%2520potent%252C%2520and%2520selective%2520trans-2-%255B3-oxospiro%255Bisobenzofuran-1%25283H%2529%252C1%25E2%2580%25B2-cyclohexan%255D-4%25E2%2580%25B2-yl%255Dbenzimidazole%2520NPY%2520Y5%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4997%26epage%3D5001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Kerr, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read de Alaniz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovis, T.</span><span> </span><span class="NLM_article-title">An efficient synthesis of achiral and chiral 1,2,4-triazolium salts: bench stable precursors for N-heterocyclic carbenes</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">5725</span><span class="NLM_x">–</span> <span class="NLM_lpage">5728</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo050645n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVymtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=5725-5728&author=M.+S.+Kerrauthor=J.+Read+de+Alanizauthor=T.+Rovis&title=An+efficient+synthesis+of+achiral+and+chiral+1%2C2%2C4-triazolium+salts%3A+bench+stable+precursors+for+N-heterocyclic+carbenes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">An Efficient Synthesis of Achiral and Chiral 1,2,4-Triazolium Salts: Bench Stable Precursors for N-Heterocyclic Carbenes</span></div><div class="casAuthors">Kerr, Mark S.; Read de Alaniz, Javier; Rovis, Tomislav</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5725-5728</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A variety of 1,2,4-triazolium salts I (R1 = Ph, 4-F3CC6H4, C6F5; R2 = H, PhCH2; X = Cl, BF4) and II (R3 = Ph, 4-MeOC6H4, C6F5; Y = BF4) was synthesized as stable precursors for N-heterocyclic carbenes.  The reactions commence from com. available amino acids and proceed in 44-68% overall yields.  The 1,2,4-triazolium salts obtained are air-stable cryst. solids that can be stored with no special precaution and can generate the active catalyst when treated with an appropriate base.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJvKHyGW1A77Vg90H21EOLACvtfcHk0li7wo08QP14RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVymtb4%253D&md5=16fcdd58d923ebb82f4e754a2ea85b87</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjo050645n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo050645n%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DM.%2BS.%26aulast%3DRead%2Bde%2BAlaniz%26aufirst%3DJ.%26aulast%3DRovis%26aufirst%3DT.%26atitle%3DAn%2520efficient%2520synthesis%2520of%2520achiral%2520and%2520chiral%25201%252C2%252C4-triazolium%2520salts%253A%2520bench%2520stable%2520precursors%2520for%2520N-heterocyclic%2520carbenes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D5725%26epage%3D5728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Appleton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babcock, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copp, B. R.</span><span> </span><span class="NLM_article-title">Novel tryptophan-derived dipeptides and bioactive metabolites from the sea hare <i>Aplysia dactylomela</i></span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10181</span><span class="NLM_x">–</span> <span class="NLM_lpage">10189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=10181-10189&author=D.+R.+Appletonauthor=R.+C.+Babcockauthor=B.+R.+Copp&title=Novel+tryptophan-derived+dipeptides+and+bioactive+metabolites+from+the+sea+hare+Aplysia+dactylomela"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppleton%26aufirst%3DD.%2BR.%26aulast%3DBabcock%26aufirst%3DR.%2BC.%26aulast%3DCopp%26aufirst%3DB.%2BR.%26atitle%3DNovel%2520tryptophan-derived%2520dipeptides%2520and%2520bioactive%2520metabolites%2520from%2520the%2520sea%2520hare%2520Aplysia%2520dactylomela%26jtitle%3DTetrahedron%26date%3D2001%26volume%3D57%26spage%3D10181%26epage%3D10189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Pearson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chelliah, M. V.</span><span> </span><span class="NLM_article-title">Synthesis of a model bicyclic CDE ring system of ristocetin A and observation of a facile inversion of configuration in a 16-membered DE ring model</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">3087</span><span class="NLM_x">–</span> <span class="NLM_lpage">3098</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo980060b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=3087-3098&author=A.+J.+Pearsonauthor=M.+V.+Chelliah&title=Synthesis+of+a+model+bicyclic+CDE+ring+system+of+ristocetin+A+and+observation+of+a+facile+inversion+of+configuration+in+a+16-membered+DE+ring+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjo980060b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo980060b%26sid%3Dliteratum%253Aachs%26aulast%3DPearson%26aufirst%3DA.%2BJ.%26aulast%3DChelliah%26aufirst%3DM.%2BV.%26atitle%3DSynthesis%2520of%2520a%2520model%2520bicyclic%2520CDE%2520ring%2520system%2520of%2520ristocetin%2520A%2520and%2520observation%2520of%2520a%2520facile%2520inversion%2520of%2520configuration%2520in%2520a%252016-membered%2520DE%2520ring%2520model%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D3087%26epage%3D3098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Chandra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, D. K.</span><span> </span><span class="NLM_article-title">Design of photocleavable lipids and their application in liposomal “uncorking”</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_fpage">3021</span><span class="NLM_x">–</span> <span class="NLM_lpage">3023</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=3021-3023&author=B.+Chandraauthor=S.+Mallikauthor=D.+K.+Srivastava&title=Design+of+photocleavable+lipids+and+their+application+in+liposomal+%E2%80%9Cuncorking%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChandra%26aufirst%3DB.%26aulast%3DMallik%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DD.%2BK.%26atitle%3DDesign%2520of%2520photocleavable%2520lipids%2520and%2520their%2520application%2520in%2520liposomal%2520%25E2%2580%259Cuncorking%25E2%2580%259D%26jtitle%3DChem.%2520Commun.%26date%3D2005%26spage%3D3021%26epage%3D3023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Petasis, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, Z. D.</span><span> </span><span class="NLM_article-title">Synthesis of piperazinones and benzopiperazinones from 1,2-diamines and organoboronic acids</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">9607</span><span class="NLM_x">–</span> <span class="NLM_lpage">9611</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=9607-9611&author=N.+A.+Petasisauthor=Z.+D.+Patel&title=Synthesis+of+piperazinones+and+benzopiperazinones+from+1%2C2-diamines+and+organoboronic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetasis%26aufirst%3DN.%2BA.%26aulast%3DPatel%26aufirst%3DZ.%2BD.%26atitle%3DSynthesis%2520of%2520piperazinones%2520and%2520benzopiperazinones%2520from%25201%252C2-diamines%2520and%2520organoboronic%2520acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D9607%26epage%3D9611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Suzuki, T.; Ando, T.; Tsuchiya, K.; Nakanishi, O.; Saito, A.; Yamashita, T.; Shiraishi, Y.; Tanaka, E.</span><span> </span><span class="NLM_article-title">Cell Differentiation Inducer</span>. U.S. Patent 6174905,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">; </span>Mitsui Chemicals Inc.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=T.+Suzuki&author=T.+Ando&author=K.+Tsuchiya&author=O.+Nakanishi&author=A.+Saito&author=T.+Yamashita&author=Y.+Shiraishi&author=E.+Tanaka&title=Cell+Differentiation+Inducer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DCell%2520Differentiation%2520Inducer%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Humljan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, S.</span><span> </span><span class="NLM_article-title">Synthesis of <i>N</i>-phthalimido β-aminoethanesulfonyl chlorides: the use of thionyl chloride for a simple and efficient synthesis of new peptidosulfonamide building blocks</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4069</span><span class="NLM_x">–</span> <span class="NLM_lpage">4072</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=4069-4072&author=J.+Humljanauthor=S.+Gobec&title=Synthesis+of+N-phthalimido+%CE%B2-aminoethanesulfonyl+chlorides%3A+the+use+of+thionyl+chloride+for+a+simple+and+efficient+synthesis+of+new+peptidosulfonamide+building+blocks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHumljan%26aufirst%3DJ.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520N-phthalimido%2520%25CE%25B2-aminoethanesulfonyl%2520chlorides%253A%2520the%2520use%2520of%2520thionyl%2520chloride%2520for%2520a%2520simple%2520and%2520efficient%2520synthesis%2520of%2520new%2520peptidosulfonamide%2520building%2520blocks%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D4069%26epage%3D4072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">McKennon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drauz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarm, M.</span><span> </span><span class="NLM_article-title">A convenient reduction of amino acids and their derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3568</span><span class="NLM_x">–</span> <span class="NLM_lpage">3571</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00065a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADyaK3sXksV2rtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=3568-3571&author=M.+J.+McKennonauthor=A.+I.+Meyersauthor=K.+Drauzauthor=M.+Schwarm&title=A+convenient+reduction+of+amino+acids+and+their+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient reduction of amino acids and their derivatives</span></div><div class="casAuthors">McKennon, Marc J.; Meyers, A. I.; Drauz, Karlheinz; Schwarm, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3568-71</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Amino acids were reduced by NaBH4 in the presence of iodine to give the corresponding amino alcs.  Thus, amino acids I (R = CMe3, CHMe2, CH2Ph, CHEtMe, CH2CH2SMe, C6H4OH-4) were reduced by NaBH4-iodine in THF to give amino alcs. II.  N-acyl amino acids III [R = CH2Ph, R1 = H, R2 = H, Me; RR1 = (CH2)3 R2 = Me; R = R1 = H, R2 = Ph] were also reduced by NaBH4-iodine in THF to give N-acyl amino alcs. IV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnnqE3R204brVg90H21EOLACvtfcHk0lgmD1n7wJ_Lcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksV2rtL8%253D&md5=d79a74af1c20e79ceee5c61ed977bccb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjo00065a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00065a020%26sid%3Dliteratum%253Aachs%26aulast%3DMcKennon%26aufirst%3DM.%2BJ.%26aulast%3DMeyers%26aufirst%3DA.%2BI.%26aulast%3DDrauz%26aufirst%3DK.%26aulast%3DSchwarm%26aufirst%3DM.%26atitle%3DA%2520convenient%2520reduction%2520of%2520amino%2520acids%2520and%2520their%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1993%26volume%3D58%26spage%3D3568%26epage%3D3571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span> </span><span class="NLM_article-title">A versatile synthesis of various substituted taurines from vicinal amino alcohols and aziridines</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">5841</span><span class="NLM_x">–</span> <span class="NLM_lpage">5846</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2009&publication_year=2009&pages=5841-5846&author=N.+Chenauthor=W.+Jiaauthor=J.+Xu&title=A+versatile+synthesis+of+various+substituted+taurines+from+vicinal+amino+alcohols+and+aziridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DN.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DA%2520versatile%2520synthesis%2520of%2520various%2520substituted%2520taurines%2520from%2520vicinal%2520amino%2520alcohols%2520and%2520aziridines%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2009%26volume%3D2009%26spage%3D5841%26epage%3D5846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Nasim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P. A.</span><span> </span><span class="NLM_article-title">Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in culture</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4879</span><span class="NLM_x">–</span> <span class="NLM_lpage">4883</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4879-4883&author=S.+Nasimauthor=M.+L.+Guzmanauthor=C.+T.+Jordanauthor=P.+A.+Crooks&title=Discovery+of+1%2C2%2C4-thiadiazolidine-3%2C5-dione+analogs+that+exhibit+unusual+and+selective+rapid+cell+death+kinetics+against+acute+myelogenous+leukemia+cells+in+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNasim%26aufirst%3DS.%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DJordan%26aufirst%3DC.%2BT.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%25201%252C2%252C4-thiadiazolidine-3%252C5-dione%2520analogs%2520that%2520exhibit%2520unusual%2520and%2520selective%2520rapid%2520cell%2520death%2520kinetics%2520against%2520acute%2520myelogenous%2520leukemia%2520cells%2520in%2520culture%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4879%26epage%3D4883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Hoffman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brosch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loidl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">First non-radioactive assay for in vitro screening of histone deacetylase inhibitors</span> <span class="citation_source-journal">Pharmazie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2000&pages=601-606&author=K.+Hoffmanauthor=G.+Broschauthor=P.+Loidlauthor=M.+Jung&title=First+non-radioactive+assay+for+in+vitro+screening+of+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DK.%26aulast%3DBrosch%26aufirst%3DG.%26aulast%3DLoidl%26aufirst%3DP.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DFirst%2520non-radioactive%2520assay%2520for%2520in%2520vitro%2520screening%2520of%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DPharmazie%26date%3D2000%26volume%3D55%26spage%3D601%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Wegener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirsching, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riester, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwienhorst, A.</span><span> </span><span class="NLM_article-title">A fluorogenic histone deacetylase assay well suited for high-throughput activity screening</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1016%2FS1074-5521%2802%2900305-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=12573699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1Skuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=61-68&author=D.+Wegenerauthor=F.+Wirschingauthor=D.+Riesterauthor=A.+Schwienhorst&title=A+fluorogenic+histone+deacetylase+assay+well+suited+for+high-throughput+activity+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A Fluorogenic Histone Deacetylase Assay Well Suited for High-Throughput Activity Screening</span></div><div class="casAuthors">Wegener, Dennis; Wirsching, Frank; Riester, Daniel; Schwienhorst, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-68</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are important enzymes for the transcriptional regulation of gene expression in eukaryotic cells.  Recent findings suggest that HDACs could be key targets for chemotherapeutic intervention in malignant diseases.  A convenient and sensitive fluorogenic assay for HDAC activity would therefore expedite studies of HDAC in transcriptional regulation and in vitro screening for drug discovery.  In this study, novel fluorogenic substrates of HDACs were synthesized with an ε-acetylated lysyl moiety and an adjacent MCA moiety at the C terminus of the peptide chain.  Upon deacetylation of the acetylated lysyl moiety, mols. became substrates for trypsin, which released highly fluorescent AMC mols. in a subsequent step of the assay.  The fluorescence increased in direct proportion to the amt. of deacetylated substrate mols., i.e., HDAC activity.  The nonisotopic, homogeneous assay is well suited for high-throughput HDAC inhibitor screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5ogyqEBSC3bVg90H21EOLACvtfcHk0lgmD1n7wJ_Lcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1Skuw%253D%253D&md5=eea350d8066f6ebd773ba50cc0211fdc</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2802%2900305-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252802%252900305-8%26sid%3Dliteratum%253Aachs%26aulast%3DWegener%26aufirst%3DD.%26aulast%3DWirsching%26aufirst%3DF.%26aulast%3DRiester%26aufirst%3DD.%26aulast%3DSchwienhorst%26aufirst%3DA.%26atitle%3DA%2520fluorogenic%2520histone%2520deacetylase%2520assay%2520well%2520suited%2520for%2520high-throughput%2520activity%2520screening%26jtitle%3DChem.%2520Biol.%26date%3D2003%26volume%3D10%26spage%3D61%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Lea, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mufti, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, N. S. B.</span><span> </span><span class="NLM_article-title">Commitment, point during Go to G1 that controls entry into the cell cycle</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2351</span><span class="NLM_x">–</span> <span class="NLM_lpage">2361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm400634n&amp;key=10.1128%2FMCB.23.7.2351-2361.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm400634n&amp;key=12640120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm400634n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFensbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=2351-2361&author=N.+C.+Leaauthor=S.+J.+Orrauthor=K.+Stoeberauthor=G.+H.+Williamsauthor=E.+W.+Lamauthor=M.+A.+Ibrahimauthor=G.+J.+Muftiauthor=N.+S.+B.+Thomas&title=Commitment%2C+point+during+Go+to+G1+that+controls+entry+into+the+cell+cycle"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Commitment point during G0→G1 that controls entry into the cell cycle</span></div><div class="casAuthors">Lea, Nicholas C.; Orr, Stephen J.; Stoeber, Kai; Williams, Gareth H.; Lam, Eric W.-F.; Ibrahim, Mohammad A. A.; Mufti, Ghulam J.; Thomas, N. Shaun B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2351-2361</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Initiation of T-lymphocyte-mediated immune responses involves two cellular processes: entry into the cell cycle (G0→G1) for clonal proliferation and coordinated changes in surface and secreted mols. that mediate effector functions.  However, a point during G0→G1 beyond which T cells are committed to enter the cell cycle has not been defined.  We define here a G0→G1 commitment point that occurs 3 to 5 h after CD3 and CD28 stimulation of human CD4 or CD8 T cells.  Transition through this point requires cdk6/4-cyclin D, since inhibition with TAT-p16INK4A during the first 3 to 5 h prevents cell cycle entry and maintains both naive and memory T cells in G0.  Transition through the G0→G1 commitment point is also necessary for T cells to increase in size, i.e., to enter the cellular growth cycle.  However, transition through this point is not required for the induction of effector functions.  These can be initiated while cells are maintained in G0 with TAT-p16INK4A.  We have termed this quiescent, activated state G0(A).  Our data provide proof of the principle that entry of T cells into the cell cycle and cellular growth cycles are coupled at the G0→G1 commitment point but that these processes can be uncoupled from the early expression of mols. of effector functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWTDtobHcVrbVg90H21EOLACvtfcHk0lj5sTRx6Qepcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFensbs%253D&md5=458dfd0326c14bbc5d41f67112da20f7</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.7.2351-2361.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.7.2351-2361.2003%26sid%3Dliteratum%253Aachs%26aulast%3DLea%26aufirst%3DN.%2BC.%26aulast%3DOrr%26aufirst%3DS.%2BJ.%26aulast%3DStoeber%26aufirst%3DK.%26aulast%3DWilliams%26aufirst%3DG.%2BH.%26aulast%3DLam%26aufirst%3DE.%2BW.%26aulast%3DIbrahim%26aufirst%3DM.%2BA.%26aulast%3DMufti%26aufirst%3DG.%2BJ.%26aulast%3DThomas%26aufirst%3DN.%2BS.%2BB.%26atitle%3DCommitment%252C%2520point%2520during%2520Go%2520to%2520G1%2520that%2520controls%2520entry%2520into%2520the%2520cell%2520cycle%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D2351%26epage%3D2361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A69" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A69','PDB','4A69'); return false;">PDB: 4A69</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i70"><a href="/doi/suppl/10.1021/jm400634n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_00107"></div></div></div></div></div><hr /></hr><p class="last">Synthesis and characterization of <b>2b</b>, <b>3</b>, <b>4</b>, <b>8a</b>, <b>8b</b>, <b>8e</b>–<b>i</b>, and <b>31</b>; experimental procedure for determination of the Michaelis–Menten constant <i>K</i><sub>m</sub> for MAL; profiles of the preincubation of HDAC3-NCoR1 and HDAC8 with mocetinostat; HDAC inhibition assay using a progression method and results. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400634n/suppl_file/jm400634n_si_001.pdf">jm400634n_si_001.pdf (1.08 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400634n&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-15%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm400634n%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400634n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679973ecaff63d48","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
